<!DOCTYPE html>

<html lang="en">


<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
      
        <link rel="prev" href="../Immunology/">
      
      
      
      <link rel="icon" href="../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.5.3, mkdocs-material-9.5.12">
    
    
<title>Literature Survey (VPE)</title>

    
      <link rel="stylesheet" href="../assets/stylesheets/main.7e359304.min.css">
      
        
        <link rel="stylesheet" href="../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
  <!-- Add scripts that need to run before here -->
  <!-- Add jquery script -->
  <script src="https://code.jquery.com/jquery-3.7.1.js"></script>
  <!-- Add data table libraries -->
  <script src="https://cdn.datatables.net/2.0.1/js/dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/2.0.1/css/dataTables.dataTables.css">
  <!-- Load plotly.js into the DOM -->
	<script src='https://cdn.plot.ly/plotly-2.29.1.min.js'></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/buttons/3.0.1/css/buttons.dataTables.css">
  <!-- fixedColumns -->
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/dataTables.fixedColumns.js"></script>
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/fixedColumns.dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/fixedcolumns/5.0.0/css/fixedColumns.dataTables.css">
  <!-- Already specified in mkdocs.yml -->
  <!-- <link rel="stylesheet" href="../docs/custom.css"> -->
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/dataTables.buttons.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.dataTables.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.10.1/jszip.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/pdfmake.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/vfs_fonts.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.html5.min.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.print.min.js"></script>
  <!-- Google fonts -->
  <link rel="stylesheet" href="https://fonts.googleapis.com/icon?family=Material+Icons">
  <!-- Intro.js -->
  <script src="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/intro.min.js"></script>
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/minified/introjs.min.css">


  <!-- 
      
     -->
  <!-- Add scripts that need to run afterwards here -->

    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../assets/_mkdocstrings.css">
    
      <link rel="stylesheet" href="../custom.css">
    
    <script>__md_scope=new URL("..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href=".." title="Literature Survey for Swathi" class="md-header__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Literature Survey for Swathi
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Oncology
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header__source">
        <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
    <li class="md-tabs__item">
      <a href=".." class="md-tabs__link">
        
  
    
  
  Home

      </a>
    </li>
  

      
        
  
  
  
    <li class="md-tabs__item">
      <a href="../Immunology/" class="md-tabs__link">
        
  
    
  
  Immunology

      </a>
    </li>
  

      
        
  
  
    
  
  
    <li class="md-tabs__item md-tabs__item--active">
      <a href="./" class="md-tabs__link">
        
  
    
  
  Oncology

      </a>
    </li>
  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
                
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" hidden>
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href=".." title="Literature Survey for Swathi" class="md-nav__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    Literature Survey for Swathi
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href=".." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../Immunology/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Immunology
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Oncology
  </span>
  

      </a>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
                
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  

  
  


  <h1>Oncology</h1>

<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
</head>

<body>
  <p>
  <i class="footer">This page was last updated on 2025-11-10 09:21:49 UTC</i>
  </p>

  <div class="note info" onclick="startIntro()">
    <p>
      <button type="button" class="buttons">
        <div style="display: flex; align-items: center;">
        Click here for a quick intro of the page! <i class="material-icons">help</i>
        </div>
      </button>
    </p>
  </div>

  <!--
  <div data-intro='Table of contents'>
    <p>
    <h3>Table of Contents</h3>
      <a href="#plot1">1. Citations over time on Oncology</a><br>
      <a href="#manually_curated_articles">2. Manually curated articles on Oncology</a><br>
      <a href="#recommended_articles">3. Recommended articles on Oncology</a><br>
    <p>
  </div>

  <div data-intro='Plot displaying number of citations over time 
                  on the given topic based on recommended articles'>
    <p>
    <h3 id="plot1">1. Citations over time on Oncology</h3>
      <div id='myDiv1'>
      </div>
    </p>
  </div>
  -->

  <div data-intro='Manually curated articles on the given topic'>
    <p>
    <h3 id="manually_curated_articles">Manually curated articles on <i>Oncology</i></h3>
    <table id="table1" class="display" style="width:100%">
    <thead>
      <tr>
          <th data-intro='Click to view the abstract (if available)'>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th data-intro='Highest h-index among the authors'>Highest h-index</th>
          <th data-intro='Recommended articles extracted by considering
                          only the given article'>
              View recommendations
              </th>
      </tr>
    </thead>
    <tbody>

        <tr id="Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis1. Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells2. However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Complex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system3. Blocking mitochondrial complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in vivo in an animal disease model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf" target='_blank'>
                Mitochondrial complex I activity in microglia sustains neuroinflammation
                </a>
              </td>
          <td>
            L. Peruzzotti-Jametti, C. Willis, G. Krzak, R. Hamel, L. Pirvan, Rosana-Bristena Ionescu, J. Reisz, H. Prag, M. E. Garcia-Segura, V. Wu, Y. Xiang, B. Barlas, A. Casey, A. van den Bosch, A. Nicaise, L. Roth, G. R. Bates, H. Huang, P. Prasad, A. E. Vincent, C. Frezza, C. Viscomi, G. Balmus, Z. Takáts, J. Marioni, A. D'alessandro, M. P. Murphy, I. Mohorianu, S. Pluchino
          </td>
          <td>2024-03-13</td>
          <td>Nature</td>
          <td>118</td>
          <td>31</td>

            <td><a href='../recommendations/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

        <tr id="The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited1. Here in our SARS-CoV-2 human challenge study, we used single-cell multi-omics profiling of nasopharyngeal swabs and blood to temporally resolve abortive, transient and sustained infections in seronegative individuals challenged with pre-Alpha SARS-CoV-2. Our analyses revealed rapid changes in cell-type proportions and dozens of highly dynamic cellular response states in epithelial and immune cells associated with specific time points and infection status. We observed that the interferon response in blood preceded the nasopharyngeal response. Moreover, nasopharyngeal immune infiltration occurred early in samples from individuals with only transient infection and later in samples from individuals with sustained infection. High expression of HLA-DQA2 before inoculation was associated with preventing sustained infection. Ciliated cells showed multiple immune responses and were most permissive for viral replication, whereas nasopharyngeal T cells and macrophages were infected non-productively. We resolved 54 T cell states, including acutely activated T cells that clonally expanded while carrying convergent SARS-CoV-2 motifs. Our new computational pipeline Cell2TCR identifies activated antigen-responding T cells based on a gene expression signature and clusters these into clonotype groups and motifs. Overall, our detailed time series data can serve as a Rosetta stone for epithelial and immune cell responses and reveals early dynamic responses associated with protection against infection. A human SARS-CoV-2 challenge study in individuals without previous exposure to the virus or vaccines provides detailed profiles of local and systemic epithelial and immune cell response dynamics over time and infection status.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/380489b0c6f9106219184f0c5fe6612e0b4e165a" target='_blank'>
                Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
                </a>
              </td>
          <td>
            Rik G. H. Lindeboom, Kaylee B. Worlock, L. Dratva, M. Yoshida, David Scobie, Helen R. Wagstaffe, Laura Richardson, A. Wilbrey-Clark, Josephine L. Barnes, Lorenz Kretschmer, K. Polański, J. Allen-Hyttinen, Puja Mehta, D. Sumanaweera, J. M. Boccacino, W. Sungnak, R. Elmentaite, Ni Huang, L. Mamanova, R. Kapuge, L. Bolt, E. Prigmore, B. Killingley, M. Kalinova, Maria Mayer, A. Boyers, Alex J. Mann, Leo Swadling, M. Woodall, Samuel Ellis, Claire M. Smith, V. Teixeira, Sam M. Janes, R. Chambers, M. Haniffa, A. Catchpole, R. Heyderman, M. Noursadeghi, Benjamin M. Chain, Andreas Mayer, Kerstin B. Meyer, Christopher Chiu, Marko Z. Nikolić, Sarah A. Teichmann
          </td>
          <td>2024-06-19</td>
          <td>Nature</td>
          <td>68</td>
          <td>75</td>

            <td><a href='../recommendations/380489b0c6f9106219184f0c5fe6612e0b4e165a' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
          <th>View recommendations</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

  <div data-intro='Recommended articles extracted by contrasting
                  articles that are relevant against not relevant for Oncology'>
    <p>
    <h3 id="recommended_articles">Recommended articles on <i>Oncology</i></h3>
    <table id="table2" class="display" style="width:100%">
    <thead>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </thead>
    <tbody>

        <tr id="CNS infection by HIV-1 contributes to neuroinflammation, cognitive impairments, and the establishment of viral reservoirs. Although HIV-1 is known to enter the brain early in infection via “Trojan horse” leukocytes, including infected monocytes and CD4⁺ T cells, the specific cellular phenotypes facilitating this process during acute infection remain incompletely characterized. This study aims to characterize the roles of brain lymphocytes during acute infection and primary CD4 + T cell phenotypes seeding the SIV to the CNS. scRNA-seq was performed on brain and blood cells of three acutely SIV-infected rhesus macaques. The transcriptomic data were analyzed using bioinformatics approaches and validated through in vitro co-culture assays and re-analysis of a publicly available scRNA-seq dataset. scRNA-seq of brain and blood immune cells from acutely SIV-infected rhesus macaques revealed an expansion of proliferating CD4⁺ cytotoxic T lymphocytes (CTLs) in the blood, characterized by high CD4, CCR5, and adhesion molecule expression, indicating strong potential for CNS infiltration. In the brain, CD4⁺ CTLs, tissue-resident memory cells, and a unique Myeloid–T cell cluster were enriched for SIV⁺ cells. Integration of brain and blood data revealed transcriptomic maturation of CD4⁺ CTLs upon brain entry. To validate the biological relevance of the Myeloid–T cluster, we used a macrophage–T cell co-culture system, which reproduced similar dual-marker expression and identified chemokines (e.g., CCL3, CCL4) as potential markers of T cell–myeloid cell interaction. Our findings suggest that CD4⁺ cytotoxic-like T cells represent a key lymphocyte subset responsible for initiating SIV entry into the brain and triggering neuroinflammatory processes. Furthermore, interactions between infiltrating lymphocytes and brain-resident myeloid cells, potentially through chemokine signaling, may facilitate viral propagation within the CNS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/72fbfac68579326979ef04a1dc07549f993cb4aa" target='_blank'>
              T cell-mediated SIV dissemination into the CNS: a single-cell transcriptomic analysis
              </a>
            </td>
          <td>
            Xiaoke Xu, Meng Niu, Benjamin G. Lamberty, Kathleen M. Emanuel, L. D. Estrella, Howard S. Fox
          </td>
          <td>2025-10-08</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79890359565389b73c061b8b182c8a9f91a90fcd" target='_blank'>
              Mechanisms of sex differences in acute and long COVID sequelae in mice
              </a>
            </td>
          <td>
            Jennifer A. Liu, Sabal Chaulagain, Patrick S. Creisher, Weizhi Zhong, Tianle Zhang, Maraake Taddese, Karly Shi, Han-sol Park, Haley Hcnir, Arthur P. Arnold, Ralph S. Baric, Natasha B Barahona, Elizabeth Engler-Chiurazzi, Kevin J. Zwezdaryk, Chloe L. Thio, A. Balagopal, J.R. Harkema, Elizabeth A. Thompson, A. Pekosz, Andrea L Cox, S. Klein
          </td>
          <td>2025-10-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is an autoimmune and neuroinflammation disease characterized by axonal damage, inflammatory demyelination, and neurodegeneration. However, the precise mechanisms underlying MS pathogenesis remain largely unclear. Here, we identify ZNRF1, an E3 ubiquitin ligase, as a critical regulator of experimental autoimmune encephalomyelitis (EAE), a murine model that recapitulates the autoimmune demyelination features of MS. Mice lacking ZNRF1 exhibit increased susceptibility to EAE progression. Notably, ZNRF1 depletion in peripheral myeloid cells, but not in microglia, leads to enhanced immune cell infiltration into the central nervous system, resulting in demyelination and exacerbated disease severity. The heightened EAE severity in Znrf1-deficient mice is associated with increased polarization of Th1 and Th17 cells, elevated antigen-specific T helper cell proliferation, and amplified immune responses. Furthermore, following EAE induction, macrophages from Znrf1-deficient mice display elevated surface expression of MHC class II (MHC-II) molecules. Collectively, our findings suggest that ZNRF1 in peripheral myeloid cells plays a suppressive role in neuroinflammation by regulating MHC-II surface expression, thereby controlling antigen-specific T-cell proliferation and activation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f962a55325851d781ba99d1de0343d57aac16244" target='_blank'>
              Myeloid ZNRF1 suppresses autoimmune demyelination and neuroinflammation by regulating MHC-II-mediated T cell activation
              </a>
            </td>
          <td>
            Yung-Chi Chang, Ching-Chih Wu, Fu-Ting Hsiao, You-Sheng Lin, Ting-Yu Lai, Kang-Hsuan Huang, Shiue-Cheng Tang, Chih-Yuan Lee, Shen-Ju Chou, Li-Chung Hsu
          </td>
          <td>2025-10-22</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Aberrant and sustained activation of microglia is implicated in the progression and severity of multiple sclerosis (MS). However, whether intrinsic alterations in microglial function impact the pathogenesis of this disease remains unclear. We conducted transcriptomic and functional analyses of microglia-like cells (iMGLs) differentiated from induced pluripotent stem cells (iPSCs) from patients with MS (pwMS) to answer this question. We generated iPSCs from six pwMS showing increased microglial activity via translocator protein (TSPO)-PET imaging. We demonstrated that the differentiated iMGL transcriptional profile resembled the microglial signature found in MS lesions. Importantly, compared with healthy controls, MS iMGLs presented cell-autonomous differences in their regulation of inflammation, both in the basal state and following inflammatory lipopolysaccharide challenge. Through transcriptomic profiling, we showed that MS iMGLs display increased expression of genes known to be upregulated in MS microglia. Furthermore, upregulated genes in MS iMGLs were associated with immune receptor activation, antigen presentation, and the complement system, with known MS implications. Finally, functional analyses indicated that the transcriptional changes in MS iMGLs corresponded with alterations in the secretion of inflammatory cytokines and chemokines and increased phagocytosis. Together, our results provide evidence of putative cell-autonomous microglial activation in pwMS and identify transcriptomic and functional changes that recapitulate the phenotypes observed in vivo in microglia from pwMS. These findings indicate that MS disease-specific iPSCs are valuable tools for studying disease-specific microglial activation in vitro and highlight microglia as potential therapeutic targets in MS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ce483627b1620ca8e2ea90bf499e8cad452ba523" target='_blank'>
              Microglia from patients with multiple sclerosis display a cell-autonomous immune activation state
              </a>
            </td>
          <td>
            Tanja Hyvärinen, J. Lotila, Luca Giudice, Iisa Tujula, M. Nylund, S. Ohtonen, Flavia Scoyni, Henna Jäntti, Sara Pihlava, H. Skottman, Susanna Narkilahti, L. Airas, T. Malm, S. Hagman
          </td>
          <td>2024-12-11</td>
          <td>Journal of Neuroinflammation</td>
          <td>2</td>
          <td>47</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fa0d09c722147bd759ef9cedc307b8c6a5fb7718" target='_blank'>
              Caspase-11 Mediated Hyperinflammation Impairs CD8⁺ T Cell Immunity and Viral Clearance in Severe SARS-CoV-2 Infection
              </a>
            </td>
          <td>
            Mostafa Eltobgy, Mohamed M. Shamseldin, Owen Whitham, Heba M Amer, Jeffery Atkinson, Asmaa Badr, Jesse Hall, Jihad Omran, Gauruv A. Gupta, Yara Hassan, Rabab Abdelaleem, Richard Perez, Sarah Faber, Maciej Pietrzak, Amy Webb, Xiaoli Zhang, A. Kenney, Destiny Bissel, Shady Z K Estfanous, Kylene P. Daily, Andrew Mcnamara, K. Mahesh, M. Peeples, Emily A. Hemann, Shahid M. Nimjee, E. Cormet-Boyaka, Jianrong Li, P. Boyaka, Jacob S. Yount, Benjamin M. Segal, Purnima Dubey, Amal O Amer
          </td>
          <td>2025-11-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="In multiple sclerosis (MS), chronic compartmentalized inflammation is thought to drive relentless clinical deterioration. Here, we investigate the link between unresolved parenchymal inflammation and cellular senescence in MS progression. Single-cell transcriptomic analysis of human brain tissue reveals an accumulation of senescent-like glial cells in diseased white matter, especially in chronic active lesions, and to a lesser extent in the cortex. Spatial transcriptomics show gradients of senescence-like signatures extending from lesion cores to periplaque regions, alongside rewired cellular networks. Experimental induction of senescence in MS hiPSC-derived neural organoids demonstrates that microglia are especially vulnerable to inflammation-induced senescence, which can be partially rescued by CNS-penetrant anti-inflammatory drugs. At the patient level (n = 466), increased 3T MRI-estimated brain-age is observed, especially in individuals with more than four chronic active lesions. These findings suggest that chronic inflammation might accelerate senescence-like processes, potentially contributing to disease progression, and that its modulation might help limit further propagation. In multiple sclerosis, smoldering inflammation contributes to clinical progression. Using multi-omics data, here the authors link chronic inflammation to senescence-like processes and cellular network changes, suggesting a potential therapeutic target.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b77d9523c82f1187be87e3bd2154d78aa2798954" target='_blank'>
              Spatially-restricted inflammation-induced senescent-like glia in multiple sclerosis and patient-derived organoids
              </a>
            </td>
          <td>
            Francesca Fagiani, Edoardo Pedrini, Maria Sofia Martire, Gaia Gastoldi, Colin Vanden Bulcke, Jing-Ping Lin, Dragan Maric, Elena Brambilla, F. Ruffini, Carolina Peri, P. Calabresi, Pietro Maggi, Paola Panina-Bordignon, Gianvito Martino, D. Reich, Martina Absinta
          </td>
          <td>2025-09-26</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e1f062d3d912692ad94fd023b7389eaa8ae74fd9" target='_blank'>
              Temporal Dynamics of Antigen-Specific T Cell Expansion in Primary SARS-CoV-2 Infection
              </a>
            </td>
          <td>
            Andrew Pyo, Adlina Chan, J. Rosenheim, Clare Thakker, Lucy Bell, Gayathrie Nageswaran, Suzanne Byrne, Ben Killingley, David Scobie, M. Kalinova, A. Boyers, A. Catchpole, Alex J. Mann, Rik G. H. Lindeboom, Marko Z. Nikolić, Sarah A. Teichmann, H. Wagstaffe, M. Noursadeghi, Christopher Chiu, Curtis G. Callan, Andreas Tiffeau-Mayer, N. Wingreen, Benjamin M. Chain
          </td>
          <td>2025-11-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>79</td>
        </tr>

        <tr id="The importance of astrocytes for Alzheimer’s disease (AD) pathology is increasingly appreciated, yet the mechanisms whereby this cell type impacts neurodegenerative processes remain elusive. Here we show that, in a genetic mouse model with diminished astrocyte stress response, even low levels of amyloid-β trigger astrocyte reactivity, resulting in brain inflammation and massive amyloid and tau pathologies. This dysfunctional response of astrocytes to amyloid-β acts through activation of δ secretase, a stress-induced protease implicated in both amyloid and tau-related proteolytic processing. Our findings identify a failed astrocyte stress response to amyloid-β as an early inducer of amyloid and tau co-morbidity, a noxious process in AD acting through a non-canonical secretase pathway. The role of astrocytes in Alzheimer’s disease pathology remains insufficiently characterized. Here, the authors show that aggravated astrocyte response to Aβ causes brain inflammation, and amyloid and tau co-morbidity, driven by aberrant induction of δ secretase.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2052efa29c380e9e8e0affc372e65ce6d25d12f3" target='_blank'>
              Astrocytes distress triggers brain pathology through induction of δ secretase in a murine model of Alzheimer’s disease
              </a>
            </td>
          <td>
            Vanessa Schmidt, E. Ziemlińska, Tomasz Obrebski, Jemila P Gomes, Ewa Zurawska-Plaksej, J. Cendrowski, Johan Palmfeldt, Barbara L. Hempstead, Thomas E. Willnow, Anna R. Malik
          </td>
          <td>2025-10-31</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d74835f8e845ea18beb20340e5bd3f281ac019ce" target='_blank'>
              Tonic type I interferon signaling optimizes the antiviral function of plasmacytoid dendritic cells
              </a>
            </td>
          <td>
            Joseph N. Pucella, Raul A Maqueda-Alfaro, Hai Ni, Fernando Bandeira Sulczewski, Anna Eichinger, E. Esteva, Ai C Ra, Annesa Das, Oriana A. Perez, Jue Feng, Marlon Stoeckius, Peter Smibert, Alireza Khodadadi-Jamayran, Igor Dolgalev, E. Ivanova, Stela Sota, Ken Cadwell, S. Koralov, Judy Zhong, Chetna Soni, Daniel B. Stetson, Stuart P Weisberg, Donna L. Farber, Juliana Idoyaga, Boris Reizis
          </td>
          <td>2025-10-14</td>
          <td>Nature Immunology</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/05a71100671b244cc8f79397a31cb08b678438b9" target='_blank'>
              Patient-derived lymphocytes drive smoldering lesion pathology in a chimeric multiple sclerosis mouse model
              </a>
            </td>
          <td>
            O. Perrot, M. Nordbeck, C. Bachelin, A. Luong, D. Roussel, D. Akbar, N. Sarrazin, A. Tenenhaus, C. Louapre, V. Zujovic
          </td>
          <td>2025-09-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="A 48-year-old patient underwent lung transplantation because of severe COVID-19, which aggravated his underlying interstitial lung disease, despite the presence of detectable SARS-CoV-2. Subsequently, the graft is re-infected early in the post-procedural phase, leading to viral persistence for more than five months. By analyzing viral evolution and effector immune response within the transplanted organ, we observe three main findings. First, virus evolution differs in the transplanted organ compared to that in the upper respiratory tract and is affected by monoclonal SARS-CoV-2-specific antibodies and molnupiravir. Second, we show the potential clinical relevance of T cell HLA restriction that may facilitate viral clearance in the upper respiratory tract compared to the ongoing viral replication in the HLA mismatch organ. Third, close monitoring and modulation of immunosuppressive and antiviral therapy enables viral clearance in a lung transplantation setting despite incomplete SARS-CoV-2 clearance prior to transplantation. Human transplantation with allogeneic donor organs results in non-matching of MHC and differential presentation of T cell antigens. Here the authors show that in a lung transplanted SARS-CoV-2 infected patient T cell responses generated from the host may not be able to recognise infected cells within the graft and this may contribute to virus persistence.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/569199782c3445155a7ccd2d640593b92abe836a" target='_blank'>
              SARS-CoV-2 infection dynamics in a MHCI-mismatched lung transplant recipient
              </a>
            </td>
          <td>
            Jonas Fuchs, V. Karl, Ina Hettich, Jaime Alvarado, Daniel Eckert, Lena Jaki, Ann-Kathrin Kohl, Anastasia Kremser, Anastasija Maks, C. Terschluse, P. Agarwal, F. Emmerich, Sebastian Fähndrich, Annabelle Flügler, D. Hornuss, Johannes Kalbhenn, N. Kneidinger, Inga Lau, A. Lother, I. Moneke, David Schibilsky, Elisabeth Schygulla, N. Venhoff, Gernot Zissel, M. Czerny, D. Huzly, Georg Kochs, Christoph Neumann-Haefelin, Bernward Passlick, Daiana Stolz, R. Thimme, M. Panning, M. Hofmann, Björn C. Frye
          </td>
          <td>2025-09-16</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c2ac7be7fefad26395dcc651024f1fe069018455" target='_blank'>
              Atlas of innate immune responses to experimental cholera and IL22 treatment demonstrates protection by mucus-secreting cells
              </a>
            </td>
          <td>
            Masataka Suzuki, Yuko Hasegawa, Hailong Zhang, M. Waldor
          </td>
          <td>2025-09-12</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>93</td>
        </tr>

        <tr id="The release of danger-associated molecular patterns (DAMPs) such as ATP from stressed or damaged cells is a key initiator of sterile inflammation. In autoimmune diseases, extracellular ATP acts as a potent pro-inflammatory signal by activating the purinergic receptor P2X7, which is expressed on both mononuclear phagocytes (MPs) and T cells—key drivers of pathological processes. While it is well established that P2X7 mediates ATP-dependent immune activation, its cell-specific contributions to innate versus adaptive immunity in autoimmune conditions remain unclear, especially in autoimmune uveitis. Here we used the experimental autoimmune uveoretinitis (EAU) mouse model to delineate the cellular mechanisms underlying P2X7’s role in autoimmune responses. Using a combination of multiple cell-specific conditional models and transcriptomic approaches, we showed a pivotal role forP2X7 expressed by MPs in orchestrating T-cell mediated autoimmune responses. P2X7 deficiency in MPs decreased disease severity. Additionally, cell-specific transcriptomic analyses, including single-cell analyses, revealed that P2X7 exerted distinct modulatory effects across monocyte-derived macrophages (MdM) versus microglia. In MdM, lack of P2X7 was associated with reduced expression of genes related to the inflammasome, phagocytosis pathways, and components of the complement system, leading to a marked decrease in pathogenic Th17 cell frequency in the retina. In microglia, P2X7 deficiency instead particularly impacted an IFN-responsive microglial subset that is normally characteristic of EAU. By specifically deleting P2X7 in microglia, we demonstrate its role in driving pathogenic processes in this cell population. These findings suggest that inhibition of P2X7 could be a promising therapeutic strategy in autoimmune neuroinflammatory disorders. P2X7 expressed on MPs, rather than on CD4+ T-cells, plays a primary role in the development of EAU. Lack of P2X7 expression by MPs not only down-regulated phagocytosis and inflammasome pathways but also complement components. P2X7 indirectly influences Th17 polarization through its expression in MPs. P2X7-deficiency in MPs reduced the frequency of the IFN-responsive microglial subset during EAU. P2X7 expression by microglia contributes to the development of EAU. P2X7 expressed on MPs, rather than on CD4+ T-cells, plays a primary role in the development of EAU. Lack of P2X7 expression by MPs not only down-regulated phagocytosis and inflammasome pathways but also complement components. P2X7 indirectly influences Th17 polarization through its expression in MPs. P2X7-deficiency in MPs reduced the frequency of the IFN-responsive microglial subset during EAU. P2X7 expression by microglia contributes to the development of EAU.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/31d6dca4ac613c86885fb67afae84c460cb78a38" target='_blank'>
              Macrophage expression of P2X7 controls autoimmune uveitis
              </a>
            </td>
          <td>
            Paul-Alexandre Déchelle-Marquet, Yueshen Che, Camille Roux, Frédéric Blond, Kaitryn E. Ronning, S. Augustin, Pauline Lagouge-Roussey, C. Nous, Sara Touhami, Bahram Bodaghi, Jean Kanellopoulos, S. Adriouch, X. Guillonneau, Florian Sennlaub, Cécile Delarasse
          </td>
          <td>2025-09-25</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a progressive, chronic, and highly disabling neuroinflammatory disorder characterized by demyelination and T cell–driven inflammation. Pathogenic T cells play a central role in MS, but effective therapeutic targeting remains challenging. Here, we identified ankyrin repeat domain–containing protein 55 (ANKRD55) as a key regulator of T cell function by single-cell transcriptomic analysis of cerebrospinal fluid and blood from MS patients. ANKRD55 was predominantly expressed in CD4+ T cells in both compartments. Genetic ablation of Ankrd55 led to a robustly reduced disease severity and neuroinflammation in experimental autoimmune encephalomyelitis (EAE), a widely used animal model for MS. Furthermore, T cell–specific deficiency of Ankrd55 significantly impaired Th1 polarization and Th17 differentiation, reducing EAE pathogenicity. Mechanistically, we found that Ankrd55 deficiency disrupted T cell receptor (TCR) signaling integrity. We demonstrated that ANKRD55 regulates the formation of the immune synapse, an essential prerequisite for TCR activation, by interacting with subunits of the chaperonin-containing TCP1 (CCT) complex and modulating its activity, enhancing its assembly by competing with CCT5 for binding to TCP1, CCT3, and CCT6. This facilitates proper microtubule organization and TCR activation. These findings establish ANKRD55 as a critical regulator of TCR signaling and highlight its therapeutic potential in pathogenic T cell–driven autoimmune diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/865b26367cf4f5ce2ee12fb7cd224a9d528add57" target='_blank'>
              ANKRD55 is a key regulator of T cell inflammation in multiple sclerosis
              </a>
            </td>
          <td>
            Chuyu Wu, Mei-Ling Jiang, Xue Yang, Yixuan Liu, Bin Huang, Yi Guo, Runjing Cao, Zhihui Cui, Guozhen Deng, Weiyan Wang, Mengdi Guo, Zhiyong Lin, Jiahui Fan, Lin-ming Zhang, Lorenzo Di Cesare Mannelli, Tao Pang, Chenhui Wang, Cun-Jin Zhang
          </td>
          <td>2025-10-15</td>
          <td>The Journal of Clinical Investigation</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a significant global health burden, characterized by complex host–pathogen interactions that drive heterogeneous clinical outcomes. While pulmonary epithelial cells are increasingly recognized as active participants in innate immunity during Mtb infection, how host defense are altered when the epithelial barrier is compromised remains unclear. In this study, we developed a murine model combining naphthalene-induced pulmonary epithelial injury with Mtb infection and mapped the pulmonary cells landscape through single-cell RNA sequencing (scRNA-seq), followed by in vitro stimulation assays to validate macrophage functional changes. Notably, we found a pronounced impairment in pulmonary bacterial clearance. Transcriptomic analysis revealed a widespread suppression of epithelial immune functions and showed that macrophages transitioned from an antimicrobial to an antigen-presenting phenotype, indicating waning pulmonary innate defenses and heightened adaptive immune activation. In vitro experiments further suggested that this macrophage transition may be linked to epithelial cell alterations. These findings indicate that pulmonary epithelial integrity may influence early host immune responses to Mycobacterium tuberculosis and provide a transcriptomic framework for exploring epithelial–immune crosstalk as a potential therapeutic target. Single-cell transcriptomics reveal epithelial–immune crosstalk remodeling during Mtb infection in mice. Pulmonary epithelial injury weakens mucosal defense and increases bacterial burden. Macrophages shift from innate immune defense to adaptive immune activation in response to Mtb challenge.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7e41984afd63dd846e210a4451e9fc159cd48e46" target='_blank'>
              Lung epithelial injury impairs early host immune responses to Mycobacterium tuberculosis
              </a>
            </td>
          <td>
            Xuan Miao, Xue Li, Zuokuan He, Guiying Xu, Yu Li, Youwei Wang, Junping Wu, Qi Wu, Huaiyong Chen
          </td>
          <td>2025-10-03</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7926169db8376b81cfe85e7301b1ef3978ec2753" target='_blank'>
              Innate immune responses to Plasmodium falciparum disrupt the blood-brain barrier
              </a>
            </td>
          <td>
            Alina Batzilla, Pia Dernick, Jon Bezney, A. Gschwind, Fumio Nakaki, Mireia Altadill, Hannah Fleckenstein, Livia Piatti, Silvia Sanz Sender, Manuel Fiegl, O. Oyerinde, Borja Lopez Gutierrez, M. López-Botet, James Sharpe, Lars M. Steinmetz, G. Moncunill, Maria Bernabeu
          </td>
          <td>2025-10-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Abstract Background Intracerebral haemorrhage (ICH) progresses rapidly with complex pathology and limited treatment options, making it a severe subtype of stroke. The extravasation of blood into the brain parenchyma triggers a cascade of inflammatory responses, contributing to secondary injury. Single‐nucleus RNA sequencing (snRNA‐seq) data have enabled more profound insights into the cellular heterogeneity and dynamic interactions within the haemorrhagic brain. Immune cells play a crucial role in shaping neuroinflammation. However, the lack of comprehensive longitudinal studies limits our understanding of the temporal evolution of these inflammatory processes, posing a challenge to the development of targeted therapeutic strategies. Methods We used snRNA‐seq in collagenase‐induced ICH mouse models at Days 1, 3, 7, 14 and 28 post‐injury, alongside naive controls, to profile the dynamics of gene expression over time. Results We obtained 281 577 high‐quality transcriptional profiles representing 21 distinct cell types. Co‐expression network analysis revealed a prominent ‘inflammation module’ that remained active throughout ICH. Integrative single‐cell transcriptomic and immunofluorescence staining suggested that the various Mif‐expressing cells may contribute to local inflammation, potentially engaging macrophages via receptor–ligand pairs such as Cd44 and Cd74. Over time, microglia appeared to serve as key recipients of pro‐inflammatory signals increasingly. During the resolution phase, oligodendrocytes exhibited transcriptional signatures consistent with enhanced maturation and remyelination, which T cell‐mediated interactions may have facilitated. Conclusions These findings offer a systems‐level perspective on cell‐type–specific responses and immune‐mediated interactions during ICH progression and resolution. Key points Establish intracerebral haemorrhage (ICH) mouse models at various time points (Days 1, 3, 7, 14, 28) and construct a high‐quality single‐nucleus RNA sequencing (snRNA‐seq) atlas. Computational analyses suggest that macrophage recruitment in the early stage of ICH potentially involves migration inhibitory factor (MIF) signalling pathways. T cells may interact with myelin‐forming oligodendrocytes during the resolution phase, potentially contributing to remyelination after ICH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/93fbc9517918c734a8d8739f3255c47b54244947" target='_blank'>
              Single‐nucleus transcriptomic profiling reveals temporal dynamics of neuroinflammation and myelin repair after intracerebral haemorrhage
              </a>
            </td>
          <td>
            Zhan Chen, Qinglin Wang, Rong Xiang, Ruoqi Ding, Jin Tao, Qinfeng Peng, Shao-Long Wang, Nannan Cheng, Mengke Zhao, Jiaxin Li, Qidi Xue, Chuanyu Liu, Xuemei Chen, Longqi Liu, Junmin Wang, Jian Wang, Mingyue Wang
          </td>
          <td>2025-09-28</td>
          <td>Clinical and Translational Medicine</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused a global health crisis, marked by high transmissibility and virulence. Despite widespread vaccination efforts, effective treatments for COVID-19, particularly for severe cases leading to Acute Respiratory Distress Syndrome (ARDS), remain limited. This study investigates the efficacy of KVX-053, a protein tyrosine phosphatase type IVA (PTP4A3) small molecule inhibitor, in modulating SARS-CoV-2-induced inflammation and lung injury using in vitro cell models and in vivo K18-hACE2 transgenic mice. KVX-053 reduced in vitro pro-inflammatory cytokine expression, including TNFα, CXCL10, and CXCL11, without impacting viral replication or cell viability. K18-hACE2 mice treated with KVX-053 demonstrated marked improvement in clinical scores and reduced histological evidence of lung injury compared to untreated SARS-CoV-2-infected controls. KVX-053 mitigated the activation of key inflammatory mediators in the lung, including NLRP3 inflammasomes, IL-6, and phosphorylated STAT3, effectively curbing the “cytokine storm” associated with severe COVID-19. Importantly, treatment preserved lung parenchymal integrity, reduced edema, and minimized macrophage infiltration. Our findings highlight PTP4A3 as a potential critical regulator of the inflammatory response during SARS-CoV-2 infection. KVX-053, a potent and selective PTP4A3 inhibitor, emerges as a promising host-directed therapeutic strategy for mitigating ARDS and inflammation-driven lung injury in SARS-CoV-2 and potentially other respiratory viral infections. Future studies are required to optimize dosing strategies, elucidate precise molecular mechanisms, and validate these findings in clinical settings.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/20ae8d61209d49d0e74feaa9c96947aababae586" target='_blank'>
              The PTP4A3 inhibitor KVX-053 reduces Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virulence, inflammation, and development of acute lung injury in K18-hACE2 mice
              </a>
            </td>
          <td>
            Ruben M. L. Colunga-Biancatelli, P. Solopov, Caitlin M Woodson, I. Allen, I. Akhrymuk, Maryna Akhrymuk, Brittany N. Heath, Hannah M. Ivester, T. Day, Dan E. Austin, K. Kehn-Hall, John S. Lazo, E. Sharlow, J. Catravas
          </td>
          <td>2025-10-28</td>
          <td>Respiratory Research</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="Guillain-Barré syndrome (GBS) is an autoimmune disorder that causes weakness, sensory loss, autonomic dysfunction, and chronic neuropathic pain. The mediators responsible for driving early autoimmune injury in the most common GBS variant, acute inflammatory demyelinating polyradiculoneuropathy (AIDP), remain incompletely understood. We performed bulk and single-cell RNA sequencing on peripheral blood mononuclear cells collected from early untreated AIDP-variant GBS patients and healthy controls to comprehensively deduce leukocyte transcriptome alterations and predict disease-driving interactions between pathogenic leukocytes and peripheral nervous system cells. Bulk transcriptomics showed interferon- and JAK/STAT-driven proinflammatory signatures in myeloid cells. CD8+ T-cells were highly proliferative and expressed axon guidance genes. Single-cell transcriptomics revealed dysregulation of CD4+FOXP3+ regulatory and CD4+ effector memory T-cells indicative of poorly controlled type 1 and type 17 immune responses. Highly activated intermediate monocytes upregulated genes related to angiogenesis and oncostatin M. Interactome analysis between GBS leukocytes, Schwann cells, and sensory neurons predicted increased engagement of ligand-receptor pairs with nerve integrity and pain functions, including epiregulin, interferon-beta, adrenomedullin, clusterin, IL-6, IL-15, and CCL4. Functional validation demonstrated that CCL4 sensitizes human sensory neurons in vitro. These results unearth molecular interactions by which specific leukocyte populations in AIDP-variant GBS may induce peripheral nerve injury and drive neuropathic pain.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f32750fba6dd394e7dec1bcd5d3da578effc6cef" target='_blank'>
              Peripheral nerve-targeting and pain-promoting transcriptomic signatures in early Guillain-Barré syndrome
              </a>
            </td>
          <td>
            Jayden A O'Brien, Joseph B. Lesnak, Ishwarya Sankaranarayanan, A. Arendt-Tranholm, Nikhil N. Inturi, Spoorthi Sadasivuni, Hemanth Mydugolam, Katelyn E. Sadler, Theodore J. Price, E. Ubogu
          </td>
          <td>2025-09-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Chronic activation of innate immune responses in the brain is increasingly recognized as a contributor to neurodegenerative diseases, including Alzheimer's disease (AD). AD remains a major global health challenge due to the inefficacy of current therapies to modify disease progression. In AD, hyperactivated microglia, the brain’s resident macrophages, play a central role by responding to amyloid-beta peptides (Aβ) through activation of the NLRP3 inflammasome, a key innate immune sensor and a promising therapeutic target. Leishmania infantum, a protozoan parasite causing visceral leishmaniasis, is known to employ sophisticated mechanisms to subvert inflammatory responses in macrophages, including modulation of the NLRP3 inflammasome, thus representing a potential natural model for counteracting microglia-related inflammation. However, microglia-Leishmania interactions remain unexplored, particularly the parasite’s ability to modulate microglial NLRP3 activation. Here, we demonstrate that L. infantum invades and persists in microglia without inducing cell activation, indicating an immunologically silent entry. Aβ-stimulated NLRP3 activation was suppressed by Leishmania infection, as evidenced by a significant reduction in key pro-inflammatory mediators, including IL-1β, IL-18, TNF-α, and neurotoxic nitric oxide. Mechanistically, L. infantum disrupted NLRP3 priming by interfering with NF-κB signaling and upregulating the negative regulator A20. Additionally, L. infantum limited ASC speck formation, caspase-1 activation and ROS production while preserving lysosomal integrity. These findings reveal, for the first time, an unrecognized inhibitory effect of L. infantum on the microglial NLRP3/NF-κB axis and provide mechanistic insights into the parasite’s immune subversion in Aβ-activated microglia. Deciphering the molecular pathways exploited by L. infantum and the specific parasitic effectors involved could offer novel therapeutic targets and bioinspired strategies to mitigate microglial inflammatory responses in the context of AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5d4274589a2e9af8d7c8bc822e827f06747927ea" target='_blank'>
              Immune subversion by Leishmania infantum parasites suppresses NLRP3-driven inflammatory responses in amyloid-β-activated microglia
              </a>
            </td>
          <td>
            Estefanía Calvo Alvarez, Chiara Sfogliarini, F. La Rosa, M. Saresella, M. Dolci, Elisabetta Vegeto, D. Taramelli, N. Basilico, Mario Clerici
          </td>
          <td>2025-10-29</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>46</td>
        </tr>

        <tr id="Immune mechanisms contribute to the neuropathology of Alzheimer’s disease (AD) but the role of adaptive immune cells is unclear. Here we show that the brain CD8+ T cell compartment is dysregulated in AD patients and in the 3xTg-AD mouse model, accumulating activated CD103– tissue-resident memory T cells that produce large amounts of granzyme K (GrK). These CD103–CD8+ T cells originate from the circulation and migrate into the brain using LFA-1 integrin. Ablation of brain CD103–CD8+ T cells in 3xTg-AD mice ameliorates cognitive decline and reduces neuropathology. GrK induces neuronal dysfunction and tau hyperphosphorylation in human and mouse cells via protease-activated receptor-1 (PAR-1), which is expressed at higher levels in the AD brain, revealing a key immune-mediated neurotoxic axis. We conclude that communication between CD8+ T cells and the nervous system is altered in AD, paving the way for therapies targeting T cell-dependent neurotoxic inflammation. Neuroimmune communication in Alzheimer’s disease (AD) is poorly understood. Here, the authors show that CD103–CD8+ resident memory T cells induce neurotoxicity and neuroinflammation in AD via the granzyme K–PAR-1 axis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c24140f7a28c20dee970a76d1c7b38f4dde8a42" target='_blank'>
              CD103–CD8+ T cells promote neurotoxic inflammation in Alzheimer’s disease via granzyme K–PAR-1 signaling
              </a>
            </td>
          <td>
            Eleonora Terrabuio, E. Pietronigro, A. Bani, Vittorina Della Bianca, C. Laudanna, Barbara Rossi, Giulia Finotti, Bruno Santos-Lima, Elena Zenaro, Ermanna Turano, Gabriele Tosadori, M. Calgaro, Nicola Vitulo, Monica Castellucci, Daniela Cecconi, J. Brandi, Nikolaos Vareltzakis, Fabiana Mainieri, Antonella Calore, G. Angelini, Bruno Bonetti, Gabriela Constantin
          </td>
          <td>2025-09-24</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>42</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2d51f8ffabe038649dc0dfff6cbb98cd892aa0a7" target='_blank'>
              Sphingosine kinase 2 suppresses neutrophil responses to promote viral persistence while attenuating immune pathology
              </a>
            </td>
          <td>
            Vijayamahantesh Vijayamahantesh, Ying He, Lei Jiang, Hailey Huerter, Kwang Il Jung, Savannah McKenna, Caleb J. Studstill, Lee-Ann H. Allen, Ravi Nistala, Dong Xu, B. Hahm
          </td>
          <td>2025-09-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/30aa8b2f312de5ab72260d6f2d42db13d4d73388" target='_blank'>
              Immunoregulatory effect of metformin in monocytes exposed to SARS-CoV-2 spike protein subunit 1
              </a>
            </td>
          <td>
            R. M. Maurmann, K. Davis, Negin Mosalmanzadeh, Brenda Landvoigt Schmitt, B. Pence
          </td>
          <td>2025-09-12</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Tuberculosis (TB) remains a global public health challenge, with the current BCG vaccine providing limited efficacy in adults, and available treatments being lengthy and debilitating. To overcome these challenges, we have previously developed a recombinant BCG strain expressing the detoxified E. coli Heat-Labile Toxin (LTAK63), providing increased protection in mouse models and reduced lung pathology. Here, using systems biology and RNA sequencing of lung tissues in a murine model, we uncover the molecular mechanisms underlying rBCG-LTAK63’s increased protection. Immunization triggered early activation of cAMP-related pathways, leading to hypoxia, autophagy, and circadian rhythm gene regulation. These processes were associated with an enhanced innate immunity and promoted long-lasting Th1/Th17 adaptive responses. Upon challenge, mice immunized with rBCG-LTAK63 exhibited an earlier onset of interferon-gamma response, reduced bacterial burden, and improved lung histopathology. Notably, circadian rhythm regulation was directly linked to a controlled inflammatory response and reduced migration of infection-susceptible cells, resulting in decreased immunopathology. Our findings demonstrate that rBCG-LTAK63 orchestrates protection through the integration of metabolic and temporal immune pathways. This work provides mechanistic insights into how rational vaccine design can reprogram host immunity to enhance protection and reduce pathology, supporting rBCG-LTAK63 as a promising next-generation TB vaccine candidate.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a2a1c920c02189ea2ce616d05d66a9ab9edfc010" target='_blank'>
              rBCG-LTAK63 enhances protection against tuberculosis by inducing autophagy and circadian gene regulation
              </a>
            </td>
          <td>
            Lázaro M Marques-Neto, M. Trentini, Ana Carolina R. Moreno, S. F. Eto, , Almiro Pires da Silva Neto, M. S. Amaral, André G. C. Martins, André N. A. Gonçalves, A. Chudzinski-Tavassi, A. I. Kanno, A. Tagliabue, Diana Boraschi, Sergio Verjovski-Almeida, Helder Nakaya, L. P. Farias, P. I. P. Ramos, Luciana C C Leite
          </td>
          <td>2025-10-24</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bf6a125bf5a20acd2dd923b3e2909d9abf0a8c6f" target='_blank'>
              Single-cell RNA profiling of blood CD4+ T cells identifies distinct helper and dysfunctional regulatory clusters in children with SLE
              </a>
            </td>
          <td>
            Preetha Balasubramanian, Uthra Balaji, M. Santos, Jeanine Baisch, Cynthia Smitherman, Lynnette Walters, Paola Sparagana, Lorien Nassi, Katie Stewart, Julie Fuller, Terry K. Means, Virginia Savova, Jacques Banchereau, Tracey Wright, Virginia Pascual, Jinghua Gu, S. Caielli
          </td>
          <td>2025-10-21</td>
          <td>Nature Immunology</td>
          <td>1</td>
          <td>13</td>
        </tr>

        <tr id="The COVID-19 pandemic, caused by SARS-CoV-2, represents one of the most profound global public health challenges in modern history. While T cell immunity is crucial for viral clearance, the dynamics of the T cell receptor (TCR) repertoire during reinfection remain poorly understood. This study sought to characterize the TCR repertoire in peripheral blood T cells from healthy convalescent individuals (HC), patients with primary SARS-CoV-2 infection (PI), and reinfected individuals (RI), aiming to identify distinct TCR signatures linked to susceptibility or protection against reinfection. We enrolled 48 age- and sex-matched participants (18 PI, 18 RI, 12 HC), collecting blood samples during acute infection (PI/RI) or convalescence (HC). Deep TCRα/β sequencing was performed using the SMARTer Human TCR Profiling Kit with unique molecular identifiers (UMIs), followed by analysis of TCR repertoire diversity, clonal expansion, V(D)J gene usage, and CDR3 characteristics. Compared to HC, both PI and RI groups exhibited significantly reduced TCR diversity (p< 0.001), though no significant differences were observed between PI and RI. COVID-19 patients displayed skewed TCR repertoires dominated by expanded clones (>1%), whereas HC primarily harbored small clones (≤ 0.1%). RI patients demonstrated intermediate clonality, suggesting partial memory recall. Group-specific V(D)J pairings were identified, including TRAV27/TRAJ42 in RI, TRAV24/TRAJ42 in PI, and TRAV35/TRAJ42 in HC, while TRBV6-4/TRBD2/TRBJ2–3 was conserved across all groups. Additionally, HC-enriched and RI-exclusive CDR3 clusters were detected. Our findings indicate that SARS-CoV-2 reinfection is associated with impaired TCR diversity and distinct clonal expansion patterns, underscoring the role of T cell immunity in reinfection susceptibility. HC-enriched TCR clusters may represent protective memory responses, whereas RI-specific signatures suggest compromised immunity. These results offer valuable insights for vaccine design and risk stratification, though further functional validation of the identified TCRs is necessary.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2d977242eab98e457279671a381065b9ee003f60" target='_blank'>
              Distinct characteristics of T cell receptor repertoire associated with the SARS-CoV-2 reinfection
              </a>
            </td>
          <td>
            Liling Zeng, Li Liu, Baolin Ren, Bing Feng, Xudong Lai, Xunxi Lai, Zhimin Chen, Yihui Huang, Wenxin Hong
          </td>
          <td>2025-10-23</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="COVID-19 causes a wide range of complications in the central nervous system, including encephalitis and other neurological symptoms such as memory problems, psychological disorders, depression, and anxiety. We present comprehensive data on the changes in gene expression levels in astrocytes infected with the Delta or Omicron variants of SARS-CoV-2. In RNA-seq data, we found 346 genes that were significantly evoked (197 up- and 149 down-regulated) in astrocytes challenged with the Omicron variant, compared to 341 evoked genes (215 up- and 126 down-regulated) in the Delta variant. A surprisingly large number of genes were exclusively evoked by Delta (82 up- and 48 downregulated) and Omicron variants (65 up and 60 downregulated). Numerous pathways, including those pertaining to the neuronal system, metabolism, response to viral infection, signal transduction, cytokine signaling, and homeostasis, were dysregulated in infected astrocytes. In this report we have dissected major pathways that are related to pathogen recognition, integrity of the BBB and glia limitans, and neurological disorders that could lead to neurological symptoms listed above. Our findings also reveal dysregulation of a large number of non-coding RNAs. The data presented here may help us better understand the role of astrocytes in the neurological disorders seen in COVID-19 patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c339992734ddc6d228d9b0178084b42909087023" target='_blank'>
              Comprehensive mapping of the signaling events evoked by SARS-CoV-2 variants delta and omicron in human astrocytes
              </a>
            </td>
          <td>
            K. Bhide, M. Sláviková, Lea Talpašová, Katarína Kucková, Boris Klempa, Punit Tyagi, Mangesh Bhide
          </td>
          <td>2025-10-22</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2affd9966e7d74eae7ebff40360fcc4663c6bf18" target='_blank'>
              Clonal expansion of cytotoxic CD8âº T cells in lecanemab-associated ARIA
              </a>
            </td>
          <td>
            Lance A. Johnson, Kai Saito, Akhil Pallerla, Jessica L Funnell, Ashley R. Ezzo, Chelsea L. Song, Douglas A Harrison, Noah J. Norton, Lauren C. Moore, L. Eldik, D. Fardo, Greg E. Cooper, Josh M Morganti
          </td>
          <td>2025-09-21</td>
          <td>None</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1adb144859e1add4bf4fcfba4fbb11e22fcf1d31" target='_blank'>
              SAMHD1 promotes SARS-CoV-2 infection by enhancing HNF1-dependent ACE2 expression in lung epithelial cells
              </a>
            </td>
          <td>
            Pak-Hin Hinson Cheung, Pearl Chan, Hua Yang, Shravya Honne, Baek Kim, Stanley Perlman, Li Wu
          </td>
          <td>2025-10-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/92c1925b3210de9f4b794ecb86a6c3424cf3dfde" target='_blank'>
              Cellular and Spatial Drivers of Unresolved Injury and Functional Decline in the Human Kidney
              </a>
            </td>
          <td>
            B. Lake, Ricardo Melo Ferreira, Jens Hansen, Rajasree Menon, J. Basta, Heather R. Thiessen Philbrook, Stephanie Reinert, Robin Fallegger, Asmita K Lagwankar, Xi Chen, Soumya Maity, Katerina V. Djambazova, Brittney L. Gorman, Nicholas J. Lucarelli, D. Gisch, I. Schmidt, V. Nair, Fadhl M. Alakwaa, Eirini Kefaloyianni, Bo Zhang, Amanda L Knoten, Madhurima Kaushal, Edgar A. Otto, Melissa A. Farrow, D. Diep, Dušan Veličković, Angela R. Sabo, Elijah Cole, Ian Tamayo, Jovan Tanevski, Kimberly Y. Conklin, Rachel Sealfon, Y. He, Michelle Brennan, Lynn Robbins, Ying-Hua Cheng, Markus Bitzer, Aditya L. Surapaneni, Steven Menez, P. Kharchenko, Charles E. Alpers, Ulysses G J Balis, L. Barisoni, Ian H. de Boer, D. Demeke, Agnes B. Fogo, Joel M Henderson, L. Herlitz, Gilbert W. Moeckel, Parmjeet S Randhawa, Avi Z. Rosenberg, Jennifer A. Schaub, Suman Setty, F. Brosius, M. L. Caramori, Steve Coca, R. Figenshau, Eric H. Kim, Krzysztof Kiryluk, J. Lash, R. T. Miller, John O'Toole, Paul M. Palevsky, Eugene P. Rhee, Ana C. Ricardo, Sylvia E. Rosas, Prabir Roy-Chaudhury, M. Sarwal, J. Sedor, Robert D. Toto, Aydin Turkmen, S. Waikar, James C. Williams, F. P. Wilson, E. S. Woodle, Evan Z. Macosko, Julio Saez‐Rodriguez, P. Dagher, M. E. Grams, Petter Bjornstad, T. El-Achkar, Olga G. Troyanskaya, Nikole Bonevich, Pinaki Sarder, Sanjeev Kumar, C. Anderton, J. Spraggins, Kumar Sharma, Michael Rauchman, Jonathan Himmelfarb, J. Gaut, Kidney Precision Medicine Project, Kun Zhang, Ravi Iyengar, Mathias Kretzler, J. Hodgin, C. Parikh, Michael T. Eadon, Sanjay Jain
          </td>
          <td>2025-09-28</td>
          <td>bioRxiv</td>
          <td>1</td>
          <td>76</td>
        </tr>

        <tr id="SARS-CoV-2 infection is associated with long-lasting neuropsychiatric and cognitive symptoms, collectively referred to as neuro-PASC. Emerging studies indicates that accelerate brain aging and cellular senescence in COVID brain could lead to altered neuroimmune responses and neurodegenerative outcomes. However, little is known about how cellular senescence is development in neuro-PASC. Here, we examined the role of spike protein subunit S1, a persistent viral antigen, in driving the development of cellular senescence in primary human astrocytes. We have demonstrated that S1 enters endolysosomes and induces endolysosome dysfunction and cellular senescence. Moreover, the multibasic motif is critical for such S1-induced damaging effects. Importantly, we identified Toll-like receptor 7 (TLR7), an endolysosome-resident pattern recognition receptor, as a critical mediator of S1-induced damaging effects. Mechanistically, S1 interacts with TLR7 at the site of the endolysosome lumen and activates p38 MAPK signaling of downstream of TLR7, which drive the development of cellular senescence. Together, these findings suggest that TLR7 mediates S1-induced endolysosome dysfunction and cellular senescence, and that TLR7 represents a therapeutic target for mitigating neuro-PASC.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8ee07e08edc89cce8e4214928941b26b2316b896" target='_blank'>
              SARS-CoV-2 spike triggers TLR7-dependent endolysosome dysfunction and senescence in human astrocytes
              </a>
            </td>
          <td>
            Wendie A. Hasler, Emily McKay, Gaurav Datta, Samantha Johnson, Neda Rezagholizadeh, Xuesong Chen
          </td>
          <td>2025-10-31</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Interferon alpha-inducible protein 27 like 2A (Ifi27l2a) was initially identified as an interferon-stimulated gene (Isg) involved in host-dependent mechanisms during viral invasion. We have recently shown that the Ifi27l2a protein also plays a critical role in microglia and the spreading of neuroinflammation. However, the detailed mechanisms of action of intracellular and extracellular Ifi27l2a in glial cells, particularly in inflammatory and neurodegenerative diseases, are not yet defined. We now report that systemic inflammation leads to an elevated level of circulating Ifi27l2a in the plasma of lipopolysaccharide (LPS)-treated mice, which is associated with elevated Il1b mRNA expression in the brain. Elevated IFI27L2 (human isoform) was also found in plasma of human stroke patients. To test whether extracellular (e.g. secreted) Ifi27l2a can contribute as an autocrine or paracrine inducer of microglial activation and inflammation, we treated microglial cells with recombinant Ifi27l2a (rIfi27l2a). Treatment with rIfi27l2a led to increased expression of proinflammatory cytokines and elevated reactive oxygen species (ROS) levels in microglial cells. These effects resulted from alterations in mitochondrial function and a metabolic shift from oxidative phosphorylation toward glycolysis for ATP synthesis. Additionally, Ifi27l2a led to increased caspase-1 activity, demonstrating that Ifi27l2a causes Nlrp3 inflammasome activation. RNA sequencing revealed that Ifi27l2a mediates transcriptional changes reflecting activated microglia. These data support an extracellular role of Ifi27l2a as a novel cytokine, in which it promotes a phenotypic shift in microglia toward a proinflammatory phenotype. Targeting Ifi27l2a may therefore provide an additional strategy to reduce microglia-mediated inflammation in the brain.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd2010c6e0038f96da5055e23679983e49ae84e2" target='_blank'>
              Ifi27l2a acts as a cytokine that promotes a pro-inflammatory phenotype in microglia and enhances neuroinflammation
              </a>
            </td>
          <td>
            Sodam Kim, Haven Burrous, Elisabeth Harmon, Lauren Vance, Ting Wu, Alexander Andersohn, Andrea Doan, Darby Wolocko, Zachary Wise, Yuki Kitamura, Joo Eun Jung, G. Colpo, Lucy Couture, Frank Blixt, Louise McCullough, Sean P. Marrelli, G. Kim
          </td>
          <td>2025-09-24</td>
          <td>Research Square</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Background COVID-19, including its post-acute sequelae (Long COVID), is increasingly recognized as involving persistent immune dysregulation and chronic inflammation. Severe and prolonged disease states are often accompanied by sustained cytokine release, immune cell exhaustion, and ongoing cell-cell communication that shapes the inflammatory milieu. Among immune subsets, CD8+ T cells play a central role in antiviral defense, yet the molecular mechanisms linking their dysfunction to prolonged inflammation remain incompletely understood. Methods We analyzed 73,110 peripheral blood mononuclear cells (PBMCs) from individuals across four disease states (Healthy, Exposed, Infected, and Hospitalized) using single-cell RNA sequencing. Immune cell subsets were annotated, and T cell heterogeneity was profiled. Cytokine and inflammatory scores were calculated to assess immune activation. Differentially expressed genes (DEGs) underwent Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Cell-cell communication was evaluated to map ligand-receptor networks. Additionally, nine machine learning models were trained on a bulk RNA-seq cohort, and the SHapley Additive exPlanations (SHAP) framework was applied to interpret key predictive genes. Results Progressive disease severity was associated with a decline in T cell proportions, enrichment of pro-inflammatory myeloid cells, and elevated cytokine expression, particularly IL-32. Memory CD8+ T cells showed increased exhaustion and inflammatory scores while maintaining a central position in MHC-I-mediated communication networks. Persistent activation of immune and metabolic pathways, including antigen presentation and oxidative phosphorylation, was observed in prolonged disease states. Seven genes (RPS26, RPS29, RPL36, RPL39, RPS28, RPS21, and CD3E) were identified as strong predictors of chronic immune dysregulation, with the XGBoost model achieving the highest AUC. SHAP analysis confirmed their contributions to disease classification. Conclusion This study maps the immune landscape of COVID-19 and Long COVID at single-cell resolution, revealing that persistent immune cell communication, particularly involving memory CD8+ T cells, may sustain chronic inflammation beyond the acute phase. The identified molecular signatures offer potential biomarkers and therapeutic targets for mitigating post-viral inflammatory syndromes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/536000d345ef1e6f7663efc28145b0e979e70e7b" target='_blank'>
              Immune cell communication networks and memory CD8+ T cell signatures sustaining chronic inflammation in COVID-19 and Long COVID
              </a>
            </td>
          <td>
            Hengrui Liu, Zewen Xu, Ilayda Karsidag, Panpan Wang, Jieling Weng
          </td>
          <td>2025-10-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Significance Chronic neurological deficits following traumatic brain injury (TBI) are largely attributable to sustained neuroinflammation mediated by microglia/macrophages. This study identifies ALKBH5, the m6A demethylase, acting as a critical regulator of posttraumatic neuroinflammation. We demonstrate that ALKBH5 removes m6A modification from Socs3 transcripts, enhancing SOCS3 protein levels, thereby suppressing microglia/macrophages hyperactivation through inhibition of the JAK2-STAT3 signaling pathway. Mice with microglia/macrophage-specific knockout of ALKBH5 or SOCS3 exhibit exacerbated brain damage and impaired functional recovery post-TBI, emphasizing their pivotal regulatory roles in neuroimmune regulation. Our findings establish the ALKBH5–m6A–SOCS3 axis as a therapeutic target to modulate neuroinflammatory responses, providing a potential target to ameliorate neuroinflammation and improve outcomes after brain injury.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1ab00d6e30a86626729e7eff931048447acdfc72" target='_blank'>
              ALKBH5 demethylates the m6A modification of SOCS3 in microglia/macrophages and alleviates neuroinflammation after brain injury
              </a>
            </td>
          <td>
            Lin Cai, Yuqing Liang, Xiaoyu Li, Runxi Fu, Xingyu Niu, Yuxiao Jin, Yuxin Li, Yuheng Zhang, Ouyang Pei, Chen Wang, Qiuyuan Gong, Yang Yang, Lai Wei, Yao Jing, Dianxu Yang, Zhiming Xu, Fang Yuan, Jun Ding, Hao Chen, Bo Peng, Yanxia Rao, Hengli Tian
          </td>
          <td>2025-09-23</td>
          <td>Proceedings of the National Academy of Sciences of the United States of America</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="The blood–brain barrier (BBB) is critical for central nervous system homeostasis, yet it is highly vulnerable to viral insults. While acute coronavirus infections are known to impair BBB integrity, the long-term impact of persistent infection on brain endothelial cells remains poorly understood. Using an in vitro BBB model, we examined the effects of a 12-week infection with the neurotropic murine coronavirus MHV-JHM. Structural and functional changes were assessed via fluorescein isothiocyanate (FITC)-dextran permeability assay, confocal imaging of mitochondria, actin cytoskeleton, reactive oxygen species (ROS), scanning electron microscopy (SEM) and RT-qPCR for viral RNA level. Long-term infection induced progressive mitochondrial fragmentation and sustained ROS overproduction. Permeability to 70 kDa dextran increased significantly at 48 h post-infection and exceeded control levels threefold by 168 h. SEM revealed gradual endothelial surface roughening, blebbing, and eventual monolayer collapse with extensive intercellular gaps by week 12. Our study demonstrates that long-term MHV-JHM infection profoundly alters brain endothelial cell structure and function, triggering a cascade of changes that culminate in the disintegration of the BBB model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6ab1a64108138024202350f1901cc8262b24aa07" target='_blank'>
              The Effect of Long-Term Betacoronavirus Infection on the Permeability of the Blood–Brain Barrier—In Vitro Model Studies
              </a>
            </td>
          <td>
            W. D. Krahel, Marcin Chodkowski, M. Bartak, Agnieszka Ostrowska, Michał M Godlewski, Maksymilian Adamczyk, Małgorzata Krzyżowska, Joanna Cymerys
          </td>
          <td>2025-09-24</td>
          <td>Cells</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Traumatic spinal cord injury (SCI) is a severe clinical challenge, often leading to long-term sensory, motor, and autonomic dysfunction. The SCI cascade involves a primary physical damage phase, followed by a secondary phase of inflammatory signalling driven by microglia and other infiltrating immune cells. Immunomodulatory therapies may help promote healing and restrict secondary damage. We have previously demonstrated that interleukin (IL)-13 delivery improves functional and histopathological recovery after SCI in murine models, primarily by polarising macrophages towards an alternatively activated pro-reparative M2-like phenotype and reducing axonal contacts. Although microglia respond robustly to IL-13 in vitro, polarisation of microglia in vivo is more difficult. To better understand what conditions may restrict microglial responses to IL-13 in vivo, we sought to examine the effect of cellular context or microenvironment on IL-13 efficacy in forcing microglia polarisation in vitro. BV2 and murine induced pluripotent stem cell (miPSC)-derived microglia were treated with IL-13 alone or in combination with lipopolysaccharide (LPS), acidic media, extracellular matrix components, high glutamate or high potassium concentrations. Following this phenotypic changes including morphology, gene/protein expression (TNFα, IL-1β, iNOS, Arg-1, CD206, F4-80) and cytokine release (TNFα) were measured using high-content screening, RT-qPCR, immunohistochemistry, and ELISA. IL-13 leads to increased expression of the anti-inflammatory marker Arg-1 while lowering expression and secretion of the pro-inflammatory markers IL-1β, iNOS, and TNFα, and expression of the microglia activation marker F4-80, signifying effective polarisation of microglia. Concomitant administration of LPS with IL-13 reduces IL-13 polarisation efficacy in microglia. Forced polarisation of microglia is also compromised by high glutamate tone, acidosis, hyperkalemia, and extracellular fibronectin, suggesting microenvironmental contexts seen in neurotrauma directly act on microglia to limit polarisation potential. Our study demonstrates that the post-SCI environment dampens IL-13 efficacy on microglia. Taken together these data caution against simple immunomodulatory strategies and suggest that effective polarisation of microglia in vivo will require multimodal approaches.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e5c9d5c1c52800333c93ab18452901901064a33b" target='_blank'>
              Forced polarisation of microglia by IL-13 is modified by inflammatory and microenvironmental context
              </a>
            </td>
          <td>
            E. D. Aiyegbusi, James P. Reynolds, Ross O'Carroll, Ruth Colbert, Christopher Carew, D. Dooley
          </td>
          <td>2025-09-16</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="The SARS-CoV-2 Spike (S) protein is essential for viral entry and serves as the primary immunogen in most COVID-19 vaccines. While its role in adaptive immunity is well defined, its potential to contribute directly to innate immune activation remains incompletely understood. Neutrophils, in particular, are prominent effectors in COVID-19 severity, yet how they respond directly to the S protein presented in a multivalent format is unclear. Here, we investigated whether the S protein can directly activate human neutrophils ex vivo using two biologically relevant models: nanoparticles displaying multivalent stabilized prefusion trimeric S glycoprotein, and purified β-propiolactone-inactivated SARS-CoV-2 virions. Neutrophils were exposed to nanoparticles or inactivated virus, either alone or pre-coated with monoclonal or polyclonal anti-S antibodies. Nanoparticles displaying Respiratory Syncytial Virus (RSV) Fusion (F) protein and purified β-propiolactone-inactivated RSV served as comparators. Across all models and conditions tested, the S protein did not induce significant neutrophil responses. No consistent effects were observed on cell viability, surface marker expression, reactive oxygen species production, neutrophil extracellular trap formation, cytokine release, or inflammatory gene expression—even in the presence of anti-S antibodies mimicking immune complexes. Results with F-nanoparticles and inactivated RSV were similarly modest. These findings indicate that the trimeric prefusion S protein, whether displayed multivalently on nanoparticles or in the context of inactivated viral particles, is insufficient to trigger robust neutrophil activation. This work provides insight into the innate immune profile of the S protein and suggests that its use in vaccine platforms is unlikely to directly provoke neutrophil-mediated inflammatory responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/97bdff8012a9ec52bccc6095ee1db36e73e916c7" target='_blank'>
              No evidence of direct activation of human neutrophil responses by multivalent prefusion trimeric SARS-CoV-2 Spike protein ex vivo
              </a>
            </td>
          <td>
            Audray Fortin, S. Huot, E. Caron, C. Laflamme, A. Pagliuzza, N. Chomont, C. Gilbert, Baoshan Zhang, P. Kwong, Marc Pouliot, Nathalie Grandvaux
          </td>
          <td>2025-10-29</td>
          <td>PLOS One</td>
          <td>0</td>
          <td>63</td>
        </tr>

        <tr id="The central nervous system (CNS) represents a uniquely immune-privileged environment, with inflammatory responses involving several resident CNS-specific cell types. While stereotyped cellular and transcriptional responses recur across varied diseases, relevant signaling pathways and regulatory networks are not fully understood. Here, we investigate multi-modal inflammatory gene networks at large scale by developing a high-throughput RNA-seq screening and analysis workflow. As proof-of-concept, we investigate genetically heterogeneous mice from a large-scale chemical mutagenesis screen to identify novel functionally relevant variants in six genes previously linked to human CNS disorders: Nrros, Ctsd, Smpd1, Idua, Nlrp1a, and Inpp5d. We leverage the readily interpretable data from our large-scale study to demarcate distinct inflammatory states arising from each mutation. In all, our work provides a validated analysis framework for identifying discrete gene expression modules that are engaged divergently across disease contexts, which can be used to discover novel regulators of CNS neuroimmune homeostasis. Brain bulk-tissue RNA-seq database from a large-scale ENU-mutagenized mouse cohort. Variants in Nrros, Ctsd, Smpd1, Idua, Nlrp1a, and Inpp5d alter microglia homeostasis. An Nlrp1a gain-of-function mutation causes widespread astrocyte and microglia activation. Cross-comparison of six disease and inflammatory states facilitates interpretation of bulk tissue transcriptomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a51f54829abe0e8b61931cb5f83b202b5c060ee" target='_blank'>
              Modular inflammation network discovery from large-scale phenotypic screening in genetically heterogeneous mouse brains
              </a>
            </td>
          <td>
            Monica Xiong, L. Miosge, Carolina Correa-Ospina, Claudia M. Y. Yan, Tiffany Cripps, Stefan Bauernfried, Yuanyuan Wang, Maggie Crow, Lucy X Morris, T. D. Andrews, Andrew Trujillo, Mitchell G. Rezzonico, Yuxin Liang, Qixin Bei, Z. Modrusan, Kimberly L Stark, Tracy J Yuen, Brad A Friedman, Jesse E Hanson, Edward M Bertram, Christopher J Bohlen
          </td>
          <td>2025-09-29</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>95</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/955d343e5a442cc34446024d1327e4c3f7e661f0" target='_blank'>
              Oligodendrocyte progenitor cell responses to inflammatory demyelination with aging
              </a>
            </td>
          <td>
            Emily E. Fresenko, Camilla N. Bahri, Noor F. Ahmed, Davin Packer, Benjamin J. Tabor, Wenjing Sun, Michelle A. Wedemeyer, Cole A. Harrington
          </td>
          <td>2025-09-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/23d1526f5a77ff12eace732146acf8b49367f516" target='_blank'>
              Pigs lacking Natural Killer T cells have altered cellular responses to influenza
              </a>
            </td>
          <td>
            T. Kwon, Weihong Gu, Igor Morozov, Mariano Carossino, Eu-Lim Lyoo, Chester D. McDowell, Yonghai Li, U. Balasuriya, Yi Huang, Kiho Lee, Juergen A Richt, John P Driver
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="COVID-19 has triggered the rapid adoption of human organoid-based tissue culture models to overcome the limitations of the commonly used Vero cell line that did not fully recapitulate SARS-CoV-2 infection of human tissues. As the primary site of SARS-CoV-2 infection, the human nasal epithelium (HNE) cultivated in vitro and differentiated at air–liquid interface (ALI) is an ideal model to study infection processes and for testing anti-viral antibodies and drugs. However, the need for primary basal cells to establish the ALI-HNE limits the scalability of this model system. To try and bypass this bottleneck, we devised an ALI-differentiated form of the human adenocarcinoma cell line Calu-3, reported to model most aspects of authentic SARS-CoV-2 infection, including viral entry. The ALI-Calu-3 were tested for infection by a panel of SARS-CoV-2 variants, including ancestral (VIC01) and early pandemic lineages (VIC2089, Beta, Delta), and Omicron subvariants (BA2.75, BA4, BA5, XBB1.5). All tested lineages infected the ALI-HNE. In stark contrast, infection of the ALI-Calu-3 by Omicron subvariants BA4 and XBB1.5 was reduced. These data support the use of ALI-Calu-3 as a complementary, intermediary model for most but not all SARS-CoV-2 lineages, and places the ALI-HNE as the benchmark culture model for SARS-CoV-2 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3755ae5e522c5f24ca6798beedee88af6fabec9e" target='_blank'>
              Air–Liquid-Interface-Differentiated Human Nose Epithelium: The Benchmark Culture Model for SARS-CoV-2 Infection
              </a>
            </td>
          <td>
            Sarah L. Harbach, B. Tran, Abderrahman Hachani, S. Grimley, Damian F. J. Purcell, Georgia Deliyannis, J. Torresi, Julie L. McAuley, Elizabeth Vincan
          </td>
          <td>2025-09-18</td>
          <td>Organoids</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Long-duration spaceflight imposes significant physiological stress on astronauts, including profound alterations in immune function. This study investigated epigenetic changes in immune cells following prolonged orbital spaceflight by analysing histone modifications in CD4+ and CD8+ T-cells from astronauts before, immediately after, and during recovery from spaceflight. Using Cleavage Under Targets and Tagmentation (Cut&Tag) to assess H3K27ac modifications, we identified significant alterations in chromatin accessibility, predominantly involving immune response pathways, gene regulation, and cellular adaptation mechanisms. While some epigenetic changes were transient, others persisted beyond 50 days post-return, suggesting long-term effects. These findings enhance our understanding of immune adaptation to spaceflight and have implications for mitigating spaceflight-associated health risks. Furthermore, they provide valuable insights into immune system regulation under high-stress conditions, potentially informing research on immunodeficiency disorders, cancer epigenetics, and aging-related immune decline on Earth. This study underscores the critical role of epigenetics in long-term space missions and terrestrial health applications.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/780844a1fbbba164d7db3cc05f2ab99cc5e6866c" target='_blank'>
              Epigenomic profiling of immune cell subtypes reveals H3K27ac-marked stress signatures after long-duration spaceflight
              </a>
            </td>
          <td>
            Tabea L Fullstone, Lukas F J Fischer, Maria Bohmeier, Petra Frings-Meuthen, Brian E. Crucian, Philipp Rathert
          </td>
          <td>2025-09-12</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/65799dca4a24e6fbcd774c66d4741d26a7a006c5" target='_blank'>
              Targeting a macrophage stemness factor to mitigate diseases post respiratory viral infection
              </a>
            </td>
          <td>
            Mohd Arish, A. Chaudhuri, Janli Tang, H. Narasimhan, An Fang, Jinyi Tang, Xiaoqin Wei, Chaofan Li, I. Cheon, Wei Qian, Farha Naz, Gislane Almeida-Santos, Samuel Young, T. Parimon, Y. Shim, Robert Vassallo, Peter Chen, Jie Sun
          </td>
          <td>2025-10-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="Background Acute rejection is a significant cause of impaired graft survival in the early post-transplantation period, and the early-stage immune cell dynamics with local intercellular communication during this process require further elucidation. Methods We performed single-cell RNA sequencing (scRNA-seq) on CD45+ immune cells isolated from rat renal allografts during the early phase of acute rejection (days 0, 1, 3, and 7). Using unsupervised clustering, functional enrichment analysis, cellular trajectory inference, and intercellular communication network mapping, we delineated the immune cell dynamics and local communication networks at single-cell resolution. Our findings were subsequently validated through multiplex immunofluorescence and therapeutic intervention experiments. Results Macrophages constituted the dominant immune population during acute rejection. Sub-clustering analysis revealed a rapid expansion of the Isg15+Mac subset by post-transplant day 1, which persisted at elevated levels thereafter. Functional enrichment and trajectory inference demonstrated the pro-inflammatory properties of Isg15+Mac, implicating this subset in acute rejection. Cell-cell communication analysis identified Ccl3-Ccr5 ligand-receptor interactions between Isg15+Mac and T cells. Multiplex immunofluorescence confirmed abundance of Isg15+Mac within the allografts. Moreover, the acute rejection after kidney transplantation was alleviated by the FDA-approved Ccr5 blocker Maraviroc. Conclusions Our study establishes an in-depth, early-stage immune landscape of renal transplantation, revealed that the Isg15+Mac subset activates T cells via the Ccl3–Ccr5 axis and thereby serves as a critical driver of acute rejection. And indicating that Maraviroc may potentially be a therapeutic candidate for transplant rejection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0e9d767fb56923b15a4ac52a99263c253eebc577" target='_blank'>
              Single-cell transcriptomics unravels the early immune landscape of renal allograft rejection and nominates Ccl3-Ccr5 as a therapeutic target
              </a>
            </td>
          <td>
            Fanchao Wei, Zhaoxiang Wang, Ruochen Qi, Jingliang Zhang, Shichao Han, Changhong Shi, Tong Lu, Zhite Zhao, Zhengxuan Li, Lang Li, Weijun Qin, Shuaijun Ma, Lijun Yang
          </td>
          <td>2025-10-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/929f5e64525cee92d0f3fab0ebf61c85bfdd0623" target='_blank'>
              The spatial landscape of infectious mononucleosis tonsils
              </a>
            </td>
          <td>
            Ciara I Leahy, Matthew Pugh, Aoife Hennessy, Nadezhda Nikulina, Stefan Dojcinov, Gerald Niedobitek, Graham S. Taylor, Paul G Murray, É. Fennell
          </td>
          <td>2025-10-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/251bfd5a2d1d023592577c6a5e0b4f67420d1e06" target='_blank'>
              RIG-I-like receptor-dependent type I Interferon regulates antigen dose and activation in yellow fever vaccine 17D-infected antigen presenting cells
              </a>
            </td>
          <td>
            M. Zaucha, Elena Winheim, Antonio Santos-Peral, Apurva Dhavale, Paul Schwarzlmueller, Frank Dahlstroem, Giulia Spielmann, Magdalena K. Scheck, Linus Rinke, Yiqi Huang, Varvara Arzhakova, Katharina Eisenächer, Hadi Karimzadeh, M. Pritsch, Julia Spanier, U. Kalinke, Julia Thorn-Seshold, G. Barba-Spaeth, S. Rothenfusser, Anne B. Krug
          </td>
          <td>2025-10-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0f99bb18019cd4b39bd05d6d11bec440e5d21593" target='_blank'>
              B cell transcriptomics reveals lasting dysregulation and rapid decline of protective immune memory after chronic hepatitis C cure
              </a>
            </td>
          <td>
            Fang Chen, E. Giang, Padmaja Natarajan, Tony S. Mondala, Steven R. Head, Sing Chau Lau, Aishwarya Sundaresan, Liudmila Kulakova, Xiaohe Lin, Jasneet Aneja, R. Andrabi, Yun Zhang, Richard H. Scheuermann, Eric A. Toth, Thomas R. Fuerst, Lia Lewis-Ximenez, Arthur Y Kim, Paul Pockros, Georg M Lauer, M. Law
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="Microglia and CNS-associated macrophages (CAMs) are the primary targets of human immunodeficiency virus (HIV-1) in humans and simian immunodeficiency virus (SIV) infection in nonhuman primates, contributing to HIV-associated neurocognitive disorders and establishment of a persistent viral reservoir in the central nervous system (CNS). Despite antiretroviral therapy (ART), neurocognitive and other neurological disorders persist in people with HIV (PWH). Opioid users can suffer exacerbated disease progression and neurological complications. However, the impact of ART-treated infection and opioids on brain myeloid cells, the main targets for HIV/SIV in the brain, remains poorly understood. Using an SIV-infected rhesus macaque model and single-cell multi-omic sequencing, we show that ART promotes the restoration of homeostatic microglial states, while morphine exerts immunosuppressive effects on brain myeloid cells. Consistent with this immunosuppression, in morphine-treated, SIV-infected ART-suppressed macaques we found that myeloid cells exhibited reduced antiviral gene expression, including downregulation of MHC class II and interferon-stimulated genes, as well as decreased activity of AP-1 and ETS transcription factors. Furthermore, through the integration of single-cell data from PWH, we found that homeostatic microglial signatures were also evident in ART-treated PWH, although the microglia from PWH exhibited more activated/inflammatory phenotypes than those from the macaque model. These findings reveal distinct effects of ART and morphine on brain myeloid cell dynamics during SIV infection, indicating potential mechanisms underlying worsened neurocognitive outcomes in opioid-using PWH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dbf3e359f11b660c49cf0e6f0056e5add76f6a24" target='_blank'>
              Opioid-induced immunosuppression of brain myeloid cells in SIV-infected rhesus macaques
              </a>
            </td>
          <td>
            Howard S. Fox, Xiaoke Xu, Meng Niu, Benjamin G. Lamberty, Kathleen M. Emanuel, Shannon E. Callen, Shilpa Buch, Arpan Acharya, S. Byrareddy
          </td>
          <td>2025-09-18</td>
          <td>Research Square</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="Introduction In severe COVID-19, direct-acting antiviral drugs were not effective in hyperinflammatory stages and steroid treatment may weaken host immunity. The MEK inhibitor zapnometinib, as a host-targeting drug, has demonstrated promising efficacy against severe acute viral infections. Proof-of-concept for the innovative approach was presented in a clinical Phase 2 trial with hospitalized COVID-19 patients. Methods The antiviral and immunomodulatory potential of zapnometinib was investigated in samples obtained from COVID-19 patients enrolled in a Phase 2 clinical trial (RESPIRE), as well as in a SARS-CoV-2 Syrian hamster model, an acute lung injury mouse model, and in cell culture. The antiviral activity of zapnometinib was assessed using viral load reduction assays and RT-qPCR. Cytokines and chemokines were analyzed via ELISA and RT-qPCR. Alterations in T and B cells from COVID-19 patients were analyzed using flow cytometry. Biomarker analysis in hamster serum was conducted to monitor potential toxic effects. Results Zapnometinib reduced SARS-CoV-2 viral load in hospitalized COVID-19 patients, in the hamster model and in various highly pathogenic coronaviruses in vitro. Pro-inflammatory cytokines and chemokines decreased in COVID-19 patients, in a lung injury mouse model, and in vitro in primary human blood cells treated with zapnometinib. In the hamster model, zapnometinib alleviated SARS-CoV-2-mediated lung pathology. In patients with COVID-19, zapnometinib increased T and plasma B cells. Conclusion Unlike direct-acting antivirals, zapnometinib’s dual effect highlights its therapeutic potential in the treatment of severe acute viral infections, with favorable antiviral and immunomodulatory properties.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/663d1de063408dd2a575fb958f6e07a877642b1a" target='_blank'>
              Antiviral and immunomodulatory effect of zapnometinib in animal models and hospitalized COVID-19 patients
              </a>
            </td>
          <td>
            Yvonne Füll, Lara M. Schüssele, Hazem Hamza, Helen Hoffmann, Martin Bauer, Stephan Stenglein, Oliver Pötz, Andreas Steinhilber, Viktoria Anselm, M. Delany, J. V. D. van den Brand, G. van Amerongen, Leon de Waal, S. Pleschka, Stephan Ludwig, Oliver Planz
          </td>
          <td>2025-09-22</td>
          <td>Frontiers in Immunology</td>
          <td>1</td>
          <td>49</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/27118e0d8c7e391446d9e4844b490cabe504b043" target='_blank'>
              Vaccination protects against COVID-associated pulmonary fibrin deposition
              </a>
            </td>
          <td>
            Joanna Ireland, David Myers, Chang Huang, Cameron Allen, Gwynne Roth, Zhongcheng Zou, Ming Zhao, Motoshi Suzuki, Lisa Olano, Joshua Tan, Shreya Kanth, J.A. Huapaya, Homer Twigg, A. Suffredini, Peter D Sun
          </td>
          <td>2025-11-06</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="Severe influenza virus infection often triggers acute lung injury, and the efficacy of respiratory functional recovery critically depends on timely alveolar regeneration. However, the cellular dynamics and regulatory mechanisms underlying post-infectious alveolar repair remain incompletely understood. Utilizing Sftpc-CreER; Rosa26-mTmG lineage-tracing model, we determine the main stem cell population responsible for alveolar regeneration following influenza-induced injury. Through integrated single-cell RNA sequencing (scRNA-seq), immunofluorescence, and electron microscopy approaches, we mapped cellular transcriptional landscapes and spatial interactions. Key macrophage-epithelial crosstalk was further investigated via in vitro co-culture systems and in vivo conditional depletion models using diphtheria toxin receptor-transgenic mice. Putative regulatory factors were predicted through ligand-receptor interaction analysis and functionally validated in ex vivo organoid models. In this study, we revealed that the severely damaged alveolar barrier after influenza virus infection was rebuilt by the proliferation and differentiation of residual type II alveolar epithelial (AT2) cells in an inflammatory niche. In particular, monocyte-derived macrophage (Mo-Macs) expand, displaying intimate spatial proximity with AT2 cells. In addition, the cellular transcriptional status determined by scRNA-seq revealed that Mo-Macs regulate epithelial cell proliferation. Mo-Macs promoted the formation of AT2 spheres in vitro. Moreover, Mo-Mac depletion resulted in delayed repair of the alveolar epithelial structure in vivo. In addition, the mechanism by which Mo-Macs regulate alveolar epithelial repair involves the secretion of oncostatin M (OSM), which stimulates p-STAT3 activation and promotes AT2 cell proliferation. Our findings revealed that residual AT2 cells act as stem cells in the alveolus and are regulated by Mo-Macs through OSM secretion. These findings increase our understanding of the role of inflammatory signals in regulating tissue repair after severe injury, which may provide a potential avenue for therapeutic intervention in recovered patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c77e7cb9a0802132b1fb5c49fb2be2fef756fe89" target='_blank'>
              Monocyte-derived macrophages support alveolar regeneration via oncostatin M post-H1N1 infection during the recovery phase
              </a>
            </td>
          <td>
            Xiaoan Shang, J. Jia, Jiapei Yu, Shumei Zou, Zeyi Wang, Jiuyang Xu, Hui Li, Bin Cao
          </td>
          <td>2025-10-08</td>
          <td>Respiratory Research</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="African swine fever virus (ASFV) is an important transboundary animal pathogen with significant impacts on the global swine industry. Overwhelming proinflammatory responses are a major virulence mechanism for ASFV, but the dynamics of these changes during clinical disease are not completely understood. We constructed a detailed portrait of the innate immune responses during acute African swine fever (ASF) at the cellular, transcriptomic, and cytokine levels. Samples serially obtained from infected piglets show that progression of acute ASF is characterized by rapid increases in plasma type I interferons, TNF-α, IL-12p40, and IL-10, which coincide with the manifestation of clinical disease and viral DNAemia. Lymphocytes and natural killer (NK) cells progressively declined, with fluctuations in B cell, CD8+ T cell, and CD4+/CD8+ T cell populations. Blood monocytes and macrophages were highly variable throughout infection, with an abrupt spike in CD203+ mature macrophages immediately prior to death. Transcriptomic analysis of blood showed downregulation of cellular translation as early as 1 day post-challenge (DPC) and significant upregulation of antiviral immune processes at 5 DPC and 7 DPC, which overlapped with the onset of clinical disease. Together, these results present a detailed delineation of fatal ASF which involves an initial infection and damage of susceptible myeloid cells prior to symptomatic disease characterized by pro-inflammatory immune responses, lymphoid depletion, and clinical deterioration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b6a3491e33824aacb30f83f82721a1e7ae4367b7" target='_blank'>
              Temporal Dynamics of Cytokine, Leukocyte, and Whole Blood Transcriptome Profiles of Pigs Infected with African Swine Fever Virus
              </a>
            </td>
          <td>
            Daniel W Madden, B. Artiaga, J. Trujillo, Patricia Assato, Chester D. McDowell, Isaac Fitz, T. Kwon, K. Cool, Yonghai Li, N. Gaudreault, Igor Morozov, Juergen A Richt
          </td>
          <td>2025-10-01</td>
          <td>Pathogens</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Severe COVID‐19 is an immunological disorder characterized by a hyper‐inflammatory reaction of the immune system. SARS‐CoV‐2 anti‐spike antibodies of the IgG isotype are known to strongly contribute to this hyperinflammation by overactivation of alveolar macrophages. However, while the pathogenic function of IgG has been extensively studied, very little is known about the function of IgA, the most abundant immunoglobulin isotype in the airways. Although IgA is generally considered noninflammatory, in this study, we show that anti‐spike IgA induces pronounced proinflammatory responses. We demonstrate that stimulation of macrophages with anti‐spike IgA immune complexes in combination with a viral stimulus amplifies proinflammatory cytokine production. This IgA‐induced inflammation is particularly driven by IgA2, the IgA subclass that is increased in the plasma of severely ill COVID‐19 patients. We identified that IgA2‐induced inflammation is predominantly dependent on FcαRI‐Syk signaling. Mechanistically, IgA2‐induced inflammation is linked to enhanced glycolysis and altered mitochondrial function, indicating subclass‐specific immunometabolic reprogramming. Taken together, these data indicate a pathogenic role for IgA2 in severe COVID‐19 and highlight its signaling cascades and metabolic pathways as potential druggable targets to counteract hyperinflammation in severe coronavirus infections, such as COVID‐19, SARS, MERS, and potential future outbreaks.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/108f6fbe490f0df81a3f8e4a427171366e4fce33" target='_blank'>
              Anti‐SARS‐CoV‐2 Spike IgA2 Induces Inflammation by Human Macrophages
              </a>
            </td>
          <td>
            Lynn Mes, Jennifer Veth, Julie Van Coillie, J. Keijser, Elise Mantel, R. van der Mast, Theo Rispens, G. Vidarsson, M. van Egmond, J. den Dunnen, Hung-Jen Chen
          </td>
          <td>2025-10-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>55</td>
        </tr>

        <tr id="Host responses – autophagy, cell death, and inflammation – limit the growth of bacterial pathogens while minimizing tissue damage. During the early stages of infection, Mycobacterium tuberculosis (Mtb) thwarts these and other innate immune defense mechanisms in alveolar macrophages (AMs) derived from the yolk sac; in later stages, it circumvents defenses in recruited mononuclear cells (MNCs) and survives within them despite additional cytokine stimulation from recruited T cells. The mechanisms that drive variable rates of Mtb growth in different macrophage subtypes and how Mtb manipulates inflammatory responses to grow within innate immune cells remain obscure. Here we explored the role of the host factor, Tax-1 binding protein 1 (Tax1bp1), an autophagy receptor that targets pathogens for degradation through selective autophagy and terminates pro-inflammatory cytokine responses. Unexpectedly, we found that Tax1bp1-deficient mice were less susceptible to Mtb infection, and generated reduced inflammatory cytokine responses, compared to wild-type mice; the same mutant mice exhibited decreased growth of, and inflammatory cytokine responses to, Listeria monocytogenes, suggesting that Tax1bp1 plays a role in host responses to multiple intracellular pathogens. Contrary to our previous ex vivo findings in bone marrow-derived macrophages (BMDMs), in vivo growth of Mtb in AMs and a subset of recruited MNCs was more limited in mice lacking Tax1bp1 relative to wild-type mice. To better understand these differences, we performed global protein abundance measurements in mock- and Mtb-infected AM samples ex vivo from wild-type mice. These experiments revealed that Tax1bp1 protein abundance does not significantly change early after infection in AMs but does in BMDMs; moreover, early after infection, Tax1bp1-deficiency reduced necrotic-like cell death -- an outcome that favors Mtb replication -- in AMs but not BMDMs. Together, these results show that deficiency of Tax1bp1 plays a crucial, cell type-specific role in linking the regulation of autophagy, cell death, and anti-inflammatory host responses and overall reducing bacterial growth.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7346e21902a5204769fdc46d4603e81b0700379e" target='_blank'>
              Mycobacterium tuberculosis triggers reduced inflammatory cytokine responses and virulence in mice lacking Tax1bp1
              </a>
            </td>
          <td>
            Jeffrey Chin, Nalin Abeydeera, Teresa Repasy, Rafael Rivera-Lugo, Gabriel Mitchell, Vinh Q Nguyen, Weihao Zheng, Alicia L. Richards, Erica Stevenson, Danielle L. Swaney, N. Krogan, J. Ernst, Jeffery S. Cox, Jonathan M Budzik
          </td>
          <td>2025-10-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Introduction In human neurocysticercosis (NCC), the cellular and molecular mechanisms of host-parasite interactions triggering brain inflammation and epileptic seizures in Sub-Saharan Africa are poorly understood. Emerging evidence indicates that the viability of the cyst of the pork tapeworm Taenia solium determines brain inflammation and, thus, symptom development and disease severity. We have previously shown that while viable cyst-released molecules promote immune regulation and often asymptomatic disease, the fluid from degenerating cysts causes inflammation in microglia and peripheral immune cells, potentially driving immune-mediated pathology. This study aims to elucidate the apoptotic signaling pathways underlying this process and their relevance for symptomatic disease in NCC patients. Materials and methods Human and porcine peripheral immune cells, as well as murine microglia, were exposed to T. solium cyst vesicular fluid (CVF). Apoptosis signaling pathways were analysed using flow cytometric FLICA (fluorochrome-labeled inhibitors of caspases) caspase 8 and 9 assays, while mitochondrial dysfunction was assessed via TMRE and MitoTracker Deep Red and Green fluorescent probes. Apoptosis-inducing CVF molecules were identified by differential mass spectrometry and functionally tested using specific inhibitors. Caspase activity and soluble mediators (FasL, ROS, TNFα) were measured in NCC asymptomatic and symptomatic patients’ sera, and inflammatory T cell infiltrates expressing caspases near viable and degenerating cysts in naturally infected pig brain slices were examined via immunohistology. Results We found that vesicular fluid derived from cysts primarily induced apoptosis and caspase 3 and 9 activity, and only minimal necrosis, in a dose-dependent manner across central and peripheral immune cells. This effect was prominent in CD16+ monocytes, microglia, and in CD3+ T cell-expressing caspase 3 near degenerating brain cysts. Apoptotic signaling was predominantly mediated by a dynamic remodeling of caspase 9 pathway, accompanied by a significant loss of mitochondrial potential and a sharp decrease in Bid and Bcl2 transcription, favoring the intrinsic over the FasL-dependent extrinsic pathway and mechanisms. This process is primarily mediated by small molecules (< 30 kDa), and remained unaffected by heat and proteinase treatment. Notably, symptomatic NCC patients exhibited elevated FasL levels correlating with increased caspase activity, underscoring the potential contribution of apoptosis to disease pathogenesis. Conclusions This study identifies caspase 9-mediated apoptosis as a mechanism of helminth-induced brain inflammation and implicates FasL in symptomatic disease progression. These insights enhance our understanding of NCC immunopathogenesis and may inform future therapeutic strategies targeting apoptotic pathways.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e6a1fef84d50d723dd9a0b4e1aa6dfcd7f5051b9" target='_blank'>
              Helminthic larval stage induces cellular apoptosis via caspase 9-mediated mitochondrial dysfunction
              </a>
            </td>
          <td>
            Leonardo Elias Sternkopf, Ulrich F Prodjinotho, Vitka Gres, Nikolaus Repgen, Katja Steiger, Julia Schluckebier, Chummy Sikasunge, Dominik Stelzle, C. Makasi, Andrea S Winkler, B. Ngowi, Nelly Villalobos, Friederike Ebner, Georg Häcker, Philipp Henneke, C. U. Prazeres da Costa
          </td>
          <td>2025-09-25</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="Introduction Sepsis is a life-threatening condition characterized by immune dysregulation, yet the mechanisms underlying T cell dysfunction remain poorly understood. Methods We integrated multi-omics data from public GEO datasets and prospective cohorts. Single-cell transcriptomic analysis was applied to identify core genes, followed by diagnostic and prognostic validation. Cell–cell interaction networks were constructed to investigate signaling alterations, and cross-platform validation was conducted. Results Seven core genes (LTB, CD3D, TRAF3IP3, CD3G, GZMM, HLA-DPB1, CD3E) were identified, showing strong diagnostic value (AUC ≥ 0.86) and prognostic significance (HR=4.50 for CD3E). Network analysis revealed collapse of critical signaling axes (HLA-DRA-MHCII, ITGB2-CD226) and aberrant activation of inhibitory pathways (LGALS9-CD45), leading to a “co-stimulation inhibition–checkpoint activation” imbalance. Cross-platform validation confirmed conserved downregulation of these genes in sepsis, which contributed to immune exhaustion via disrupted T cell differentiation trajectories and impaired intercellular communication. Conclusion Our findings highlight novel biomarkers and potential therapeutic targets for sepsis immunotherapy by systematically deciphering core gene networks and immune interaction collapse in T cell dysfunction.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4507e6cde0317e8b062b7f1ee229b5df2a8fe7bf" target='_blank'>
              Single-Cell Multi-Omics Deciphers Core Gene Networks and Immune Interaction Collapse in Sepsis-Associated T Cell Dysfunction
              </a>
            </td>
          <td>
            Xiang Li, Zhibin Chen, Yandong Yao, Muhu Chen, Ying Hu
          </td>
          <td>2025-09-13</td>
          <td>Infection and Drug Resistance</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fdbae78251ccd4fa8f2487fe48e2a546a3022eef" target='_blank'>
              Antiviral and Anti-inflammatory Effects of Cannabidiol in HIV/SIV Infection
              </a>
            </td>
          <td>
            AL Ellison, J. Rosado-Franco, L. Mamun, S. Knerler, M. Daniali, K. Mehta, S. Williams-McLeod, J. Alvarez, SS Joyner, R. Vandrey, Elise M. Weerts, Peter J. Gaskill, MJ Corley, LC Ndhlovu, DW Williams
          </td>
          <td>2025-09-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="The mechanisms by which SARS-CoV-2 infection lead to neuroinflammation and cognitive impairment in COVID-19 and Long COVID are unclear. Cerebrovascular Wnt/β-catenin pathway activity is suppressed in association with neuroinflammation and cognitive impairment in a mouse model of COVID-19. In this study, we asked whether SARS-CoV-2 (NY Iota strain) infection of astrocytes would result in cell-autonomous changes in Wnt/β-catenin pathway components. We report that induced pluripotent stem cell (hiPSC)-derived human astrocytes (iAs) are susceptible to sustained infection with SARS-CoV-2 in vitro. Real-time PCR revealed that SARS-CoV-2 infection of iAs decreased transcripts for Wnt3a, Wnt10b, and the downstream pathway effectors β-catenin and TCF3. Wnt7b was increased, as was the proinflammatory chemokine CXCL10. No changes were noted in Wnt3, Wnt7a, TCF1, TCF4, or LEF1. These data indicate that SARS-CoV-2 infection differentially influences Wnt/β-catenin pathway components in astrocytes. These data could have implications for the mechanistic basis of COVID-19 and Long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2df9142f8c924fe780ce7108a7ee825da25ea8a8" target='_blank'>
              SARS-CoV-2 Infection Influences Wnt/β-Catenin Pathway Components in Astrocytes
              </a>
            </td>
          <td>
            KaReisha F. Robinson, Avantika I. Ahiya, Justin M. Richner, Sarah E. Lutz
          </td>
          <td>2025-10-01</td>
          <td>Pathogens</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d9c9b38fe853594879683a6fa8be1e981c5a697b" target='_blank'>
              Persistent Classical and Atypical Memory B Cells Underlie Heterogeneous Vaccine Responses in Ocrelizumab-Treated Multiple Sclerosis
              </a>
            </td>
          <td>
            R. Curtin, Y. Velmurugu, Fatoumatta Dibba, Yuan Hao, Chaitra Sreenivasaiah, Alireza Khodadadi-Jamayran, S. Nyovanie, Angie Kim, Marie L Samanovic, Mark Mulligan, J. Priest, M. Cabatingan, R. C. Winger, Y. Patskovsky, I. Kister, G. J. Silverman, M. Krogsgaard
          </td>
          <td>2025-11-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Intoduction T lymphocytes, along with cytokines and chemokines-dependent pathways are primarily responsible for regulating the immune response, controlling inflammation and eliminating viral infections. However, excessive immune activity can lead to pathological effects such as cytokine storm, which may cause severe respiratory distress syndrome and multi-organ damage in COVID-19. The aim of this study was to identify potential biomarkers of SARS-CoV-2 infection that could predict the severity of COVID-19 progression. Methods The cohort in this study included 52 hospitalized adult patients with SARS-CoV-2 infection from Warsaw, Poland admitted to the hospital during COVID-19 pandemic (February to November 2021). Based on clinical symptoms, patients were divided into two groups: (i) mild/moderate symptoms (non-severe) – 44 patients and (ii) severe respiratory failure (severe) – 8 patients. The control group consisted of 26 individuals without COVID-19. All COVID-19 patients and healthy controls underwent immunophenotyping of peripheral blood to assess the abundance of T lymphocytes and regulatory T lymphocytes, as well as measurement of selected cytokine and chemokine concentrations in corresponding serum samples. Data analysis was performed using CytoFLEX Flow Cytometer. Results and discussion Decreased percentages of total lymphocytes and T lymphocytes in peripheral blood were observed across all COVID-19 patients, with varying degrees between the non-severe and severe groups. A significant reduction was also noted in double-positive lymphocytes (CD4+CD8+), regulatory T lymphocytes ( CD4+ CD25HiCD127Lo and CD4+CD25HiCD127LoFoxP3+), as well as CD4+CD25+/-, CD4+CD45RA+/-, and CD8+CD45RA+/- subsets. Elevated levels of IL-6, IL-10, IL-17A, IFN-g, CCL2, CXCL8, and CXCL10 were observed in the non-severe and/or severe groups compared to healthy controls. Most importantly, only CXCL10 was significantly elevated in the severe group at admission compared to the non-severe group. In this study, we identified the chemokine CXCL10 as a crucial marker for distinguishing the severe course of COVID-19 from non-severe form at the time of admission. It may serve as an early indicator of diseases progression during hospitalization, potentially allowing prediction of the disease course. Moreover, elevated CXCL10 levels, in combination with decreased total lymphocytes counts and increased levels of IL-6, IL10, IFNg, CCL2 and CXCL9, may represent a more comprehensive biomarker panel suitable for predicting the severity of COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/befe135670515a1bc53405d52fd1e7cbd7111080" target='_blank'>
              Identification of blood immunological biomarkers of SARS-CoV-2 infection during pandemic in Poland
              </a>
            </td>
          <td>
            Monika Leśniak, A. Borkowska, Krzysztof Kłos, K. Aleksandrowicz, K. Porębska, Dagmara Kobza, K. Piwowarek, K. Plewka-Barcik, Marcin Niemcewicz, Anna Lutyńska, Jacek Z. Kubiak, Andrzej Chciałowski, R. Zdanowski
          </td>
          <td>2025-09-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/61f2942696de914b8ddcd3d63d15f096d71ddb29" target='_blank'>
              Progenitor T cells drive chronic pulmonary type 2 inflammation
              </a>
            </td>
          <td>
            Radomir Kratchmarov, Xiaojiong Jia, Jun Nagai, Hiroaki Hayashi, Kinan Alhallak, Juying Lai, Chunli Feng, Jakob von Moltke, Joshua A. Boyce, Patrick J. Brennan
          </td>
          <td>2025-10-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Background Immune checkpoint inhibitor (ICI) therapies present a pillar of modern cancer therapy but can cause neurological immune-related adverse events (n-irAEs), of which up to 35% are severe or even fatal. However, the detailed immunological mechanisms and risk factors underlying n-irAEs remain largely unknown. Here, we leveraged single-cell genomics to dissect immune cell type, state, and clonal heterogeneity associated with n-irAEs. Methods We performed coupled single-cell RNA sequencing and T cell receptor (TCR) profiling on peripheral blood cells of 17 patients with cancer receiving ICI therapy, including 8 patients with acute neurotoxicity. This approach enabled integrated analyses of immune cell states and T cell clonality linked to ICI-induced n-irAEs. Results We profiled 186 435 immune cells and conducted pseudotime analyses, revealing that patients with n-irAEs, compared with controls, present with clonally expanded CD4+ cytotoxic T lymphocytes (CD4+ CTLs) with an n-irAE-specific effector gene expression profile. These T cells predominantly belong to a select set of expanded clonal families and express genes linked to antigen-induced activation, cell lysis, and neuroinflammation. Moreover, they highly express CXCR3 (FC=2.03 compared with control CD4+ CTLs, with a false discovery rate=7.7×10⁻⁴), encoding the chemokine receptor of CXCL10, previously nominated as a biomarker for severe ICI therapy-induced n-irAEs with concomitant multiple organ system toxicity. Conclusions Overall, our study highlights the expansion and activation of CD4+ CTLs in ICI-induced neurotoxicity, proposing these cells as potential targets for developing new biomarkers and therapeutic strategies to improve patient outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a4f4e0b8916eaa4261cd264db53571afd725a2f" target='_blank'>
              Clonally expanded effector CD4+ cytotoxic T lymphocytes are associated with severe neurological adverse events after immune checkpoint inhibitor therapy
              </a>
            </td>
          <td>
            Ambre Giguelay, Patrick Maschmeyer, L. Müller-Jensen, Christian Schinke, Smilla K. Maierhof, Natasha Nambiar, Manpreet Meyer, Petra Huehnchen, Wolfgang Boehmerle, Matthias Endres, Samuel Knauss, L. S. Ludwig
          </td>
          <td>2025-10-01</td>
          <td>Journal for Immunotherapy of Cancer</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="Respiratory virus infections have been presenting significant global public health challenges. The virulence of SARS-CoV-2 and seasonal influenza largely relies on triggering abnormal host immune responses, particularly the production of a cytokine storm, which is notably increased in elderly patients. However, as the mechanisms underlying this age-associated exacerbation remain unclear, we investigated the role of the aging tissue microenvironment in promoting inflammation associated with viral infection. Our research, based on clinical samples, cellular experiments, and mouse models, provides evidence that the aging lung microenvironment induces severe inflammatory responses and leads to tissue damage, with senescent cells playing a crucial role in this process. Further mechanistic insights reveal that elevated levels of downstream inflammatory factors result from a significant and robust activation of the NF-κB pathway. This increase is attributed to the accumulation of reactive oxygen species in senescent cells and subsequent reduced expression of PDLIM2, an E3 ubiquitin ligase regulating P65 degradation. Finally, restoring PDLIM2 significantly inhibits viral infection-mediated inflammatory responses and organ damage in the aging body. Therefore, this study offers a novel perspective by elucidating the molecular mechanism and exploring the therapeutic potential behind viral infection-related inflammatory responses, particularly the mechanism accelerating inflammatory storms in elderly patients post-infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e07f24dbbacd6b1011804f10fdf4109e7d35e755" target='_blank'>
              Senescent cells promote viral infection-associated inflammation and tissue damage through a robust NF-κB pathway
              </a>
            </td>
          <td>
            Mingfu Tian, June Ma, Zhiqiang Li, Chenglin Ye, Xianghua Cui, Guolei Wang, Siyu Liu, Muhammad Suhaib Qudus, Uzair Afaq, Hong Fan, Jiali Xiong, Guangli Li, Chuanjin Luo, Zhen Wang, Zhengjiang Jin, Ming Guo, Xin Wang, Zhixiang Huang, Fang Zheng, Kailang Wu, Chengliang Zhu
          </td>
          <td>2025-10-28</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Immune checkpoint inhibitors (ICIs), targeting checkpoint receptors such as programmed cell death protein 1 (PD-1), are associated with increased risk of cardiovascular events, but the underlying mechanisms remain poorly understood. Here we show that PD-1+ T cells from murine atherosclerotic aortas mainly display a progenitor exhausted phenotype (PD-1intSlamf6+Tim3−), produce IFNγ in vivo, exhibit signs of recent proliferation and maintain polyfunctionality. PD-1 blockade induced marked changes in plaque immune phenotype, with increased PD-1high T cell accumulation, IFNγ production, formation of lymphocyte foci and neutrophil recruitment. Depletion of PD-1high T cells prior to PD-1 blockade did not impede T cell recruitment, suggesting a role for progenitor exhausted PD-1int T cells in ICI-driven T cell plaque accumulation. Human circulating PD-1+ T cells produced IFNγ and were associated with subclinical coronary atherosclerosis. Our studies highlight IFNγ-producing PD-1+ T cells as a potential key immune cell population mediating increased cardiovascular risk in patients with cancer receiving ICI. Mulholland et al. identify progenitor exhausted T cells, expressing intermediate levels of PD-1 (PD-1int), as a prominent source of pro-inflammatory cytokines in the murine atherosclerotic aorta and potential cellular targets driving checkpoint inhibition-elicited pro-atherosclerotic immune responses. They further demonstrate elevated levels of circulating PD-1-expressing T cells in individuals with subclinical cardiovascular disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5a29caf4329bc4f3e79ec49abf0bdad10c56e11d" target='_blank'>
              Progenitor exhausted PD-1+ T cells are cellular targets of immune checkpoint inhibition in atherosclerosis
              </a>
            </td>
          <td>
            Megan Mulholland, Anthi Chalou, Samuel H A Andersson, M. Depuydt, Yinda Yu, Shiying Lin, Klara Tallbäck, Astrid Ericsson, G. Jakobsson, J. de Mol, Dmytro Kryvokhyzha, A. Lichtman, A. Foks, A. Schiopu, Harry Björkbacka, B. Slütter, Anton Gisterå, D. Engelbertsen
          </td>
          <td>2025-10-01</td>
          <td>Nature Cardiovascular Research</td>
          <td>0</td>
          <td>65</td>
        </tr>

        <tr id="ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remains a threat to human health, particularly among immunocompromised and elderly individuals, given their heightened vulnerability to coronavirus disease 2019 (COVID-19)-associated morbidity and mortality. Recently, omicron subvariants such as KP.3.1.1 and XEC have emerged with an enhanced ability to evade humoral immunity. The development of new strategies against these variants of concern remains an intense area of research. The small molecule VE607 is an entry inhibitor that targets the Spike glycoprotein and delays virus spread in vivo. To improve the potency of this new class of SARS-CoV-2 entry inhibitors, we generated and characterized VE607 analogs and identified candidates with enhanced activity against variants, including KP.3.1.1 and XEC. Promising analogs exhibited higher inhibitory potency than the original compound and stabilized the receptor-binding domain in its “up” conformation. Among these, DY-III-281 also reduced viral burden and delayed death in SARS-CoV-2-challenged K18-hACE2 transgenic mice. Furthermore, combining DY-III-281 with a non-neutralizing antibody engineered for Fc-enhanced functions exhibited an additive effect in reducing SARS-CoV-2-induced disease burden in mice. Our findings support the continued development of small-molecule entry inhibitors, alone or in combination with antibody-based therapies, as a promising strategy to counteract emerging SARS-CoV-2 variants. IMPORTANCE Mutations in the Spike glycoprotein drive viral evolution and confer resistance to current vaccines and some therapeutic interventions against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we report new analogs of the SARS-CoV-2 small-molecule entry inhibitor VE607. These analogs exhibited improved potency against emerging SARS-CoV-2 variants, including KP.3.1.1 and XEC. One analog, DY-III-281, delayed viral replication in SARS-CoV-2WA1-challenged K18-hACE2 transgenic mice, suggesting that small-molecule compounds targeting viral entry might be useful in fighting evolving SARS-CoV-2 variants. Mutations in the Spike glycoprotein drive viral evolution and confer resistance to current vaccines and some therapeutic interventions against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we report new analogs of the SARS-CoV-2 small-molecule entry inhibitor VE607. These analogs exhibited improved potency against emerging SARS-CoV-2 variants, including KP.3.1.1 and XEC. One analog, DY-III-281, delayed viral replication in SARS-CoV-2WA1-challenged K18-hACE2 transgenic mice, suggesting that small-molecule compounds targeting viral entry might be useful in fighting evolving SARS-CoV-2 variants.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e7804bf19b78b6272129f152154a4e455b2f378f" target='_blank'>
              Optimization of VE607 to generate analogs with improved neutralization activities against SARS-CoV-2 variants
              </a>
            </td>
          <td>
            Shilei Ding, Derek Yang, I. Ullah, Ling Niu, Matthew Unger, M. A. Díaz-Salinas, Monika Chandravanshi, Fei Zhou, Guillaume Beaudoin-Bussières, Mehdi Benlarbi, W. Tolbert, Keon-Woong Yoon, Ruixue Xu, Geneviève Laroche, F. Gaudette, Abraham J Morton, Zabrina C. Lang, Anna Son, Cameron Abrams, M. Côté, Amos B. Smith, Rick K Huang, Doreen Matthies, James B. Munro, M. Pazgier, P. Uchil, A. Finzi
          </td>
          <td>2025-10-13</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>59</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e1cac498108b5305e7d2a1dde250a33c8a3e03b2" target='_blank'>
              Acute SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Amy C. Sherman, Glenda E Gray, Bin Cao, Kelvin K W To, Nadine G Rouphael, A. Henao-Restrepo, Anthony C Gordon, Lindsey Baden
          </td>
          <td>2025-10-24</td>
          <td>Nature Reviews Disease Primers</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/68a61536fdb213f77defcf43b41942dda2c2a3d0" target='_blank'>
              SARS-CoV-2 Variant-Dependent Alterations in Nasopharyngeal Microbiota and Host Inflammatory Response
              </a>
            </td>
          <td>
            Mario Maulen, Ignacio Pezoa-Soto, Daniel León, Ela M. Dominguez, Alberto J. M. Martin, W. Díaz-Vásquez
          </td>
          <td>2025-10-30</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Severe systemic inflammatory reactions, including sepsis, often lead to shock, organ failure, and death, in part through an acute release of cytokines that promote vascular dysfunction. However, little is known about the vascular endothelial signaling pathways regulating the transcriptional profile in failing organs. Our work focused on signaling downstream of IL-6, due to its clinical importance as a biomarker for disease severity and predictor of mortality. Here, we show that loss of endothelial expression of the IL-6 pathway inhibitor SOCS3 promoted a type I IFN–like (IFNI-like) gene signature in response to endotoxemia in mouse kidneys and brains. In cultured primary human endothelial cells, IL-6 induced transient IFNI-like gene expression in a noncanonical, IFN-independent fashion. We further show that STAT3, which we had previously demonstrated to control IL-6–driven endothelial barrier function, was dispensable for this activity. Instead, IL-6 promoted a transient increase in cytosolic mitochondrial DNA and required STAT1, cGAS, STING, and IRF1, -3, and -4. Inhibition of this pathway in endothelial cell–specific STING-KO mice or global STAT1-KO mice led to reduced the severity of the response to acute endotoxemic challenge and prevented expression of an endotoxin-induced IFNI-like gene signature. These results suggest that permeability and DNA-sensing responses are driven by parallel pathways downstream of this cytokine, provide potential insights into the complex response to acute inflammatory responses, and offer the possibility of novel therapeutic strategies for independently controlling the intracellular responses to IL-6 in order to tailor the inflammatory response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/65780d592f30c68d4093888b1ed44863f3de2f35" target='_blank'>
              Endothelial STING and STAT1 mediate IFN-independent effects of IL-6 in an endotoxemia-induced model of shock
              </a>
            </td>
          <td>
            Nina Martino, Erin Sanders, Ramon Bossardi Ramos, Iria Di John Portela, Fatma Awadalla, Shuhan Lu, Dareen Chuy, Neil Poddar, M. Zuo, Uma Balasubramanian, Peter A Vincent, Pilar Alcaide, Alejandro P. Adam
          </td>
          <td>2025-09-16</td>
          <td>The Journal of Clinical Investigation</td>
          <td>1</td>
          <td>8</td>
        </tr>

        <tr id="Bacterial infection is a key trigger of inflammatory pathways that damage the preterm brain, even without direct bacterial brain invasion. However, the mechanisms underlying the involvement of intracranial tissues and cells in early immune responses to acute systemic inflammation in preterm infants remain unknown. Lipopolysaccharide (LPS) was administered with a single intraperitoneal injection into postnatal day (P) 7 mice. Four hours later, the leptomeningeal macrophages initiated an intracranial reaction by producing IL-1β, which set the stage for the arachnoid, pial, and perivascular fibroblasts to act. These brain fibroblasts produced CCL2, which increased the number of brain parenchymal macrophages/microglia and led to their hypertrophy. The macrophages/microglia isolated from the brains of mice with systemic inflammation showed marked transcript expression of genes including Saa3, Irg1, Lcn2, and Cxcl9. The expression level of Saa3 reached its peak 4 and 12 h after LPS administration. Saa3 expression was upregulated in the macrophages in the leptomeninges, perivascular space, and cerebellar medulla, as well as in the fibroblasts of the leptomeninges, choroid plexus stroma, and perivascular space. The leptomeningeal macrophages expressing Saa3 continued their developmental migration from the leptomeninges to the brain parenchyma. The blood-brain barrier of pups remained intact up to 72 h after LPS administration at P7. The expression levels of Irg1, Lcn2, and Cxcl9 peaked 4 and 12 h after LPS administration. The cells that prominently expressed Irg1, Lcn2, and Cxcl9 were the leptomeningeal macrophages, perivascular fibroblasts and choroid plexus epithelial cells, and leptomeningeal fibroblasts, respectively. The early enhancement of Saa3 expression played a key role in priming inflammation initiated by macrophages and fibroblasts. Early enhancement of Irg1 expression was crucial for determining the direction of the inflammatory response. The increase of Lcn2 was vital, sequestering the iron siderophore to limit bacterial growth. It was interesting to observe how the early immune responses to systemic inflammation in the postnatal mouse brain were initiated by migrating macrophages and leptomeningeal fibroblasts, leading to immediate gene upregulation to protect immature brain tissue.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f0b35f26b99383b11b5240dc52d6f9e54408658a" target='_blank'>
              Early immune responses to systemic inflammation in the postnatal mouse brain initiated by migrating macrophages and leptomeningeal fibroblasts
              </a>
            </td>
          <td>
            Rei Settsu, Aki Obara, Takehiko Tarui, S. Hasegawa-Ishii, Atsuyoshi Shimada
          </td>
          <td>2025-10-11</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e819f35bfc49ec2545e41780dc01e007f076a26d" target='_blank'>
              Immune Cell Dysfunction of SARS-CoV-2: Mathematical Modeling of the Within-Host Immune Dynamics
              </a>
            </td>
          <td>
            Pagnapech Ngoun, Nicolas Alvarez, Ayesh Awad, Hwayeon Ryu
          </td>
          <td>2025-10-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Influenza A virus (IAV) induces ZBP1-mediated PANoptosis, a form of lytic inflammatory cell death characterized by concurrent activation of the pyroptosis, necroptosis and apoptosis pathways. Ninjurin-1 (NINJ1) is a recently identified mediator of plasma membrane rupture but functions diversely in different types of cell death. However, little is known about the role of NINJ1 in IAV-induced PANoptosis and viral pneumonia. Here, we report that IAV infection triggered an increase in the expression of NINJ1, which then oligomerized and mediated cell lysis in infected macrophages. The deficiency of NINJ1 prevented plasma membrane rupture and the release of DAMPs and IL-1β without affecting the progression of cell death. Activation of any single PANoptosis pathway was sufficient to trigger the oligomerization of NINJ1 and robust cell lysis. Accordingly, only when all PANoptosis pathways were concurrently blocked could the oligomerization of NINJ1, cell death, and cell rupture be prevented. Ablation of NINJ1 in vivo also alleviated IAV-induced lung injury and mortality. Furthermore, we revealed an association between NINJ1 upregulation and poor outcomes in patients with COVID-19. Collectively, our findings indicate a pivotal role of NINJ1 in the immunopathology of IAV infection and its potential as a bioindicator of disease severity and prognosis in viral pneumonia and viral sepsis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f0192bd0bcdfc2176df6642ca957782529e315b2" target='_blank'>
              Ninjurin-1 mediates cell lysis and detrimental inflammation of PANoptosis during influenza A virus infection
              </a>
            </td>
          <td>
            Yitian Xu, Ying Zheng, Yan Liu, Cheng Wei, Juan Ren, Wenting Zuo, Runqing Gu, Hongyu Liu, Xiaoyan Deng, Yaxue Liu, Xiao Shang, Weiwei Ge, Ziyao Li, Yijiao Huang, Di He, Xuhui Shen, Zeyi Wang, C. Lyu, Zai Wang, Yuxian Mu, Zihuan Zhang, Hongping Wu, Haibo Li, Bin Cao
          </td>
          <td>2025-09-23</td>
          <td>Signal Transduction and Targeted Therapy</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6ff39811b58af3141f8b13471490c1f390abe0d9" target='_blank'>
              Non-canonical inflammasome drives intrinsic anti-microbial responses in human Natural Killer cells
              </a>
            </td>
          <td>
            N. G. Leborgne, Jadie Acklam, Alexander J. Hogg, Zarema Albakova, Karen Hogg, K. Robinson, Grant Calder, Arnel Villamin, Callum Robson, Freya Pealing, Matthew A. Care, Monika Gonka, James M. Fox, James Iremonger, J. Hewitson, David G. Kent, Alison M. Layton, Frances E. Pearson, Max E. Noble, W. Grey, Jillian L. Barlow, Dave Boucher
          </td>
          <td>2025-10-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bb674fe85695033b3a066007d0322414981ac69f" target='_blank'>
              Epigenetic control of microglial developmental milestones from proliferative progenitors to efficient phagocytes
              </a>
            </td>
          <td>
            Marta Pereira-Iglesias, Duncan Martinson, Carles Falcó, Joel Maldonado-Teixidó, Marco González-Domínguez, Rodrigo Senovilla-Ganzo, S. Beccari, Jorge Valero, Bella Mora-Romero, I. Ballasch, Sarah Viguier, Philipp Hane, Molly Boettiger, J. Reisz, Alba Elías-Tersa, Yasmina Manso, Laura Parkkinen, A. M. Aransay, Federico N. Soria, A. D'alessandro, Eduardo Soriano, M. S. Thion, S. Garel, M. Greter, A. Giralt, Alberto Pascual, Fernando García-Moreno, D. Menassa, José A. Carrillo, Amanda Sierra
          </td>
          <td>2025-11-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>49</td>
        </tr>

        <tr id="Elderly individuals represent a population at disproportionate risk for severe outcomes following SARS-CoV-2 infection. The humoral immune response critically controls viral replication and disease progression. However, the antibody responses and B-cell subsets to mutant strains of SARS-CoV-2 in elderly patients have not yet been fully elucidated. This study aims to elucidate the humoral immune response and B-cell subsets distribution in elderly patients infected with SARS-CoV-2 Omicron variant, thereby providing insights for identifying prognostic biomarkers and developing therapeutic strategies. Using enzyme-linked immunosorbent assays and pseudotyped virus neutralization assays, we determined plasma levels of RBD-specific IgA, IgM, IgG, and neutralizing antibodies from 46 elderly patients with SARS-CoV-2 Omicron variant infection within the first two weeks post-symptom onset (PSO). Using a multicolor flow cytometry approach, we analyze the frequencies of different B-cell subsets and assess the functional characterization of B-cells. In elderly non-severe patients, SARS-CoV-2 RBD-specific antibody levels (IgA, IgM, and IgG) increased progressively within the first two weeks post-symptom onset (PSO). In contrast, severe patients exhibited lower initial antibody levels during 0-3 days PSO but experienced a transient surge (11-fold for IgA, 12-fold for IgM, and 48-fold for IgG) during 4-7 days PSO, which was followed by a decline between 8-14 days. Despite this early elevated response in severe patients, both groups ultimately demonstrated generally weak neutralizing activity against the SARS-CoV-2 Omicron variant. Both elderly patient groups exhibited an higher proportion of plasmablasts (PB). Among these, class-switched IgM-IgG+ PB were significantly more abundant than IgM+IgG-PB. Notably, elderly severe patients showed a further lower in class-unswitched IgM+IgG-PB. Concurrently, IgA expression on PB was upregulated during early disease in all elderly patients. Beyond PB changes, IgG+double negative B (DNB) cells were higher than IgM+DNB cells in both groups. however, severe patients demonstrated a significant reduction in IgG+DNB cells frequencies. Furthermore, these elderly severe patients also exhibited a decline in co-stimulatory molecule expression (HLA-DR+CD80+) within both naive B (NB) and DNB cells, indicating a dysregulated humoral immune response. Elderly individuals generate RBD-specific and neutralizing antibody responses after SARS-CoV-2 Omicron variant infection, which correlate significantly with disease severity and infection duration. Clinically, these findings highlight the potential utility of antibody kinetics as prognostic biomarkers for stratifying elderly patients at high risk of severe outcomes, thereby informing tailored intervention strategies and vaccine booster optimization. Furthermore, SARS-CoV-2 Omicron variant infection affects the distribution of B-cell subsets, which may predict the long-term immune reconstitution capacity post-recovery. Notably, elderly patients exhibit pronounced PB expansion, a response pattern that facilitates antibody class-switching to enhance antiviral immunity. Such expansion represents a key immunologic feature in elderly patients with SARS-CoV-2 Omicron variant infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a46658b01f8e375d2ecb7d1a689cb7e49abb258f" target='_blank'>
              Differential immune profiles in elderly patients with non-severe versus severe SARS-CoV-2 omicron variant infection: dysregulation of antibody responses and B-cell subsets
              </a>
            </td>
          <td>
            Xue Li, Yuanyuan Li, Shiyang Liu, Juanjuan Zhou, Xinxin Yang, Junlian Yang, Wen Xu, Weiwei Chen
          </td>
          <td>2025-11-04</td>
          <td>Immunity & Ageing : I & A</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/587c338bb2620af1926b317f100e4174c0d8d061" target='_blank'>
              Long-term co-maturation of stem cell-derived microglia and neuronal networks: an optimized platform to assess human microglial contribution to neuronal function
              </a>
            </td>
          <td>
            A. Mordelt, I. Schuurmans, Nicky Scheefhals, Marina P. Hommersom, Koen Slottje, Kimberly Mast, Mara Graziani, , Laura J. A. Wingens, Dirk Schubert, N. N. Kasri, Lot D. de Witte
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Herpes simplex virus-1 (HSV-1) is a neurotropic virus that can infect the brain, and an uncontrolled infection can lead to severe encephalitis. NO can exert both antiviral as well as cytotoxic effects in the central nervous system (CNS) depending on its concentration and site of infection. In this study, we report that treatment of an intranasal murine HSV-1 infection with aminoguanidine (AMG) decreases both neuroinflammation and neurodegeneration markers, but its positive effect depends on the time of treatment. Specifically, early treatment with AMG impaired the activation of microglia/monocytes, leading to decreased virus-specific antiviral response and higher viral titers in the brain. However, AMG treatment during the peak of brain infection significantly improved antiviral response, reduced inflammation and improved general clinical score. We also found that treatment with AMG decreased beta amyloid levels during both primary and latent infections and protected from the accumulation of phosphorylated Tau protein during early infection. Our findings position inducible nitric oxide synthetase (iNOS) as a potential therapeutic target for mitigating virus-induced neuroinflammation and neurodegeneration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/58ab87cc99cc57e7e9c2f48c3edddb58f7cd0ecd" target='_blank'>
              The Role of Nitric Oxide in HSV-1 Infection: The Use of an Inducible Nitric Synthase Inhibitor Aminoguanidine to Treat Neuroinflammation
              </a>
            </td>
          <td>
            Magdalena Patrycy, Martyna Janicka, Agnieszka Kauc, Aleksandra Osińska, Małgorzata Antos-Bielska, Klaudia Bylińska, Oliwia Obuch-Woszczatyńska, Paweł Szymański, Marcin Chodkowski, Małgorzata Krzyżowska
          </td>
          <td>2025-09-23</td>
          <td>Microorganisms</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="COVID-19 has been a major public health concern for the past five years. While remarkable work has been done to develop therapies, there is still a need for more treatments to fight this disease. Recently, it was suggested that nisin, an FDA-approved antimicrobial compound, may interfere with SARS-CoV-2 entry into host cells. Here, we show that nisin does not inhibit SARS-CoV-2 replication in vitro. Surprisingly, nisin treatment leads to reduced host-cell death during infection in a dose-dependent manner, suggesting that nisin may mitigate SARS-CoV-2-induced pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c7881f15a54d611593c884757932bc6e4b297393" target='_blank'>
              The antimicrobial peptide nisin promotes host cell survival during SARS-CoV-2 infection
              </a>
            </td>
          <td>
            B. English, A. Radaic, Ross Barrios-Medina, Kerui Lin, P. Kamarajan, Anita Sil, Yvonne L. Kapila
          </td>
          <td>2025-10-01</td>
          <td>Virology Journal</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Microglial proliferation is a principal element of the inflammatory response to brain ischemia. However, the precise proliferation dynamics, phenotype acquisition, and functional consequences of newly emerging microglia are not yet understood. Using multicolor fate mapping and computational methods, we here demonstrate that microglia exhibit polyclonal proliferation in the ischemic lesion of female mice. The peak number of clones occurs at 14 days, while the largest clones are observed at 4 weeks post-stroke. Whole-cell patch-clamp recordings of microglia reveal a homogeneous acute response to ischemia with a pattern of outward and inward currents that evolves over time. In the resolution phase, 8 weeks post-stroke, microglial cells within one clone share similar membrane properties, while neighboring microglia from different clones display more heterogeneous electrophysiological profiles. Super-resolution microscopy and live-cell imaging unmask various forms of cell-cell interactions between microglial cells from different clones. Overall, this study demonstrates the polyclonal proliferation of microglia after cerebral ischemia and suggests that clonality contributes to their functional heterogeneity. Thus, targeting clones with specific functional phenotypes may have potential for future therapeutic modulation of microglia after stroke. Microglia proliferate in response to ischemic stroke. Here, the authors show the clonal dynamics of this proliferation and how clonality contributes to microglial heterogeneity in a mouse stroke model, revealing distinct interclonal interactions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1045bfa3e10603ddbfd71fe37720907cead5c987" target='_blank'>
              Multicolor fate mapping of microglia reveals polyclonal proliferation, heterogeneity, and cell-cell interactions after ischemic stroke in mice
              </a>
            </td>
          <td>
            M. Kikhia, Simone Schilling, Marie-Louise Herzog, Michelle Livne, M. Semtner, Tuan Leng Tay, M. Prinz, Helmut Kettenmann, Matthias Endres, G. Kronenberg, Ria Göttert, K. Gertz
          </td>
          <td>2025-09-16</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>48</td>
        </tr>

        <tr id="Immunosuppressive therapies used in clinics to reduce the risk of rejection in transplanted patients unfortunately also decrease the response of the immune system to the pathogens. Previous data has shown that the most diffuse SARS-CoV-2 variants of concern between 2020 and 2021 showed a different modulation of the host immune response in healthy subjects, with the Delta B.1.617.2 variant leading to a failure in the activation of the adaptive immune response. In this study, the transcriptomic profiles of monocyte-derived macrophages (MDM), isolated from four immunosuppressed kidney transplant patients and exposed to SARS-CoV-2 VOCs, were analyzed and compared with previously published data gathered from immune-competent subjects. Human monocytes were isolated from peripheral blood mononuclear cells (PBMCs) of four kidney transplant patients admitted to the IRCCS Policlinico San Matteo of Pavia (Italy), differentiated into macrophages, and exposed to the active and the UV-inactivated particles of the different SARS-CoV-2 VOCs (D614G, Alpha B.1.1.7, Gamma P.1, Delta B.1.617.2 and Omicron BA.1). Bulk RNA-Seq was performed and significant transcripts were assessed based on Student’s t-test (p-value < 0.05) and Fold change > 2. RNA-Seq data analyses of immunosuppressed MDMs showed that SARS-CoV-2 VOCs, although transcriptionally active, did not induce strong alterations in the transcriptomic profiles of these cells, while a strong down-regulation of key genes involved in the innate immunity pathways was observed when comparing these data to the ones obtained from immunocompetent participants. Overall, this study suggests that patients under immunosuppressive therapies do have an altered macrophage response to SARS-CoV-2 viral infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/04f26f9af852ab5923f6e34e833030407d8ac128" target='_blank'>
              Attenuated Molecular Response to SARS-CoV-2 in MDMs Isolated from Immunosuppressed Transplanted Patients
              </a>
            </td>
          <td>
            Roberta Vazzana, J. Sammartino, N. Cuscino, Roberto Giambruno, C. Carcione, V. Miceli, Matteo Bulati, Valentina Agnese, D. Lilleri, P. Conaldi, Fausto Baldanti, I. Cassaniti, Alessia Gallo
          </td>
          <td>2025-10-28</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9b18f5377f0017134020665026beaa2b6a3157ac" target='_blank'>
              Spatial transcriptomics of compartmentalised inflammation in a natural disease multiple sclerosis cohort
              </a>
            </td>
          <td>
            M. Naughton, R. Kee, Gerry Mullan, Guillermo Lopez Campos, Gavin McDonnell, Owain Howell, Denise C. Fitzgerald
          </td>
          <td>2025-09-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Mpox virus (MPXV), a member of the Orthopoxvirus genus in the Poxviridae family, has long been endemic in Africa. The interaction between MPXV infection and peripheral immune responses is of great significance. However, the activation of signaling pathways and molecular changes in peripheral blood mononuclear cells (PBMCs) following MPXV infection remain poorly understood. This study evaluated the transcriptomic profiles of rabbit PBMCs during the mpox acute and recovery phases. The results showed that MPXV infection significantly altered the transcriptomic profiles of PBMCs. At 6 days post-infection, pathways related to pathogenic infection and IL-1 response were enriched, while at 14 days post-infection, the T cell receptor signaling pathway was enriched. During the mpox acute phase, inflammatory cytokines in serum such as IL-1α, IL-1β, IL-8, and IL-21 were upregulated, while MMP-9 and NCAM-1 were downregulated. In rabbits and rhesus monkeys, key genes upregulated in common during the mpox acute period were associated with the interferon pathway (e.g., the ISG15, OAS, and IFIT families), while downregulated genes were related to B-cell activation and differentiation (e.g., the MS4A1 and FCRL families). Additionally, rabbits developed protective immunity against reinfection, with neutralizing antibodies effectively activated. These findings provide insights into the molecular characteristics of PBMCs changes in in vivo models of MPXV infection, and offer references for the diagnosis, vaccine development, and therapeutic research of mpox.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5a49c159e81a5446db89fd6f6f36a9c258007cfb" target='_blank'>
              Transcriptome Analysis Reveals Host Peripheral Blood Mononuclear Cells Response to Mpox Virus Infection
              </a>
            </td>
          <td>
            Chaode Gu, Caiyun Wang, Chenlu Zhang, Jie Ni, Yun Xia, Hongwei Wang
          </td>
          <td>2025-09-28</td>
          <td>Viruses</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Background: Currently available immunological tests for SARS-CoV-2 assess only antibody responses. Despite the growing evidence that T cells play a crucial role in protection, especially against emerging viral variants, no routine test is available to determine T cell immunity. The prognostic value of SARS-CoV-2-specific antibodies for determining whether individuals are immune and protected against disease remains uncertain. This is in part due to the following: (a) specificity and limitations such as the sensitivity of antibody tests, and (b) the lack of correlation between antibody titers (quantity) and the antiviral function of antibodies (quality). Approximately a quarter of SARS-CoV-2-infected patients with symptoms fail to show seroconversion in serological assays. Methods: The current report describes the development and application of a whole-blood-based assay to detect previous exposure to SARS-CoV-2. Whole blood is stimulated with SARS-CoV-2-derived peptides identified during assay development and stimulation-induced cytokines quantified using a multiplex testing platform. The resulting cytokine profiles are generated using computational tools to identify previous exposure to the virus. Results: The application of the assay revealed a lack of self-awareness of individuals’ COVID-19 infection history and demonstrated the value of this new assay to assess the prevalence of SARS-CoV-2 exposure history and immunity in populations. Conclusions: Positive responses in this assay can facilitate the identification of underlying causes of unexplained symptoms and provide clinically actionable insights for healthcare applications, including in the continued conundrum of post-acute sequela of SARS-CoV-2 infection (PASC or “long COVID”), for which both diagnosis and management remain challenging.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ce36d590cb16fbe5544afe4b778a161b21ae8f73" target='_blank'>
              Whole-Blood Cellular Responses: A Promising Indicator of SARS-CoV-2 Immunity Compared to Serology
              </a>
            </td>
          <td>
            Lucas M. Zhou, E. Duncan, R. Boelig, Margaret Costanzo, J. Currier, Elke S Bergmann-Leitner
          </td>
          <td>2025-09-29</td>
          <td>Journal of Clinical Medicine</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d6db7c438373e1be32f3e8f8962c7eb002d2e0ff" target='_blank'>
              Single-cell profiling reveals that dynamic lung immune responses distinguish protection from susceptibility to tuberculosis
              </a>
            </td>
          <td>
            Fergal J. Duffy, M. L. Neal, Courtney R. Plumlee, Sarah Cohen, B. Gern, A. Diercks, Michael Y Gerner, K. Urdahl, J. Aitchison
          </td>
          <td>2025-10-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Alzheimer’s disease (AD) exhibits progressive cognitive decline and recent scientific studies hint to the peripheral immune system as a contributor. In this study, we isolated peripheral immune cells including CD4 + and CD8 + T cells, CD14 + monocytes and CD19 + B cells from AD patients and age-matched controls via fluorescence-activated cell sorting. Label-free LC–MS/MS-based proteomic expression analysis within each cell type, comparing AD and control groups independently, 387 significantly altered proteins were identified in CD4 + and 121 in CD8 + T cells. Bioinformatic analysis uncovered distinct, cell-type-specific signatures: CD4 + cells showed dysregulation in ribosomal and RNA-binding proteins linked to neurodegeneration and oxidative stress while CD8 + cells showed elevated glycolytic enzyme expression and hyperpolarized mitochondrial membrane potential. Furthermore, mitochondrial functional assays, JC-1 and MitoSOX Red, further supported cell-type-dependent differences in mitochondrial activity. These findings may suggest that peripheral T cells have unique proteomic and functional alterations in AD, implicating mitochondrial dysfunction as a potential contributor to disease pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6b4b7f807e9ebfedbb7659f0f9fe80a617bdd792" target='_blank'>
              Proteomic signatures and mitochondrial dysfunctions in peripheral T cells reveal novel ınsights into Alzheimer’s disease
              </a>
            </td>
          <td>
            Sebile Koca, I. Kiris, Şevki Şahin, S. Karşıdağ, N. Çınar, A. Baykal
          </td>
          <td>2025-11-06</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1185bf27cd38b33e534c27d9aa87381e2cd898fa" target='_blank'>
              Impaired IFNγ responsiveness of monocyte-derived lung cells limits immunity to Mycobacterium tuberculosis
              </a>
            </td>
          <td>
            Weihao Zheng, J. Limberis, Zachary P. Howard, Alexander Mohapatra, Enzo Takagi, J. Ernst
          </td>
          <td>2025-11-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2fef0ecf5b990a10a1f0fae7554cfa28ceb163d2" target='_blank'>
              SARS-CoV-2-induced damage to rat cortical neuronal networks ex vivo is mediated by the pro-inflammatory activation of the cGAS-STING pathway.
              </a>
            </td>
          <td>
            Pamela Martinez-Orellana, Matteo Manzati, Diletta Pozzi, Yingying Xiao, Alessio Di Clemente, Marika Mearelli, Chiara Kalebić, Valentina Perrera, Denise Ferrarini, Tea Carletti, Carmen Falcone, Michele Giugliano, Alessandro Marcello
          </td>
          <td>2025-10-25</td>
          <td>Journal of neurovirology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Mitogen‐activated protein kinase (MAPK) p38 plays a key role in driving the pathology of acute lung injury (ALI), but effective therapeutic targeting remains elusive. Atypical p38 signaling, mediated by interaction with the adaptor protein Tumor Growth Factor β Activated Kinase 1 (TAK1) Binding Protein 1 (TAB1), has so far only been observed during pathological responses, representing a selective and alternative target during pulmonary injury. However, atypical signaling has not been investigated in the context of pulmonary injury and immune responses related to the onset and progression of ALI. Here, we utilized a genetic knock‐in mouse to block influenza A‐induced lung injury mediated by atypical signaling. We report that the loss of TAB1‐p38 interaction reduces weight loss and recovery time, reduces histopathological scores associated with influenza‐induced lung injury early during infection, and prompts earlier recruitment of monocytes to the lungs following infection. These results were found to be independent of viral replication and infectivity, representing the first evidence for the roles of atypical signaling as a driver of host‐mediated pulmonary injury following influenza infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ed7170a2d99ca1c949beb048f13b4c9bf8b5ffef" target='_blank'>
              Role of Atypical MAPK p38 Signaling in the Progression of Influenza A‐Induced Acute Lung Injury
              </a>
            </td>
          <td>
            Jeremy C Burton, Denise L Fahey, Fredejah T. Royer, Yin Zhu, Kaori Sakamoto, Duo Zhang, Wendy T. Watford, Neil J. Grimsey
          </td>
          <td>2025-09-24</td>
          <td>The FASEB Journal</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Background: The COVID-19 pandemic prompted investigation into the interaction between SARS-CoV-2 infection and immune checkpoint inhibitor (ICI) therapy in lung cancer patients. Understanding this interplay is crucial for optimizing cancer immunotherapy. Methods: A retrospective analysis was conducted on lung cancer patients, characterizing changes in peripheral immune cells and plasma cytokines (including IL-10 and IL-12p70) before, during, and after SARS-CoV-2 infection. Progression-free survival (PFS) was compared between ICI-treated patients with and without COVID-19. Cytokine dynamics were further analyzed in a non-infected cohort. Results: SARS-CoV-2 infection induced a prolonged systemic cytokine storm, with elevated IL-10 and IL-12p70 levels and reduced monocyte proportions lasting up to 10 weeks post-recovery. Despite this immune perturbation, COVID-19 did not impair long-term PFS; instead, a transient improvement in disease control was observed in infected patients. In non-infected patients, sustained or increased IL-10 and IL-12p70 levels during ICI therapy were associated with longer PFS (p < 0.05). Conclusions: SARS-CoV-2 infection transiently alters the immune landscape in lung cancer patients without compromising ICI efficacy. The sustained elevation of IL-10 and IL-12p70 may contribute to short-term clinical benefits. Monitoring cytokine dynamics could serve as a prognostic tool for predicting ICI response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/751116a96b162ead6a92605da6ef16112bc11bf9" target='_blank'>
              SARS-CoV-2 Infection Alters the Immune Microenvironment in Lung Cancer Patients Undergoing Immunotherapy and Affects Treatment Outcomes
              </a>
            </td>
          <td>
            Yanjing Peng, Panjian Wei, Meng Gu, Guirong Wang, Teng Ma, Jinjing Tan
          </td>
          <td>2025-09-28</td>
          <td>Viruses</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e56b0f654aeb93a046a73a7a4da19670e8d180d9" target='_blank'>
              Single-cell multiomics reveals archetypal regulatory programs shared across CD4 and CD8 T cell subsets in viral infection
              </a>
            </td>
          <td>
            Sarah K. Walker, J. van der Veeken, Alexander Rudensky, Yuri Pritykin
          </td>
          <td>2025-09-13</td>
          <td>bioRxiv</td>
          <td>1</td>
          <td>18</td>
        </tr>

        <tr id="Introduction Neuroinflammation is a critical factor contributing to secondary brain injury following traumatic brain injury (TBI). This process engages diverse cell types within the central nervous system (CNS), including significant infiltration of myeloid lineage cells–primarily neutrophils and macrophages–during the acute and subacute phases of TBI. These myeloid-derived cells represent a major population that critically influences the development and progression of neuroinflammation. Microglia and peripherally infiltrating macrophages exhibit polarization phenotypes that play a pivotal role in modulating inflammatory changes. Due to their functional and phenotypic similarities, their distinct contributions to the inflammatory response in TBI remain a subject of considerable debate. Lysozyme 2 (Lyz2) is a well-established marker for myeloid lineage cells (including monocytes, macrophages, and neutrophils) in mice, allowing specific targeting and depletion of these cells to dissect their functional roles in TBI. Methods In the present study, we investigated the trend of inflammatory factors during the early stage of TBI using Lyz2-IRES-DTREGFP transgenic mice, which specifically target and deplete Lyz2-positive myeloid cells. Tissue samples for RT-qPCR and flow cytometry were harvested from the perilesional cortex (within a 2-mm radius of the impact site) and the underlying hippocampus. Results and discussion Our findings revealed a considerable reduction in the expression of pro-inflammatory factors (e.g., IL-1β, iNOS, IL-6, IFN-γ) and an increase in the expression of anti-inflammatory factors (e.g., IL-4, IL-10, IL-13, Arg-1). Furthermore, we observed a shift in polarization phenotypes, characterized by a decreased proportion of M1 macrophages and an increased proportion of M2 macrophages. However, during the chronic phase, behavioral and histological analyses revealed worse outcomes. These findings demonstrate that targeted depletion of Lyz2-positive myeloid cells during acute TBI attenuates neuroinflammation. However, this early immunomodulatory shift correlates paradoxically with exacerbated chronic neurological deficits, suggesting that transient suppression of myeloid-driven inflammation may disrupt long-term reparative processes critical for functional recovery after TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f2b62a25efa9a7379563b95a2c6aaa7cdabd0939" target='_blank'>
              Dual role of Lyz2-positive myeloid cells in traumatic brain injury: acute anti-inflammatory effects vs. chronic neurological deterioration
              </a>
            </td>
          <td>
            Hua-Zheng Yan, Yi-Wan Fang, Shi-Yu Zhou, Jian-Xiong Gao, Ming-ming Bian, Yao-Mei Xu, Lin Zhang, Nan Zhang, He-Zuo Lü
          </td>
          <td>2025-10-07</td>
          <td>Frontiers in Cellular Neuroscience</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="
 Background:
 SARS-CoV-2 and influenza infections are associated with an increased risk of cardiovascular events. While the underlying mechanisms remain incompletely defined, mounting evidence points towards endothelial dysfunction and thrombotic activation, caused either directly or indirectly by viral infection.


 Aims:
 We sought to characterise the temporal effects of mild SARS-CoV-2 and H3N2 influenza infection on plasma biomarkers of endothelial, thrombotic and renal function.


 Methods:
 Plasma samples were collected from healthy volunteers enrolled in SARS-CoV-2 (n=7-10) and H3N2 (n=7-11) human challenge studies. Samples were taken at baseline (day 0/–1) and at days 3, 7, 10, 14, and 28 post-inoculation. Commercial ELISAs/colorimetric assays were used to quantify endothelial dysfunction using biomarkers of endothelial-mediated vasomotor control (endothelin-1, nitrate/nitrite, prostacyclin, ADMA, arginine), thrombosis (sCD40L, P-selectin, PSGL-1, tPA, PAI-1, D-dimer, factor IX), and renal function (uromodulin, NGAL, cystatin C, TFF3, OPN). One-way ANOVA, or a mixed effects model, and Dunnet’s test to correct for multiple comparisons, were used to compare baseline biomarker levels with levels at subsequent timepoints.


 Results:
 Infection with SARS-CoV-2 significantly increased thrombosis biomarkers (Figs. 1&2): P-selectin (p=0.025), PSGL-1 (p=0.024), sCD40L (p=0.048), PAI-1 (p=0.008) and tPA (p=0.006&0.008) at days 7 to 14. In contrast, infection with H3N2 resulted in a significant increase in D-dimer levels at day 14 (p=0.025) and no changes in other biomarkers of thrombosis. No changes from baseline were detected in biomarkers of endothelial dysfunction in either group. Uromodulin levels declined by day 28 in the SARS-CoV-2 group (p=0.034), otherwise no changes in biomarkers of renal function were noted in either group.


 Conclusions:
 There are two striking results of this study. Firstly, that for both H3N2 and SARS-CoV-2 infection, it was markers of platelet activation/thrombosis, without changes in endothelial or renal function, that increased after infection. Secondly, that a broader spectrum of these markers was increased in volunteers infected with SARS-CoV-2. These findings suggest distinct thrombotic mechanisms are activated by SARS-CoV-2 and H3N2 and support further investigation of thrombotic profiles in patients infected with other respiratory viruses allowing for strategies to identify and mitigate associated cardiovascular events.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/107604fa6ee17ee4f404ea6d1e3e14fcc6268770" target='_blank'>
              Abstract 4367854: The impact of viral infection with SARS-CoV-2 and influenza on plasma endothelial, thrombotic and renal biomarkers
              </a>
            </td>
          <td>
            Ahmed Bakr, Helen Wagstaffe, L. Papargyris, R. Vaja, Christopher Chiu, N. Kirkby, Jane A Mitchell
          </td>
          <td>2025-11-04</td>
          <td>Circulation</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="The Interferon-Stimulated Gene 15 (ISG15) has a key role during viral infections, since it can modify and regulate the expression of proteins from the host and from viruses. Isg15−/− mice are more susceptible to infectious diseases. ISG15 is induced by type I Interferons (IFN-I) and apart from defense against pathogens, it can also play an important function in cancer or immune-mediated inflammatory diseases. Previous studies reported that ISG15 expression is increased in post-synaptic dendritic cells (DCs) upon interaction with CD4 + T cells. However, data regarding the role of ISG15 in DCs are scarce. The present study assesses the function of ISG15 in DCs activation, migration and ability to mediate T cell activation using bone marrow-derived DCs (BMDCs) and stimulation with lipopolysaccharide (LPS). Activation of DCs was not impaired but tended to be lower in Isg15-deficient mice, as observed by reduced CD40 induction in Isg15−/− BMDCs. Isg15−/− BMDCs induced less proliferation and Granzyme B expression in co-cultured CD8 + T cells. Interestingly, Isg15−/− BMDCs secreted reduced levels of the pro-inflammatory cytokines IL-1β and IL-12 upon LPS stimulation. Mechanistically, our data suggest that ISG15 regulates Caspase-1 activity in DCs leading to lower IL-1 β secretion. In conclusion, this study reveals an essential role for ISG15 modulating DCs inflammatory activity and raises new questions regarding the specific mechanisms of how this protein regulates innate immune responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/05fa00535a2acdc99ae44733e69601b7e28b4dad" target='_blank'>
              ISG15 modulates inflammatory profiles and ability to activate CD8 + T cells in bone marrow-derived dendritic cells
              </a>
            </td>
          <td>
            P. Martínez-Fleta, Clara Pertusa, Irene Fernández-Delgado, R. Izquierdo-Serrano, M. Ramírez-Huesca, Nieves Fernández-Gallego, D. Calzada-Fraile, Elena Moya-Ruiz, Raquel Castillo-González, Susana Guerra, E. Martín-Gayo, F. Sánchez-Madrid
          </td>
          <td>2025-10-24</td>
          <td>Cellular and Molecular Life Sciences: CMLS</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/15afe5675b76ae8f25b12b76fc0894e683993e3d" target='_blank'>
              ODC1 restricts meningeal B cell age-associated-like phenotype and function in multiple sclerosis: a human and experimental study
              </a>
            </td>
          <td>
            J. Zurawski, Martin R. Profant, Alara Tuncer, Jianuo Wang, Miranda Green, Ke Cao, Simon Paris, S. Tauhid, Youmna Jalkh, Molly Quattrucci, R. Chu, Xingshan Cao, Alex Kiss, Tanuja Chitnis, Howard L. Weiner, C. Clish, Rohit Bakshi, Chao Wang
          </td>
          <td>2025-09-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Adipocytes can be infected by SARS-CoV-2, potentially contributing to the obesity-associated severity of COVID-19. Circumstantial evidence points to angiotensin-converting enzyme 2 (ACE2) as the necessary receptor for adipocyte infection, but this has not been demonstrated experimentally. Using differentiated immortalized human preadipocyte lines that we developed, we found that visceral adipocytes express higher levels of ACE2 and are more susceptible to SARS-CoV-2 spike (S)-mediated luciferase-VSV infection than subcutaneous adipocytes. Overexpression of ACE2 significantly increased infection, whereas knockout of ACE2 significantly decreased S-mediated infection. Visceral adipocytes at baseline were susceptible to infection by SARS-CoV-2 (Delta variant); however, increased levels of viral transcript with time were not apparent. ACE2 knockout significantly decreased the susceptibility of visceral adipocytes to SARS-CoV-2, whereas overexpression of ACE2 resulted in increased SARS-CoV-2 infection and was associated with increased viral transcript levels with time, as well as induction of IL6, a marker of the proinflammatory response. Our results demonstrate that ACE2 confers susceptibility to SARS-CoV-2 infection of visceral adipocytes. Higher levels of ACE2 in these cells may play a role in establishment of infection and a proinflammatory response, potentially leading to pathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/02642fcf5cb0da22d039410a9d363e14d3e80030" target='_blank'>
              ACE2-Mediated Infection of Immortalized Human Visceral Adipocytes by SARS-CoV-2
              </a>
            </td>
          <td>
            Francoise Gourronc, Megan I. Ahmann, Michael R. Rebagliati, Aloysious Klingelhutz
          </td>
          <td>2025-09-27</td>
          <td>Viruses</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="ABSTRACT In vitro studies have repeatedly showed that extracellular vimentin (eVIM) promotes the penetration of viruses by acting as an adhesion factor, suggesting that reducing eVIM density in the blood could be an effective approach to treat viral infections. However, despite solid evidence, it has not been previously investigated whether eVIM plays a pathogenic role during viral infections in vivo experiments. Here, we provide in vivo evidence that eVIM plays a critical role during viral infections. The severity of COVID-19 in Roborovski SH101 hamsters was positively correlated with blood concentrations of eVIM during the infection period. The reduction of blood eVIM in the SARS-CoV-2-infected Roborovski SH101 hamster through intravenous injection of hzVSF-v13, a humanized anti-eVIM monoclonal antibody, dramatically improved disease manifestations, such as body weight reduction, body temperature, death rate, and more. It also inhibited the formation of blood clots and systemic inflammation compared to remdesivir or a SARS-CoV-2 neutralizing antibody (6D11F2). Histological examination confirmed the significantly better therapeutic efficacy of anti-eVIM compared to remdesivir or the neutralizing antibody. Quantification of SARS-CoV-2 in the hamsters’ lungs revealed that the viral titer in the anti-eVIM-treated groups was 77% to 80% lower than that in the infection group, while remdesivir and the neutralizing antibody resulted in reductions of 41.9% and 34.7% to 44.1%, respectively. We believe that this work provides a foundation for the development of hzVSF-v13 as an antiviral drug for COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4aeac131b55b918a235c7cedc73efe1a44e4a271" target='_blank'>
              Reduction of extracellular vimentin in blood provides protection against SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Hae-Mi Kim, Mingda Wang, Chongkai Zhai, Sura Kim, Jungha Park, Seong-Tshool Hong
          </td>
          <td>2025-10-07</td>
          <td>Virulence</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e63b1279f51d73cda78726f8cc10b215549aa1ac" target='_blank'>
              NK cells undergo transcriptional and functional reprogramming following Streptococcus pneumoniae infection
              </a>
            </td>
          <td>
            Júlia Torné, Claudia Chica, Tiphaine Camarasa, Bernd Jagla, Matilde Diaz Enes, Aymeric Zellner, S. Mella, V. Libri, M. Hamon
          </td>
          <td>2025-09-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9f82ed18b01ce85ca6d33c26f7281540d94ac720" target='_blank'>
              Respiratory viruses induce ferroptosis-like features in lung epithelial cells
              </a>
            </td>
          <td>
            Ana L. Manzano-Covarrubias, Alessandra Tosato, C. H. Mol-van der Veen, Philip Ahmadyar, Jai Walia, J. De Vries-Idema, Anke Huckriede, Amalia Dolga, Martina Schmidt, Karim Rafie
          </td>
          <td>2025-10-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="A certain degree of self-repair is initiated following spinal cord injury (SCI). Although intraneuronal regeneration and a supportive growth environment are limited, they serve as the foundation for functional recovery after SCI. In this study, we conducted single-cell RNA sequencing combined with spatial transcriptomics and spatial metabolomics to reveal the spatial molecular characteristics of self-repair processes after SCI at single-cell resolution. We identified three cell subsets-Mic2 (a microglia subset), Mac4 (a macrophage subset), and Fib4 (a fibroblast subset)-that express markers associated with spinal cord repair. Mic2 and Mac4 exhibit clustered spatial distribution patterns, whereas Fib4 is predominantly located around the injured spinal cord. Additionally, Mic2 is predominantly distributed in the white matter, particularly in the dorsal region of the injured spinal cord, and exhibits high expression of taurine. Mac4 and Fib4 exhibit high expression of copalic acid and uridine, respectively. In this study, we have identified three distinct cell subsets that express markers associated with wound healing and may promote regenerative processes, and we have determined their spatial transcriptional and metabolic features enriched within these regions. Our dataset represents a valuable resource that offers novel mechanistic insights into the pathobiology of spinal cord injury.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ac7f990261ab040d2dcb9732e55fa91a396956f2" target='_blank'>
              Integrating single-cell RNA sequencing and spatial multi-omics reveals the molecular signature of regeneration after spinal cord injury
              </a>
            </td>
          <td>
            Haoru Dong, Yuanqing Ding, Xingyu Chen, Xiao Xiao, Longnian Zhou, Haiyue Lin, Zezhen Zhang, Yiming Tao, Shiyi Cai, Jianlan Zhao, Xiaomu Li, Rong Xie
          </td>
          <td>2025-10-21</td>
          <td>Biomarker Research</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/42649e5799d217ae2a59e14c7eb9e6893e79caba" target='_blank'>
              Pathogenicity and Transcriptomic Profiling Revealed Activation of Apoptosis and Pyroptosis in Brain of Mice Infected with the Beta Variant of SARS-CoV-2.
              </a>
            </td>
          <td>
            Han Li, Bao-Ying Huang, Gao Qian Zhang, Fei Ye, Li Zhao, Weibang Huo, Zhong Xian Zhang, W. Wang, W. Wang, Xiao Ling Shen, C. Wu, Wen Jie Tan
          </td>
          <td>2025-09-20</td>
          <td>Biomedical and environmental sciences : BES</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Primary open-angle glaucoma (POAG), a leading cause of irreversible blindness, involves complex neurodegeneration in which the contribution of systemic immunity remains enigmatic. Here, we dissect the circulating immune landscape in POAG patients via high-resolution single-cell RNA sequencing of ~1.4 million peripheral blood mononuclear cells (PBMCs) from 110 patients and 110 controls of Chinese ancestry. We revealed significant immune remodeling in POAG, characterized by increased CD4+ T lymphocytes and myeloid cells and impaired cytolytic potential, as evidenced by reduced cell proportions of terminally differentiated CD8+ GZMK+ T cells and NK cells. Transcriptomic analysis revealed a sophisticated dual transcriptional landscape in which both proinflammatory and neuroprotective signaling pathways coexist across multiple immune cell lineages. While TNF and IFNG pathway genes were broadly downregulated, specific inflammatory activation components and neuroprotective genes were upregulated in distinct cell populations, suggesting that POAG represents a complex immunometabolic syndrome characterized by a dysregulated balance between inflammatory and neuroprotective signaling. Cell type-specific eQTL mapping and SMR analysis revealed that POAG genetic risk loci exert their effects through immune gene regulation in specific PBMC subsets. Functional validation using Ifng-/- and Tnf+/- mice in an LPS/NMDA-induced retinal injury model, which mirrored the immune alterations observed in human POAG, demonstrated that genetic deficiency in these pathways markedly exacerbated retinal ganglion cell loss and visual pathway deficits. Our study establishes a crucial link between systemic immune dysregulation—specifically the disrupted balance between inflammatory and neuroprotective signaling—and retinal health, highlighting the importance of restoring this balance for future POAG therapeutic strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fae6abc08a14880e3feddb70f5fc769e7cfeff07" target='_blank'>
              Single-cell RNA-seq reveals cell type-specific molecular and genetic associations with primary open-angle glaucoma
              </a>
            </td>
          <td>
            Huaping Tian, Yuhong Chen, Tujing Zhao, Lin Ye, Hongjing Li, Zheng Li, Wenqiao Qiu, Wentao Wang, Runze Li, Fulin Liu, Haojue Xue, Ruilin Liao, Chao Qu, Jie Li, Liang Zou, Yi Shi, Zhenglin Yang, Lulin Huang
          </td>
          <td>2025-10-10</td>
          <td>Signal Transduction and Targeted Therapy</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Cryptococcal meningitis is a fungal infection in patients with compromised CD4 T cell function. CD4 T cells provide killing signals to macrophages, principally IFNγ, to limit intracellular fungal replication. However, CD4 T cells may also drive inflammatory tissue damage. Yet, it is not fully understood how fungal-specific CD4 T cells infiltrate the brain and how they influence functional phenotypes of CNS-resident myeloid cells. In the current work, we develop a mouse model to track fungal-specific CD4 T cells and determine their influence on microglia. We found IFNγ+ fungal-specific CD4 T cells have limited TCR signalling and characterise a population of inflammatory microglia that upregulate MHCII and IFNγ-regulated genes during infection. Inflammatory microglia have poor fungicidal capacity and significantly expand during infection, a process that depends on CD4 T cell infiltration. Taken together, these data identify the early inflammatory consequences of fungal-specific CD4 T cell infiltration and identify proliferating microglia as important drivers of brain inflammation during infection. Cryptococcal meningitis is a common infection in patients with compromised CD4 T cell function. Using a CD4 T cell activation tracking mouse the authors show the localisation and activation of CD4 T cells in the brain after cryptococcus infection and how these cells interact with MHCII expressing microglia which may increase pathologic brain inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/37f4633c141c3226368499b170bc53f8df43b779" target='_blank'>
              Brain-infiltrating CD4 T cells drive inflammatory microglia proliferation during cryptococcal meningitis in mice
              </a>
            </td>
          <td>
            Sofia Hain, Man Shun Fu, Lucy Wigg, Lorna S. George, D. Lecky, Alexander J Whitehead, Erin Clipston, Ko Sato, Masahiro Ono, Marcel Wuthrich, Bruce Klein, Kazuyoshi Kawakami, J. Rayes, D. Bending, Rebecca A. Drummond
          </td>
          <td>2025-10-09</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a562ae04ce5e7352d04c04260cd955aebf004a62" target='_blank'>
              Spatial transcriptomics reveals injury-responsive compartments and coordinated immune–fibrotic signaling in ANCA-associated renal vasculitis
              </a>
            </td>
          <td>
            Yucheng Tang, Chunhua Zhu, Shuang Chen, Huimei Chen, Hai Qian, Aihua Zhang, Enrico Petretto
          </td>
          <td>2025-09-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Atherosclerosis is a chronic inflammatory disease characterized by lipid accumulation and immune dysregulation, including expansion of pro-inflammatory monocytes and effector T cells, alongside reduced regulatory T cells (Tregs). Bacillus subtilis natto, a spore-forming probiotic, has shown anti-atherosclerotic effects, though its systemic immunomodulatory mechanisms remain unclear. In this study, we employed an AAV-mPCSK9-induced murine atherosclerotic model to investigate the effects of daily B. subtilis natto NTU-18 administration over 16 weeks. High-dimensional flow cytometry using two 13-marker panels enabled longitudinal profiling of 18 peripheral immune cell subsets across lymphoid and myeloid compartments. While no significant changes in serum cholesterol and mild decrease of body weight were observed, B. subtilis natto NTU-18-treated mice presented a significant reduction in aortic lesion area compared to PBS-treated controls. Immune profiling revealed a transient expansion of peripheral myeloid cells and CD44⁺ trained CD8⁺ T cells, followed by increased frequencies of naïve CD8⁺ T cells and reduced central/effector memory subsets at longer time point treatment. In the CD4⁺ T cell compartment, a transient increase in trained cells was accompanied by a sustained enrichment of CD25⁺CD4⁺ Tregs throughout the daily B. subtilis natto NTU-18 treatment. In contrast, no significant differences were observed in Ly6C⁻ or Ly6C⁺ monocytes, neutrophils, or eosinophils. These findings suggest that B. subtilis natto NTU-18 attenuates atherosclerosis progression not through lipid lowering or broad myeloid modulation, but via targeted reprogramming of peripheral T cell responses. This work provides mechanistic insight into the immunotherapeutic potential of B. subtilis natto NTU-18 in atherosclerosis prevention and treatment. • B. subtilis natto NTU-18 significantly reduces aortic plaque burden in atherosclerotic mice without affecting serum cholesterol levels. • B. subtilis natto NTU-18 induces transient immune remodeling, marked by early expansion of trained CD8⁺ and CD4⁺ T cells, followed by increased naïve and regulatory T cells. • The atheroprotective effect is primarily mediated through adaptive immunity as myeloid subsets remain unchanged throughout B. subtilis natto NTU-18 treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/45dd339de260cb5a70cef21d3c450ab6682f7820" target='_blank'>
              Bacillus subtilis natto NTU-18 attenuates atherosclerosis progression by modulating peripheral immune cell alterations
              </a>
            </td>
          <td>
            Jian-Da Lin, Yu-Zhen Ye, Sin-Ren Wang, Wen-Yi Kao, Kung-Ta Lee
          </td>
          <td>2025-10-17</td>
          <td>Applied Microbiology and Biotechnology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a2eb2098ca977adca760b354d10cab15c1ffbb47" target='_blank'>
              Acute Pericentral Liver Injury Induces a Novel Transient Hepatocyte Population
              </a>
            </td>
          <td>
            Syeda Nayab Fatima Abidi, Kerstin Seidel, Ginny Xiaohe Li, Matthew Fernandez, Robert Piskol, Eliah R. Shamir, Christopher W. Siebel, Louis Vermeulen
          </td>
          <td>2025-09-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Acute respiratory distress syndrome (ARDS) is a critical condition characterized by diffuse alveolar damage and intense inflammatory responses. During the COVID‐19 pandemic, its incidence and mortality have remained persistently high. Conventional approaches have struggled to uncover the complex cellular heterogeneity and dynamic inflammatory networks underlying ARDS. The advent of single‐cell sequencing technologies has revolutionized our ability to dissect the molecular mechanisms of ARDS. This review systematically summarizes recent advances in the application of single‐cell sequencing in studying pulmonary inflammation in ARDS, with a focus on its strengths in elucidating immune cell heterogeneity, reconstructing intercellular communication networks, and identifying potential therapeutic targets. Furthermore, we discuss current technical limitations and translational challenges, aiming to provide a theoretical foundation and future direction for translating mechanistic insights into precision medicine for ARDS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b7061390b06d4776270be5e5161ae41668426e25" target='_blank'>
              Single‐Cell Sequencing Redefines Immune Heterogeneity and Communication Networks in ARDS: Toward Precision Therapeutics
              </a>
            </td>
          <td>
            Han-Bing Chen, Anmin Xu, , Jie Chao, Songyun Zhao
          </td>
          <td>2025-01-01</td>
          <td>International Journal of Genomics</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Canine parvovirus (CPV) is a highly contagious virus that can lead to severe clinical complications in dogs. RNA-binding proteins (RBPs) play a crucial role in regulating translation and stabilizing RNA. Due to the failure of the immune system to respond effectively in dogs infected with CPV, this study aimed to investigate various immunological markers in CPV-infected dogs and to evaluate the impact of RBPs from these infected dogs on immune responses. Blood samples were collected from both healthy and parvovirus-infected dogs. Parvovirus infection was confirmed using immunochromatographic kits. Monocytes were isolated, and exosomes were extracted from these cells and other leukocytes. RBPs were isolated from the leukocytes of parvovirus-infected dogs using Fe-nanoparticles conjugated to RNA. The delivery of RBPs into monocytes and leukocytes was achieved through exosomes. Subsequently, the activities of anti-protease, lysozyme, myeloperoxidase, survival rates, and the expression some of the inflammatory response genes were assessed in the recipient cells. Dogs with acute CPV exhibited significantly lower specific antibody titers and comparable total immunoglobulin levels, along with reduced lysozyme and myeloperoxidase activities in their leukocytes compared to asymptomatic dogs. A significant effect of exosomes and RBPs were observed on lysozyme activity, myeloperoxidase levels, and leukocyte survival. The expression of interferon-gamma (IFN-γ) (16.4-fold) and NOX2 (7.61-fold) was significantly elevated in monocytes treated with RBPs compared to untreated cells. Additionally, no viral proteins were found in RBPs extracted from infected animals. The RBPs from infected dogs demonstrated a compensatory role in regulating immune responses in infected animals, rather than mediating immune regulation by CPV through RBPs. These findings enhance our understanding of the immune response alterations in dogs affected by parvovirus infection, the role of RBPs in this process, and the potential development of novel therapeutic approaches.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/826353c3bf2a6b1bbe2291b7e66f76b47184b4f0" target='_blank'>
              The effects of leukocyte’s RNA-binding proteins on the immune responses of dogs infected with canine parvovirus
              </a>
            </td>
          <td>
            Khosravi Mohammad, Bakhshandeh Maedeh, Mosallanejad Bahman
          </td>
          <td>2025-11-07</td>
          <td>BMC Veterinary Research</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="ABSTRACT Human cytomegalovirus (HCMV) is a prolific human herpesvirus that infects most individuals by adulthood. While typically asymptomatic in adults, congenital infection can induce serious neurological symptoms, including hearing loss, visual deficits, cognitive impairment, and microcephaly in 10%–15% of cases. HCMV has been shown to infect most neural cells, with our group recently demonstrating this capacity in stem cell-derived forebrain neurons. Infection of neurons induces deleterious effects on calcium dynamics and electrophysiological function paired with gross restructuring of neuronal morphology. Here, we utilize an induced pluripotent stem cell-derived model of the human forebrain to demonstrate how HCMV infection induces syncytia, drives neurite retraction, and remodels microtubule networks to promote viral production and release. We establish that HCMV downregulates microtubule-associated proteins while largely sparing other cytoskeletal elements. Furthermore, we pharmacologically modulate microtubule dynamics using paclitaxel (stabilize) and colchicine (destabilize) to examine the effects on neurite structure, syncytial morphology, and viral release. With paclitaxel, we found improvement of neurite outgrowth, but neither paclitaxel nor colchicine impacted viral titers. Together, these data suggest that HCMV infection-induced disruption of microtubules in human cortical neurons can be partially mitigated with microtubule stabilization, suggesting a potential avenue for future neuroprotective strategies. IMPORTANCE Infection by human cytomegalovirus (HCMV) continues to cause significant damage to human health. In the absence of a vaccine, vertical transmission from mother to fetus can result in profound neurological damage impacting quality of life. These studies focus on understanding the impact of HCMV infection on forebrain cortical neurons derived from induced pluripotent stem cells (iPSCs). We show that infection results in loss of neurite extension accompanied by cell-to-cell fusion. These pathogenic changes involve HCMV infection-mediated disruption of the microtubule network in iPSCs from different patient backgrounds. The microtubule stabilization agent paclitaxel partially protected neurite length and altered syncytia morphology without impacting viral replication. This work is part of our continued efforts to define putative strategies to limit HCMV-induced neurological damage. Infection by human cytomegalovirus (HCMV) continues to cause significant damage to human health. In the absence of a vaccine, vertical transmission from mother to fetus can result in profound neurological damage impacting quality of life. These studies focus on understanding the impact of HCMV infection on forebrain cortical neurons derived from induced pluripotent stem cells (iPSCs). We show that infection results in loss of neurite extension accompanied by cell-to-cell fusion. These pathogenic changes involve HCMV infection-mediated disruption of the microtubule network in iPSCs from different patient backgrounds. The microtubule stabilization agent paclitaxel partially protected neurite length and altered syncytia morphology without impacting viral replication. This work is part of our continued efforts to define putative strategies to limit HCMV-induced neurological damage.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/43ff406a50f0e094bdc2efb44261948bcae00376" target='_blank'>
              HCMV infection of terminally differentiated neurons disrupts microtubule organization, resulting in neurite retraction
              </a>
            </td>
          <td>
            Jacob W. Adelman, Andrew T Sukowaty, Kaitlyn J Partridge, Jessica E. Gawrys, Allison Akins, S. Terhune, Allison D. Ebert
          </td>
          <td>2025-10-08</td>
          <td>Microbiology Spectrum</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3d493562d9cbf669c771bb336ea8a59baf52c39a" target='_blank'>
              A TLR7/9-IFNα-LDHB axis drives vital NET release and compromises antibacterial defense in lupus
              </a>
            </td>
          <td>
            Eden G. TenBarge, Ashley D. Wise, Morgan L. Hetzel, Helene A. Hoover, Helia Esfandiari, Bailey E. Holder, Eva Belevska, Ellie C. Mennen, Sarah R. McDaniel, Nicole M. Vaccaro, Courtney C. Lucca, Jonathan M. Williams, Jennifer Ferris, Timothy E Sparer, Leslie J. Crofford, Jeffry D. Bieber, Andrew J. Monteith
          </td>
          <td>2025-10-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Background PDLIM2, a PDZ-LIM domain-containing protein expressed highest in the lung and immune cells, serves as a unique tumor suppressor and immune modulator, mainly by turning off the activation of the master transcription factors NF-ΚB and STAT3. While its role in cancer is established, the involvement of PDLIM2 in viral infection remains unclear. Results Here, we analyzed public gene expression data of blood leukocytes, bronchoalveolar lavage cells, and lung tissues from uninfected healthy humans and those infected with the respiratory virus SARS-CoV-2 or influenza. We found that PDLIM2 expression was repressed by viral infection, and notably, this repression correlated with the severity of infectious diseases. Consistently, the expression level of PDLIM2 was negatively associated with NF-ΚB and STAT3 activity across a diverse range of cell types, such as macrophages, monocytes, neutrophils, T cells, alveolar type 1 and 2 epithelial cells, airway epithelial cells, and fibroblasts. Accordingly, cells with low PDLIM2 expression exhibited aberrant activation of signaling pathways essential for cellular functions and immune responses. Conclusions These findings highlight PDLIM2 repression as a common mechanism underlying human viral infectious diseases and suggest PDLIM2 as a potential biomarker and therapeutic target for disease prognosis, prevention, and treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/528f6601512aa6e797b7f0747ef8e893f248a31f" target='_blank'>
              PDLIM2 Repression: A Common Mechanism in Viral Lung Infection
              </a>
            </td>
          <td>
            Feng Gao, Yongzheng W. Chen, Steven D. Shapiro, Gutian Xiao, Z. Qu
          </td>
          <td>2025-09-15</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1effa2c7ea912aff0bb83ba34f27469859a34952" target='_blank'>
              Chronic sensing of host-derived lipids is an all-in-one signal that primes and activates NLRP3
              </a>
            </td>
          <td>
            Océane Dufies, M. di Gioia, Roberto Spreafico, Piao J Tan, James R. Springstead, Sean A Prell, Junning Case, C. Gao, K. Wei, Hao Wu, Ivan Zanoni
          </td>
          <td>2025-10-30</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c48ccb41d3f252f85b5277e853ac6cb2ae72c91e" target='_blank'>
              Human immune response to primary cryptosporidiosis parallels murine infection models
              </a>
            </td>
          <td>
            Dana M. Van Fossen, Haroldo J. Rodriguez, Farha Naz, Carol A. Gilchrist, Justin J. Taylor, W. A. Petri, Audrey C. Brown
          </td>
          <td>2025-10-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Despite heavy exposure to Mycobacterium tuberculosis (Mtb), some individuals are resistant to TST and IGRA conversion (RSTRs). The functional and immunological mechanisms governing resistance are poorly understood. We hypothesized that RSTR and LTBI alveolar macrophages (AMs) respond differently to Mtb infection with transcriptional programs that are distinct from peripheral blood monocytes. We examined media and Mtb-infected AMs from bronchoalveolar lavage fluid collected from a RSTR cohort in Uganda with over 10 years of clinical follow-up. With transcriptional profiles of BAL cells analyzed immediately after collection, gene set enrichment analysis (GSEA) revealed 13 differentially expressed gene sets between RSTR (n = 19) and LTBI (n = 26) groups, including one (Hallmark E2F targets) which was positively enriched in the RSTR group (FDR < 0.3). In a subset of this cohort (n = 7 RSTR and 8 LTBI), AMs were examined with and without Mtb infection. When comparing the RSTR and LTBI groups, we identified 52 DEGs including 22 in the media condition, 15 with Mtb stimulation, and 11 with the interaction term (FDR < 0.2, Log 2-fold change > 1/<-1). Notably, RSTR AMs appear to upregulate inflammation more strongly than LTBI counterparts, including Hallmark inflammatory response (FDR < 0.2), IFNγ response (FDR < 0.1), and IFNα response (FDR < 0.1) while existing in a more non-inflammatory state at baseline (Hallmark TNF signaling via NF-kB (down, FDR < 0.1), inflammatory response (down, FDR < 0.1). In a comparison of peripheral blood monocyte gene expression profiles from the same cohort, there were both shared and AM-specific RSTR profiles detected. Together, these results suggest that RSTR and LTBI AMs have different basal and Mtb-induced transcriptional profiles, including some that differ from peripheral blood monocytes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/74f6f6a91106ca8fedadea27abfb904beaf5f882" target='_blank'>
              Alveolar macrophage transcriptional signatures associated with resistance to TST/IGRA conversion following Mycobacterium tuberculosis exposure
              </a>
            </td>
          <td>
            Austin M. Haynes, Cristian Ovadiuc, G. Peterson, William Worodria, Sophie Nalukwago, Timothy Muwanguzi, M. Nsereko, Catherine M. Stein, Kimberly A. Dill-McFarland, Harriet Mayanja-Kizza, W. H. Boom, R. M. Segnitz, T. Hawn
          </td>
          <td>2025-10-31</td>
          <td>BMC Genomics</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="BACKGROUND: The high incidence of thrombotic complications in patients with SARS-CoV-2 infection significantly worsens the prognosis of the disease. The primary issue is limited comprehension on the mechanisms by which systemic inflammation, neutrophil activation, extracellular neutrophil traps, and microvesicle-mediated hemostasis disorders are interconnected. 
AIM: This study aimed to investigate the link between microvesicles and extracellular neutrophil traps and the occurrence of coagulopathies in patients with SARS-CoV-2 infection. The quantitative and qualitative characteristics of these phenomena were assessed based on the severity of the patients’ condition. 
METHODS: The study included 213 patients with SARS-CoV-2 infection (138 patients with moderate disease and 75 with severe disease) and 20 healthy donors. The patients underwent blood chemistry, coagulation, and hematology tests. A quantitative analysis of microvesicles was performed using flow cytometry with monoclonal antibodies specific for surface markers (CD45, CD3, CD14, CD15, and CD61). The interaction of microvesicles with extracellular neutrophil traps was observed by confocal microscopy (Leica TCS SP5) using fluorescent labels (DAPI, FITC, APC, and PE) and subsequently analyzed for colocalization using a LAS AF package. Statistical analysis was conducted using the Student’s t-test, Spearman’s correlation coefficient, and linear regression methods. 
RESULTS: The patients with moderate SARS-CoV-2 infection had hypercoagulation (fibrinogen, 4.8 [4.00; 5.60] g/L; D-dimer, 0.78 [0.30; 1.28] mg/L), with increased levels of neutrophil-derived (CD15⁺, 53.34% ± 6.92%) and platelet-derived (CD61⁺, 59.74% ± 11.22%) microvesicles. Tissue factor-enriched filamentous extracellular neutrophil traps with microvesicles were identified. The severe cases were associated with decreased levels of neutrophil-derived (CD15⁺, 10.32% ± 4.29%) and platelet-derived (CD61⁺, 20.9% ± 6.01%) microvesicles, thrombocytopenia (139.5 [104.25; 177.75] × 10⁹/L), hypocoagulation (international normalized ratio: 2.60 [2.32; 3.58]), and CD62⁺-positive aggregates. 
CONCLUSION: Microvesicles and extracellular neutrophil traps play a key role in dysregulated hemostasis in patients with SARS-CoV-2 infection. Early hypercoagulation is mediated by their procoagulant activity, and severe cases are associated with decreased levels of peripheral microvesicles, which is indicative of consumptive coagulopathy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8626ad642543d166828191cbb50e38f6c9ad655a" target='_blank'>
              Role of Microvesicles and Netosis in Coagulopathy in Patients With SARS-CoV-2 Infection: A Randomized Clinical Trial
              </a>
            </td>
          <td>
            Elena S. Gracheva, Ilshat G. Mustafin, Dmitry V. Samigullin, D. Abdulganieva
          </td>
          <td>2025-09-24</td>
          <td>Kazan medical journal</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="ntroduction. Recent studies have convincingly demonstrated the ability of the SARS-CоV-2 coronavirus pathogen to exacerbate the severity of cardiovascular diseases through the formation of cardiorespiratory pathology, partly due to endothelial injury. Purpose. To determine the impact of cardiovascular disease on the incidence of SARS-CoV-2 coronavirus infection in patients residing in southern Iraq. Materials and methods. An analysis of 120 blood samples from patients residing was conducted to identify the presence of SARS-CoV-2 coronavirus infection in patients with cardiovascular disease manifestations and in patients with no confirmed cardiovascular pathology. A high-tech research method, the quantitative PCR (qPCR), was used to detect SARS-CoV-2. Results. The study found 95 positive and 25 negative samples for SARS-CoV-2. The positive blood samples contained RdRp, E, and N genes, and the cycle threshold (CT) depended on their identification. The highest number of positive samples was detected in autumn and in the first month of winter, mainly in patients aged 19–27, 64–72, and 73–81. A higher prevalence of viral infection was observed among women and patients with ventricular septal defects. Conclusion. The SARS-CoV-2 infection is influenced by patients’ age and the presence of clinical manifestations of cardiovascular pathology. The data obtained serve as a basis for planning further studies aimed at analyzing the entire SARS-CoV-2 genome to identify the strains identified in this study.
 Введение. Исследованиями последних лет показана способность возбудителя коронавирусной инфекции SARS-CoV-2 усугублять тяжесть течения сердечно-сосудистых заболеваний вследствие формирования кардиореспираторной патологии, отчасти за счет поражения эндотелия. Цель. Определить влияние сердечно-сосудистых заболеваний на частоту встречаемости коронавирусной инфекции SARS-CoV-2 у пациентов, проживающих на юге Ирака, в зависимости от их возраста и пола. Материалы и методы. Осуществлен анализ 120 образцов крови пациентов, проживающих в провинции Ти-Кар на юге Ирака, на предмет выявления наличия коронавирусной инфекции SARS-CoV-2 у пациентов с проявлениями сердечно-сосудистых заболеваний и у пациентов с отсутствием констатированной сердечно-сосудистой патологии. Для выявления SARS-CoV-2 использован высокотехнологичный метод исследования – количественной ПЦР (qPCR). Результаты. По результатам исследования выявлено 95 положительных (в отношении вируса SARS-CoV-2) образцов, 25 образцов были отрицательными. В положительных образцах крови обнаружены гены RdRp, E и N, а порог цикла (CT) зависел от их идентификации. Наибольшее количество положительных проб выявлено в осенний период и первый месяц зимнего периода времени, преимущественно у пациентов в возрасте 19–27, 64–72 и 73–81 года. Большее носительство вирусной инфекции наблюдалось среди женщин и пациентов с дефектами межжелудочковой перегородки. Заключение. На инфицированность SARS-CoV-2 влияет возраст пациентов и наличие у них клинических проявлений сердечно-сосудистой патологии. Полученные данные служат основой для планирования выполнения дальнейших исследований, направленных на анализ всего генома SARS-CoV-2 для выявления его штаммов, идентифицированных в данном исследовании.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d4b65adae6d5521e19a9e776877483c21a7f49d1" target='_blank'>
              Molecular Identification of SARS-CoV-2 in Patients with Heart Diseases in Thi-Qar Province, South of Iraq
              </a>
            </td>
          <td>
            T.R. Lafta, B.A. Jarullah
          </td>
          <td>2025-09-22</td>
          <td>Лабораторная диагностика. Восточная Европа</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e4a5d524256ca24b7d9653ca688695b9cdf80bc2" target='_blank'>
              Selective S1P Receptor Modulation in Multiple Sclerosis Alters CXCL13:CXCR5-Associated Immune Activities Without Impacting Anti-SARS-CoV-2 Immunity.
              </a>
            </td>
          <td>
            A. Harrer, RF Radlberger, Beate Buchegger, Brooke Slade, Thomas Haybaeck, Hannes Oberkofler, Konstantin E Thiel, Ferdinand Otto, Tobias Moser, P. Wipfler
          </td>
          <td>2025-10-08</td>
          <td>Neurology and therapy</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/49cdf4d2b06dc0c77173ce97caf0d6a3fa0e9a28" target='_blank'>
              Single-Cell Immune Profiling Reveals Non-classical Monocyte-Driven Immunodepression in Tuberculosis Treatment Non-Responders
              </a>
            </td>
          <td>
            Yang Che, Yiqun Xiong, Dongliang Zhang, Yahong Qu, Hao Shen, Weixin Wang, Junshun Gao, ZhenBo Wang, Yi Chen, Zhihong Shen
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Innate immunity is the first line of defense against infections, including the detection and response to SARS-CoV-2. Cells of the innate system are usually activated within hours after pathogen exposure and do not generate conventional immunological memory. In this review, the current knowledge of the innate immune cells and of pattern-recognition receptors in sensing and responding to SARS-CoV-2 to mount a protective response has been shortly reviewed. Subsequently, the evasion strategies of the virus, as the inhibition of IFN-I/III production and autophagic response, counteracting the innate cell activity (including NK cells), have been briefly outlined. In the course of the infection, these strategies are also capable of rendering dysfunctional most innate cells, thus deeply interfering with the onset and maintenance of adaptive immunity. Possible mechanism(s) for the maintenance of dysfunctional innate immune response are also discussed. In this context, the importance of a rapid and robust activation of innate immunity through toll-like receptor (TLR) 4 as a key paradigm central to host defense against COVID-19 pathogenesis is also illustrated. We also discuss how the viral excess plus inflammatory signals upregulating TLR4 on innate cells may initiate a vicious loop which maintains and improves hyperinflammation, leading to the most critical outcomes. Targeting the TLR4 or its signaling pathway may be a promising therapeutic strategy, offering the dual benefits of viral suppression and decreasing inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cf626753ecf348c0167bafcded213489d5356d66" target='_blank'>
              The innate immune response in SARS-CoV2 infection: focus on toll-like receptor 4 in severe disease outcomes
              </a>
            </td>
          <td>
            Enrico Maggi, Nadine Landolina, Francesca Romana Mariotti, E. Munari, N. Tumino, P. Vacca, B. Azzarone, Lorenzo Moretta
          </td>
          <td>2025-10-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="To investigate relevant biomarkers that might aid in the diagnosis and monitoring of long COVID (LC), an analysis of IFN-α, IFN-β, ISG15, and ISG56 transcripts was performed by Real-Time PCR among people of working age who had been infected with SARS-CoV-2 one year prior to the study [LC and non-long COVID (NLC)]. Despite no differences in the transcript levels of IFN-α, IFN-β, ISG15, and ISG56 between LC and NLC, higher IFN-β mRNA levels were observed among LC compared to NLC individuals who were hospitalized for more than 10 days during acute SARS-CoV-2 infection. Moreover, previously SARS-CoV-2 infected participants that did not require respiratory support and developed LC exhibited higher levels of IFN-α and IFN-β compared to NLC with the same clinical characteristics. These results highlight that SARS-CoV-2 infection leads to changes in peripheral innate immune pathways, which could have implications for the development of LC.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f03dce13a960828a5cadacfe53978386574cb65f" target='_blank'>
              Long COVID and Type I IFN Signature in Working-Age Adults: A Cross-Sectional Study
              </a>
            </td>
          <td>
            Letizia Santinelli, E. Gentilini Cacciola, L. Bortolani, M. Ridolfi, L. Maddaloni, Federica Frasca, M. Fracella, Ginevra Bugani, G. d’Ettorre, Claudio M Mastroianni, Giancarlo Ceccarelli, G. d'Ettorre
          </td>
          <td>2025-09-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>41</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/eaf43845c509a3749cf591b678f0bedd9e366627" target='_blank'>
              Alzheimer’s disease causes bone marrow myelopoiesis dysfunction
              </a>
            </td>
          <td>
            M. A. Abellanas, Leyre Basurco, Maitreyee Purnapatre, Chiara Burgaletto, Giulia Castellani, Sarah Phoebeluc Colaiuta, Javier Maria Peralta-Ramos, Angham Ibraheem, Sama Murad, Paola Antonello, Mariángeles Kovacs, Yuliya Androsova, Bar Nathansohn, Hannah Partney, L. Cahalon, Rafael Valdes-Mas, Joseph M. Josephides, T. Salame, M. Espelosin, M. Cuadrado‐Tejedor, A. García-Osta, Aleksandra Deczkowska, Michal Schwartz
          </td>
          <td>2025-10-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Epigenetic scarring of terminally dysfunctional (TDysf) CD8+ T cells hinders long-term protection and response to immune checkpoint blockade during chronic infections and cancer. We developed a faithful in vitro model for CD8+ T cell terminal dysfunction as a platform to advance T cell immunotherapy. Using TCR-transgenic CD8+ T cells, we found that 1-week peptide stimulation, mimicking conditions in previous models, failed to induce a stable exhaustion program. In contrast, prolonged stimulation for 2–3 weeks induced T cell dysfunction but triggered activation-induced cell death, precluding long-term investigation of exhaustion programs. To better mimic in vivo exhaustion, we provided post-effector, chronic TGF-β1 signals, enabling survival of chronically stimulated CD8+ T cells for over 3 weeks. These conditions induced a state of terminal dysfunction, marked by a stable loss of effector, cytotoxicity, and memory programs, along with mitochondrial stress and impaired protein translation. Importantly, transcriptomic and epigenetic analyses verified the development of terminal exhaustion-specific signatures in TDysf cells. Adoptive transfer of TDysf cells revealed their inability to recall effector functions or proliferate after acute lymphocytic choriomeningitis virus rechallenge. This tractable model system enables investigation of molecular pathways driving T cell terminal dysfunction and discovery of therapeutic targets for cancer or chronic infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cc4dbe9ec01dc079f493706a4c9a1123f839c591" target='_blank'>
              Faithful modeling of terminal CD8+T cell dysfunction and epigenetic stabilization in vitro
              </a>
            </td>
          <td>
            Amira Yousif, Abbey A. Saadey, Ava Lowin, Asmaa M. Yousif, Ankita Saini, Madeline R. Allison, Kelley Ptak, Eugene M Oltz, Hazem E. Ghoneim
          </td>
          <td>2025-10-08</td>
          <td>JCI Insight</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="A Proliferation-Inducing Ligand (APRIL) is a tumour necrosis factor superfamily member with multiple effector roles in the peripheral and central nervous system (CNS). In the CNS, APRIL helps maintain immune homeostasis and supports neuronal survival, yet whether it can therapeutically modulate acute neuro-inflammatory and neurodegenerative processes is unclear. To investigate this in a severe neuro-inflammatory context, we tested whether local APRIL delivery can influence microglial/astrocytic responses and demyelination in the cuprizone (CPZ) mouse model of neuro-inflammation and demyelination. We applied adeno-associated virus (AAV)–mediated gene transfer to drive APRIL expression by cortical neurons positioned directly above the splenium of the corpus callosum. Following CPZ intoxication, we evaluated microglial and astrocytic activation and myelin content by in vivo T2 and diffusion magnetic resonance imaging (MRI), and validated them by post-mortem quantitative immunohistochemistry (IHC) and bulk transcriptomic and proteomic profiling. T2 and diffusion MRI, corroborated by quantitative IHC, demonstrated that secretion of APRIL by cortical neurons attenuated CPZ-induced microglial recruitment and demyelination in the splenium, but not in the cortex. Integrated transcriptome-proteome analysis of splenium and cortex, further supported by IHC, highlighted astroglial lipid-metabolic circuitry - marked by the astrocytic fatty-acid-binding protein 7 (Fabp7) - as a candidate axis underlying APRIL’s effects to reduce inflammatory cell recruitment and myelin preservation. AAV-mediated expression of APRIL by cortical neuron counteracted microglial recruitment and demyelination in the splenium of CPZ-treated mice. Our multi-omics integration analysis nominated several pathways, including Fabp7-linked astrocytic lipid metabolism, to elucidate APRIL’s mechanism of action. Together, these findings provide a framework for the mechanistic dissection of APRIL’s therapeutic potential and further translational evaluation in CNS pathologies characterised by acute neuro-inflammatory responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b73ba8336580ec9e7f5e7539d0fbcc48e4944d3b" target='_blank'>
              AAV-mediated delivery of a proliferation inducing ligand (APRIL) to cortical neurons limits inflammation and demyelination in the corpus callosum of the cuprizone mouse model
              </a>
            </td>
          <td>
            Leonardo Ricciardi, Federica Di Marco, Marion Decrop, Julia Di Stefano, Tejaswini Kakunuri, Joëlle van Rijswijk, N. Vidas-Guscic, Yousra El Ouaamari, Alexandro A. Bufi, Ignace Van Spilbeeck, Johan van Audekerke, Carole Faghel, Esther Bartholomeus, Eva Lion, Nathalie Cools, Steven Van Laere, I. Cicalini, Vincenzo de Laurenzi, Una Fitzgerald, D. Pieragostino, B. Huard, P. Del Boccio, Peter Ponsaerts, M. Verhoye
          </td>
          <td>2025-10-27</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Background: Current disease-modifying therapies (DMTs) for multiple sclerosis (MS) attenuate pathogenic immune responses but are limited by safety and tolerability concerns. Antigen-specific tolerance approaches provide targeted immunomodulation yet remain constrained by their dependence on known autoantigens. LPX-TI641, an orally bioavailable, clinical-stage small-molecule agonist of Tim-3/4, represents an antigen-independent strategy to restore immune tolerance by expanding regulatory T cells (Tregs). Methods: LPX-TI641 was evaluated in vitro for its ability to induce Treg populations in murine splenocytes. Therapeutic efficacy was assessed in vivo using MOG35–55- and PLP139–151-induced experimental autoimmune encephalomyelitis (EAE) mouse models. Ex vivo, peripheral blood mononuclear cells (PBMCs) from people with MS (PwMS) were analyzed for Treg phenotype and function in response to LPX-TI641. Results: LPX-TI641 induced dose-dependent expansion of CD4+Foxp3+ and CD4+Foxp3+Tim-3+ Tregs in vitro. In EAE models, treatment significantly reduced disease severity, prevented relapses, and maintained clinical benefit after discontinuation. In PBMCs from patients with MS, LPX-TI641 restored diminished Tim-3+ Treg populations and reversed Treg dysfunction in recall assays. Efficacy in animal models was comparable to or exceeded that of high-efficacy DMTs, including natalizumab. Conclusions: LPX-TI641 promotes antigen-independent immune tolerance through Tim receptor agonism and Treg expansion. These findings support its potential as a novel therapeutic candidate for MS, addressing the limitations of current DMTs.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/af8adb7960be79136d7ae8d5239c89d671d625cc" target='_blank'>
              LPX-TI641, a Tim3/4 Agonist, Induces Long-Term Immune Tolerance in Multiple Sclerosis Models
              </a>
            </td>
          <td>
            Anas M. Fathallah, Abdulraouf Ramadan, Basel Karzoun, Hannah Leahy, Nimita Dave, Raed Khashan, Saleh Allababidi, S. Saidha, Sarah Madani
          </td>
          <td>2025-10-30</td>
          <td>Pharmaceutics</td>
          <td>0</td>
          <td>44</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dc9320984fb7ca80afa8b2d49d724dd86390a378" target='_blank'>
              Transposable Elements and Homotypic Niches Drive Immune Dynamics and Resistance in Melanoma Epigenetic-based immunotherapy
              </a>
            </td>
          <td>
            Erika Ciervo, Francesco Ceccarelli, A. D. Di Giacomo, Piera Grisolia, A. Covre, Z. M. Besharat, Antonio De Falco, F. Caruso, Luigi Laezza, Luigi Ferraro, Gloria Mas Martin, M. F. Lofiego, Tommaso Sani, E. Ferretti, Yan Guo, Sean B. Holden, R. Mortarini, A. Anichini, M. Maio, T. Noviello, M. Ceccarelli
          </td>
          <td>2025-10-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>60</td>
        </tr>

        <tr id="Ferroptosis plays a key role in neuronal death and functional outcomes following traumatic brain injury (TBI). While TBI affects diverse cell types in injured brain regions, the sex- and cell type-specific responses to ferroptosis during the acute phase in the immature brain remain poorly understood. Dexmedetomidine (DEX), a selective alpha-2 adrenergic receptor agonist, has been shown to reduce inflammation and improve survival outcomes in TBI patients, but its sex- and cell type-specific effects on ferroptosis are unclear. This study investigated whether TBI induces sex- and cell type-specific ferroptotic responses and examined the effects of DEX during the acute post-injury phase in a juvenile mouse model. By concurrently isolating neurons and microglia from the same animals, we demonstrate that TBI prompts distinct sex- and cell type-specific ferroptosis responses, including differential regulation of genes involved in iron and lipid metabolism, oxidative stress, and proinflammatory pathways in neurons and microglia. DEX treatment significantly improved behavioral outcomes and reduced iron overload, lipid peroxidation, and neuroinflammation, thereby decreasing ferroptosis in both neurons and microglia. However, its effects were less prominent in neurons from female mice. Further analysis indicated that these sex- and cell type-specific responses to DEX may be partially due to differences in alpha-2 adrenergic receptor expression in neurons and microglia following TBI. Overall, our findings offer new insights into the mechanisms underlying sex- and cell type-specific responses to ferroptosis and DEX treatment, highlighting the broader implications for lipid metabolism, oxidative stress, and inflammation in the immature brain during the acute phase after TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a73bf058969e84b7af62fcf495bc38cca54174d0" target='_blank'>
              Sex- and cell type-specific effects of dexmedetomidine on ferroptosis in neurons and microglia following traumatic brain injury in juvenile mice
              </a>
            </td>
          <td>
            Jie Fan, Stefanie Tasevski, Yara Mashal, Tia Atoui, Zahrah Naseer, Zhi Zhang
          </td>
          <td>2025-11-06</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Inflammation is a key driver of atherosclerosis, yet the mechanisms sustaining inflammation in human plaques remain poorly understood. This study uses a network-based approach to identify immune gene programs involved in the transition from low- to high-risk (rupture-prone) human atherosclerotic plaques. Expression data from human carotid artery plaques, both stable (low-risk, n = 16) and unstable (high-risk, n = 27), were analyzed using Weighted Gene Co-expression Network Analysis (WGCNA). Bayesian network inference, operated on the eigengene values from the WGCNA, further extended the WGCNA analysis, and similarity to the signature of T cell subsets was validated in single-cell RNA sequencing data of human plaques, and a loss-of-function study in a mouse model of atherosclerosis. In silico drug repurposing was performed to identify potential therapeutic targets. Our analysis revealed a distinct gene module with a prominent T cell signature, particularly in unstable plaques. Key regulatory factors, RUNX3, IRF7 and in particular PRDM1, were significantly downregulated in plaque T cells from symptomatic versus asymptomatic patients, indicating a protective role. Additionally, as PRDM1 is downstream of IRF7, we opted for PRDM1 as a key target. T cell-specific Prdm1 deficiency in Western-type diet fed Ldlr knockout mice featured accelerated plaque progression. Finally, as PRDM1 targeting drugs are not yet available, we performed in silico drug repurposing, identifying EGFR inhibitors as promising therapeutic candidates. This study highlights a PRDM1-regulated T cell network that distinguishes high-risk from low-risk plaques and demonstrates the regulatory role of T cell PRDM1 in controlling atherosclerosis, positioning this pathway as a promising therapeutic target.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f34e4554f0ac8ef0c24371ddf088cb18d8078602" target='_blank'>
              Identification of a PRDM1-regulated T cell network to regulate atherosclerotic plaque inflammation
              </a>
            </td>
          <td>
            Han Jin, Sanne L. Maas, Yuchi Zou, Chang Lu, Baixue Yu, Rosanna Huchzermeier, S. Nadeau, Jessica Dos Santos, M. Gijbels, Barend M. E. Mees, Evgueni Smirnov, L. Matic, Ulf Hedin, Pasquale Maffia, Claudia Monaco, J. Sluimer, Gislâine A. Martins, Emiel P. C. van der Vorst, Erik A. L. Biessen
          </td>
          <td>2025-10-02</td>
          <td>Genome Medicine</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="HIV-associated neurocognitive impairment (HIV-NCI), a comorbidity of human immunodeficiency virus (HIV) infection, affects up to 50% of people with HIV (PWH). HIV-infected monocytes that transmigrate across the blood–brain barrier and mature into macrophages establish a central nervous system (CNS) viral reservoir that activates and infects parenchymal cells, contributing to neuronal damage that characterizes HIV-NCI. Methamphetamine (meth) use is prevalent in PWH and further impairs cognitive functioning. To examine whether meth-mediated dysregulation of macrophage functions may contribute to increased HIV-NCI, we characterized differential gene expression in primary human HIV-infected macrophages treated daily with meth for five days by RNA-sequencing. We identified increases in multiple gene isoforms of metallothionein 1 (MT1), a heavy metal binding protein involved in protective mechanisms against metal toxicity and oxidative stress. Nuclear localization of MT1 protein was previously shown to either positively or negatively affect nuclear factor κB (NF-κB) activity in a cell type specific manner, with nuclear MT1 contributing to LPS-induced TNF-α and IL-6 in macrophages. We found that daily meth treatment for one to five days increased nuclear localization of MT1 in macrophages acutely infected with HIV which was associated with increased LPS-induced CXCL8 and CCL8, and a trend towards increased basal and/or LPS-induced expression of other cytokines/chemokines, including TNF-α and IL-6, that was donor specific. Reactive oxygen species (ROS) levels were not changed with meth treatment although there was a donor specific trend towards increased ROS with multiple days of meth treatment. These data indicate that repeated exposure of macrophages to meth in the context of HIV increases nuclear MT1 localization, which is associated with increased inflammatory mediator production, and therefore may be a mechanism that contributes to meth-mediated exacerbation of HIV-NCI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f9329bb1c83ed1fd2d8eb8fde23d750ee8b8e128" target='_blank'>
              Methamphetamine Induces Metallothionein 1 Expression and an Inflammatory Phenotype in Primary Human HIV-Infected Macrophages
              </a>
            </td>
          <td>
            Jessica Weiselberg, Meng Niu, Cristian A. Hernandez, Howard S. Fox, T. Calderon, Joan W. Berman
          </td>
          <td>2025-09-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>1</td>
          <td>29</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ad8d7f31daa325339652b8ffaff3613cfad600cf" target='_blank'>
              Phagocytes as Plaque Catalysts: Human Macrophages Actively Generate Pathogenic Aβ42 Fibrils with Seeding and Cross-Seeding Potency
              </a>
            </td>
          <td>
            Katerina Konstantoulea, M. Ramakers, Sarah C. Borrie, Dries T’Syen, Daan Moechars, Malgorzata A. Sliwinska, Brajabandhu Pradhan, Giulia Albertini, Grigoria Tsaka, Bert Houben, M. Fiers, Dewilde Maarten, D. Thal, Willem Michael, Jonas J. Neher, Bart de Strooper, F. Rousseau, J. Schymkowitz
          </td>
          <td>2025-10-12</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>62</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1381579458dad0f9eaa04f54a5f62506afb46bc5" target='_blank'>
              Neuroimmune crosstalk in Parkinson’s disease: the pivotal role of microglia and infiltrating T cells
              </a>
            </td>
          <td>
            Xinze Li, Wangjie Sun, Wenmo Chen, Naixuan Wang, Shaoxia Wang
          </td>
          <td>2025-09-26</td>
          <td>Molecular Biology Reports</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Degeneration of myelinating oligodendrocytes and the resulting breakdown of the myelin sheath are key drivers of neurodegeneration and disability across numerous central nervous system pathologies. Thus, a compelling strategy to preserve neuronal function is to promote endogenous myelin repair by oligodendrocyte precursor cells (OPCs). Extracellular vesicles (EVs) secreted by pro-regenerative microglia have been shown to enhance OPC maturation and remyelination across different experimental models. Yet, the mechanisms by which microglia-derived EVs exert their beneficial effects on OPCs are not fully understood. In this study, we performed transcriptomic profiling of primary murine OPCs treated during differentiation with EVs obtained from donor microglia following stimulation with pro-inflammatory cytokines (i-EVs), interleukin-4 (IL4-EVs), or mesenchymal stem cells in the presence of the inflammatory cocktail (MSC-EVs; GEO accession number: GSE304130). Compared to controls, IL4-EVs and MSC-EVs induced robust changes in gene expression, whereas i-EVs elicited far fewer alterations. Using bioinformatic analyses, we identified the molecular pathways significantly modulated by microglial EVs, revealing a large overlap between IL4-EV and MSC-EV targets. Notably, many of these shared pathways centered on mitochondrial function and bioenergetic metabolism. Upstream regulatory network inference further pinpointed candidate transcription factors and kinases that may drive EV-induced transcriptional reprogramming in OPCs. Hence, our findings indicate that rewiring mitochondria-associated pathways is a core mechanism underlying the pro-differentiation effects of microglial EVs on OPCs. Elucidating these intracellular circuits will open new avenues for developing EV-based or mitochondria-targeted remyelinating therapies. Transcriptional effects of microglia-derived extracellular vesicles on oligodendrocyte maturation. Transcriptomics profiling revealed that extracellular vesicles derived from pro-regenerative microglia (IL4-EVs and MSC-EVs) reprogram oligodendrocyte precursor cells (OPCs) by modulating mitochondrial and bioenergetic pathways, promoting their maturation. In contrast, pro-inflammatory i-EVs induce minimal transcriptional changes and have a limited impact on OPC differentiation Transcriptional effects of microglia-derived extracellular vesicles on oligodendrocyte maturation. Transcriptomics profiling revealed that extracellular vesicles derived from pro-regenerative microglia (IL4-EVs and MSC-EVs) reprogram oligodendrocyte precursor cells (OPCs) by modulating mitochondrial and bioenergetic pathways, promoting their maturation. In contrast, pro-inflammatory i-EVs induce minimal transcriptional changes and have a limited impact on OPC differentiation">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1b95243ad26d133386a4eadb6ee422c452782bc0" target='_blank'>
              Microglia-Derived Extracellular Vesicles Enhance Oligodendrocyte Maturation by Transcriptionally Regulating Mitochondrial Molecular Pathways
              </a>
            </td>
          <td>
            S. Raffaele, Marta Lombardi, Davide Marangon, M. Abbracchio, D. Lecca, C. Verderio, Marta Fumagalli
          </td>
          <td>2025-10-21</td>
          <td>Cellular and Molecular Neurobiology</td>
          <td>0</td>
          <td>66</td>
        </tr>

        <tr id="Sepsis, due to dysregulated host responses to infection, demands early intervention. Nevertheless, it is challenging to identify immune changes in the transition from high-risk states to sepsis, which remains unclear. Here, we profiled the single-cell transcriptome of peripheral blood immune cells in healthy controls, high-risk individuals, and clinical sepsis patients to characterize the transcriptomic reprogramming featured by the monocyte and platelet activation across sepsis progression. Particularly, a core gene set (S100A8, S100A9, IFITM2, IFITM3) showed significant upregulation in monocytes in both the high-risk stage and clinical sepsis. Moreover, platelets also exhibited early activation of coagulation and inflammatory pathways, notably sharing this core gene set upregulation. We further analyzed Single-cell RNA Sequencing (scRNA-seq) data from independent cohorts of very preterm infants with sepsis and elderly patients with diabetes. The consistent, early, and persistent upregulation of the S100A8/A9 and IFITM2/3 monocyte signature was strikingly observed across these diverse, high-risk populations. This study provides novel single-cell insights into immune dysregulation during sepsis onset, pinpointing specific transcriptomic signatures in monocytes and platelets emerging during the high-risk phase.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/762ecf8be789dd05f23d4604ee048954d159d87d" target='_blank'>
              Single-Cell transcriptomic profiles of peripheral blood immune cells reveal early monocyte and platelet activation in the transition from high-risk states to clinical sepsis
              </a>
            </td>
          <td>
            Lanlan Sun, Peng Zhang, Haikun Zhang, Hailang Fan, Yansheng Li, Yaqian Zhao, Mengtong Wang, Yingdi Huang, Mingyang Liu, Dake Zhang, Xin Zhang
          </td>
          <td>2025-09-25</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="BACKGROUND
The COVID-19 pandemic, caused by SARS-CoV-2, has led to the first approval of mRNA vaccines in humans. By producing the full-length SARS-CoV-2 Spike protein, they induce protective antiviral immunity. Acute myopericarditis (AMP) development after vaccination has repeatedly been reported; however, the pathogenesis of this complication remains elusive.


METHODS
In-depth phenotyping of peripheral blood T cells was undertaken in cohorts of patients who developed AMP after mRNA vaccination, patients hospitalized for severe COVID-19, and healthy subjects with no cardiac side effects after mRNA vaccine. Validation studies were carried out using an experimental model of cardiac inflammation, in which a shared epitope elicits functional responses in patients and mice and induces AMP.


RESULTS
We show that T cells from patients with AMP recognize vaccine-encoded Spike epitopes homologous to those of cardiac self-proteins. One of these epitopes, mimicking an amino acid sequence from a cardiomyocyte-expressed K+ channel, induced AMP in mice. When functional responses to the Kv2 were analyzed, patients with AMP after mRNA vaccination, but not patients with COVID-19, displayed an expanded pattern of cytokine production similar to that observed in AMP mice and in autoimmune myocarditis. Crucially, T-cell autoimmunity segregates to cardiotropic cMet (c-mesenchymal epithelial transition factor)-expressing T cells and is prevented by cMet inhibition, suggesting that heart homing imprinting, permitted by the unique mRNA vaccine biodistribution, is required for AMP development.


CONCLUSIONS
AMP development after mRNA vaccines is mediated by distinct immune components, including molecular mimicry, T-cell receptor affinity, and, importantly, homing imprinting.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7a2c7768da7a26c5948ed8c2a53768a7ad48ff71" target='_blank'>
              Combined Adaptive Immune Mechanisms Mediate Cardiac Injury After COVID-19 Vaccination.
              </a>
            </td>
          <td>
            Silvia Fanti, Carlene Dyer, I. J. Ingimarsdóttir, Daniel Harding, Guosu Wang, Antonio d'Amati, Eriomina Shahaj, Aðalbjörg Ýr Sigurbergsdóttir, Helga Thorsdottir, Oddný Brattberg Gunnarsdóttir, S. Kanoni, Paul Wright, John Martin, J. Chorlton, Zoe Hollowood, S. F. Brynjólfsson, Bjorn Rúnar Lúdvíksson, Egle Solito, Serena Bert, Jack M. Keane, S. Mohiddin, M. Longhi, F. Marelli-Berg
          </td>
          <td>2025-10-30</td>
          <td>Circulation</td>
          <td>0</td>
          <td>69</td>
        </tr>

        <tr id="Since its emergence, the coronavirus (SARS-CoV-2) outbreak has been a pandemic responsible for about 7 million deaths worldwide. Numerous studies have been conducted to determine the virus’s multiorgan system involvement, particularly its relation to cancer biology. Spontaneous regression of cancer has been observed in some patients with the coronavirus, which may be attributed to the virus’s ability to trigger specific immune responses that can be oncolytic and help reduce and eliminate oncogenic cells. This study aims to explore the paradoxical effects of COVID-19 in inducing cancer regression. The paradoxical effect of SARS-CoV-2 infection has been attributed to the possibility of a heightened immune activation possibly triggered by the virus, and some of these include increased levels of cytokines such as interferon and tumor necrosis factor-alpha (TNF-α), as well as the activation of T cells and natural killer (NK) cells. COVID-19-induced cancer regression presents new perspectives on the relationship between viral infections and the immune system’s antitumor capabilities. This would help foster future research investigating specific immune pathways activated during SARS-CoV-2 and discover how these can be therapeutically harnessed to aid cancer regression. Not applicable.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2b70234ee10e35d21e82680c57b0003d8503d4e0" target='_blank'>
              COVID-19 infection and cancer regression: a review of current evidence, potential mechanisms, and clinical perspectives on a Paradoxical phenomenon
              </a>
            </td>
          <td>
            I. Ogieuhi, V. Ajekiigbe, C. Agbo, Chidera Stanley Anthony, Adegbesan Abiodun Christopher, Jennifer Chinaecherem Onyehalu, M. C. Agu, Sylvia Mmesomachi Mbaji, Adewunmi Akingbola, Bisharat Ahmed, Owa Ogieuhi, O. Akinmeji
          </td>
          <td>2025-10-23</td>
          <td>Infectious Agents and Cancer</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="The SARS-CoV-2 pandemic had unprecedented impacts on public health and the economy. Many studies have focused on the mechanisms of SARS-CoV-2 entry into host cells, particularly the spike (S) protein mediated receptor engagement and subsequent virus-host membrane fusion dynamics. However, the mechanistic contribution of cholesterol within spike-incorporated viral envelopes to infectivity has not been well characterized. Herein, we show that targeted cholesterol depletion from the viral envelopes of SARS-CoV-2, SARS-CoV, and MERS-CoV directly impaired viral infectivity in a dose-dependent manner. Although modulation of host cell membrane cholesterol exerted relatively minor effects on viral entry, host cellular cholesterol homeostasis critically governs progeny virion infectivity by determining cholesterol content within nascent viral envelopes. Virions derived from cells with reduced plasma membrane cholesterol demonstrate significantly attenuated infectivity in SARS-CoV-2 and related coronaviruses. In addition, we detected that exogenous cholesterol replenishment restored SARS-CoV-2 entry efficiency by augmenting virus attachment. Collectively, our data demonstrate that biophysical properties of human coronavirus envelopes, particularly cholesterol stoichiometry, function as a key molecular determinant regulating host cell susceptibility. These findings position viral lipidome remodeling as a viable therapeutic target for developing host-directed broad-spectrum antivirals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2b66bac5249cf5d92ba8f485c839bbe27a7cb1e6" target='_blank'>
              Cholesterol in viral envelope determines infectivity of SARS-CoV-2 and other coronaviruses
              </a>
            </td>
          <td>
            Xiaoying Xu, Xueyan Wang, Xiafeng Zhang, Xin Jin, Yun Tan, Lin Huang, Mingqian Zhou, Chengping Wen
          </td>
          <td>2025-09-18</td>
          <td>Frontiers in Microbiology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Recurrent pregnancy loss (RPL) profoundly impacts not only the physical health but also the psychological well-being of women. Despite its profound effects, the underlying pathophysiological mechanisms of RPL remain largely elusive, with few discernible warning signs. Lymphocyte activation gene-3 (LAG-3) is a crucial immune checkpoint that modulates immune responses during infection and tumor. In the present study, we examined the expression of LAG-3 on CD4+T cells during pregnancy via cytometry by time-of-flight and flow cytometry. Our findings revealed a higher frequency of LAG-3+ decidual CD4+T (dCD4+T) cells in response to trophoblasts during normal pregnancy. This specific LAG-3+ subset of dCD4+T cells was found to produce a greater number of anti-inflammatory cytokines. Notably, blocking LAG-3 was highly effective in inhibiting the production of anti-inflammatory cytokines, which is detrimental to the maintenance of pregnancy. A decrease in the number of LAG-3+dCD4+T cells was correlated with miscarriage. Interestingly, the RNA level of LAG-3 (data analyzed from the two published single-cell databases) remained stable in RPL. Palmitoylation might play a role in regulating LAG-3 expression during RPL, as the palmitoylation of LAG-3+dCD4+T cells was increased in RPL. Additionally, the general palmitoylation inhibitor 2-bromopalmitate was found to upregulate LAG-3 expression on dCD4+T cells both in vitro and in vivo. Collectively, these findings highlighted the significant roles of LAG-3 in regulating the function of dCD4+T cell and maintaining normal pregnancy. Furthermore, they suggested that lower LAG-3 expression on dCD4+T cells could serve as a potential biomarker for diagnosis of RPL.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fffd707a87006ae812efe04e7e914df2c52cf9ee" target='_blank'>
              LAG-3 palmitoylation-inducing dysfunction of decidual CD4+T cells is associated with recurrent pregnancy loss
              </a>
            </td>
          <td>
            L. Cui, Fengrun Sun, Xinhang Meng, Yujie Luo, Jinfeng Qian, Songcun Wang
          </td>
          <td>2025-09-29</td>
          <td>Molecular Medicine</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/10d55887dd7d12323eb386296c4572af9c380d12" target='_blank'>
              The nuclear receptor NR4A1 serves as a neutrophil-intrinsic regulator mitigating stroke severity
              </a>
            </td>
          <td>
            Jan-Kolja Strecker, Yannick Schmidt, M. Liebmann, Carolin Walter, Stefan Roth, Hanna Aleth, Anna-Lena Börsch, Antje Schmidt-Pogoda, Carolin Beuker, Ayan Mohamud Yusuf, Julian Revenstorff, Collins Osei-Sarpong, Lisa Krafft, Anna-Sophie Schwarze, M. Heming, Mathis Richter, Tanja Kuhlmann, S. Hucke, Jan-Niklas Heming, Uwe Hansen, Nina Hagemann, A. Bader, Jincheng Gao, Barbara Walzog, Daniela Maier-Begandt, Raphael Chevre, E. Hanschmann, Martin Lücke, Clemens Sommer, Dirk M. Hermann, Johannes Roth, Christian Thomas, G. Meyer zu Hörste, Matthias Gunzer, Thomas Vogl, Alexander Zarbock, Frank Rosenbauer, Carlos Silvestre-Roig, Oliver Söhnlein, L. Klotz, J. Minnerup
          </td>
          <td>2025-09-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Tuberculosis (TB) remains a major global health challenge. Peripheral blood immune cell composition provides valuable insights into TB progression and management. In this study, we analyzed cellular dynamics across the TB disease spectrum using 43 global transcriptomic datasets encompassing 5,902 blood samples. Distinct immune changes were identified during the early stages of TB progression. Transition from latent infection to incipient TB was associated with reduced proportions of natural killer (NK) cells. In subclinical TB, monocyte proportions increased further, accompanied by additional reductions in NK cells and B cells. These early immune shifts preceded the pronounced alterations observed in active TB, characterized by elevated monocytes and neutrophils alongside markedly decreased lymphocyte populations. During successful anti-TB treatment, immune profiles gradually normalized. Cellular dynamics were also influenced by TB burden, age, and HIV coinfection, with stronger immune responses observed in adults and in regions with lower TB burdens. Overall, this study highlights early-stage peripheral blood biomarkers, particularly NK cell changes, as potential indicators of TB progression and targets for preventive interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f8574e17dda1b09d6c703a7d3ef93ad3a9f3cdff" target='_blank'>
              Peripheral blood cellular dynamics during the progression of human tuberculosis
              </a>
            </td>
          <td>
            Shanshan Zhu, Qiuchen Dai, Kai Wang, Hanlin Yan, Yuexuan Ma, Yayan Niu, Cheng Chen, Meiying Wu, Xueying Xie, Wanjun Gu
          </td>
          <td>2025-10-27</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="The ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has highlighted the virus's remarkable ability to evolve and adapt in diverse hosts. Despite the observation of recurrent mutations and convergent evolution in the viral genome, the mechanisms driving these processes remain poorly understood, particularly in the context of diverse host environments and limited genomic surveillance. We established a rigorously controlled in vitro cellular system within a Biosafety Level 3 Laboratory, ensuring strict adherence to biosafety protocols while passaging the virus in seven cell lines derived from four tissues across five mammalian species. High-throughput sequencing revealed consistent positive selection on the Spike (S) protein, highlighting its adaptability in the absence of adaptive immune responses or therapeutic pressures. Type I interferons (IFN-I) and APOBEC-mediated editing may emerge as key modulators of viral evolution. Notably, IFN-I activation is inversely correlated with the accumulation of S protein mutations (E484D, P812R/L, L1186R). Our findings uncover host-specific selective forces in shaping SARS-CoV-2 evolution and highlight the need for systematic approaches to mitigate viral transmission and emerging variants.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/461722f90e682345662c6276a91b4383ad6356c7" target='_blank'>
              Convergent evolution and host-limiting impacts of SARS-CoV-2 revealed by cellular experiments.
              </a>
            </td>
          <td>
            Ting Zhang, Ren-Rong Tian, Fengyi Li, Xiaolu Tang, Wenbin He, Zhen-Ping Hao, Lin Zhuo, Jian Lu, Xuemei Lu, Yong-Tang Zheng
          </td>
          <td>2025-10-28</td>
          <td>Molecular biology and evolution</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/36e9b1a92955cd9fb81f83d2cc7d3196d038b91a" target='_blank'>
              Comparative analysis of T-cell signatures and astroglial reactivity in Parkinson’s pathology across animal models with distinct regenerative capacities
              </a>
            </td>
          <td>
            Simona Intonti, Volker Enzmann, Amalia Perna, Ferdinando Spagnolo, Claudia Curcio, F. M. Conedera
          </td>
          <td>2025-10-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Macrophage senescence is increasingly recognized as a key contributor to immune dysfunction during aging and chronic inflammation. Here, we developed a reproducible long-term in vitro culture model to investigate the senescence’s phenotypic and functional consequences in human macrophages. Monocyte-derived macrophages (MDMs) were cultured for 7, 14, or 21 days and assessed for canonical senescence markers and immune function. While macrophages at day 7 exhibited minimal expression of β-galactosidase, H2AXpS139, and CDKN2A (p16INK4a), these markers were significantly upregulated at days 14 and 21, indicating progressive acquisition of a senescent phenotype. Cell viability remained above 95% across all time points, confirming the system’s stability. High-dimensional flow cytometry and unsupervised clustering revealed marked phenotypic remodeling over time, shifting from anti-inflammatory CD163+/CD206+ profiles to proinflammatory CD14+/CD64+/TLR2+ populations. Five distinct macrophage subpopulations were identified, each with dynamic temporal distribution and unique marker expression, highlighting a loss of plasticity and emergence of senescence-associated states. Functionally, day 7 macrophages produced a diverse cytokine panel responding to lipopolysaccharide (LPS), including IL-2, IL-12p70, IL-4, IL-5, TNF-α, GM-CSF, IFN-γ, and IL-10. In contrast, macrophages at days 14 and 21 displayed a markedly restricted cytokine profile, retaining the secretion of cytokines but significantly downregulating the secretion of Th1-type cytokines. This long-term culture model constitutes a robust, physiologically relevant tool to study immune aging, senescence-driven immune reprogramming, and inflammation in macrophages with the potential for the preclinical evaluation of therapeutic strategies to ameliorate inflammaging and restore immune competence.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ab95a8839ef87268195895ca58ab1a30d34a0c3f" target='_blank'>
              A long-term culture model for investigating senescence-associated dysregulation in macrophages
              </a>
            </td>
          <td>
            Andy Ruiz, María Guadalupe Lucero-Gil, Martha Torres, Esmeralda Juárez
          </td>
          <td>2025-10-02</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Severe acute pancreatitis (SAP) is characterized by biphasic systemic inflammation, progressing from initial pro-inflammatory systemic inflammatory response syndrome (SIRS) to subsequent immunosuppressive compensatory anti-inflammatory response syndrome (CARS), which increases infection risks and predicts poor prognosis. Using a pancreatic duct ligation and caerulein-induced SAP murine model, we demonstrate that macrophage extracellular traps (METs) play a pivotal role in immune regulation. Mechanistically, acinar cell activation of the cGAS-STING pathway triggers pyroptosis-mediated IL-33 release. METs subsequently process IL-33 into highly bioactive isoforms through METs-derived proteases (including MMP-12), thereby initiating ST2 receptor-mediated type-2 immune responses. Clinical validation revealed elevated serum METs marker and IL-33 levels in SAP patients. Therapeutic interventions with DNase I and Cl-amidine significantly attenuated IL-33 release, Th2 cell activation, and disease severity in experimental models. Our findings establish METs as critical regulators of SAP-associated CARS and propose METs inhibition as a promising therapeutic strategy for SAP management.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a4010b4f963c42ca69e0ca886cf84014a1c3bf0b" target='_blank'>
              Macrophage Extracellular Traps Modulate the Compensatory Anti-inflammatory Response Syndrome through IL-33/ST2 Signaling in Severe Acute Pancreatitis
              </a>
            </td>
          <td>
            Quan Zhou, Zhao Shi, Xuan Wang, Lingxi Meng, Kun Liu, Siqi Zhou, Yihang Jiang, S. Nie, Yuanyuan Yu, Hao Zhu, Mingdong Liu, Bo Kong, H. Friess, Lei Wang, Hongzhen Li, Shanshan Shen, Xiaoping Zou
          </td>
          <td>2025-09-22</td>
          <td>International Journal of Biological Sciences</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Macrophages are crucial for neuroinflammatory responses following traumatic brain injury (TBI), encompassing various subtypes, such as border-associated macrophages (BAMs) that contribute to both brain damage and repair. However, the pathophysiological relevance of subtype-specific molecular markers is poorly understood. This study investigated the role of the BAM marker mannose receptor C-type 1 (MRC1, also known as CD206) during the early phase of TBI using controlled cortical impact (CCI). MRC1 gene expression was up-regulated, peaking between 3 to 7 days post-injury (dpi), and MRC1 protein expression predominantly localized to BAMs. To assess pathophysiological relevance, MRC1-deficient (MRC1-KO) and wild-type littermates (MRC1-WT) were examined following CCI for early neurological deficits, brain structural damage, intracerebral hematoma, and neuroinflammatory marker expression. At 5 dpi, MRC1-KO mice showed increased brain lesion volume and hippocampal neuron loss, with minor differences in neurological deficits compared to MRC1-WT mice. Intracerebral hematoma size increased in male but remained unchanged in female MRC1-KO mice. Immunostaining revealed no genotype-specific effects on GFAP+ astrocytes, while the number of perilesional CD68+ macrophages/microglia were reduced in MRC1-KO mice. Analysis of neuroinflammatory gene markers revealed an overall reduction in MRC1-KO mice. Sex-specific regulation was observed for the M2-like macrophage/microglia marker Arg1, with decreased expression in male and increased expression in female MRC1-KO compared to MRC1-WT mice. In conclusion, lack of MRC1 exacerbated brain tissue damage following experimental TBI. Reduced CD68+ macrophages/microglia and neuroinflammatory marker expression suggests impaired neuroinflammatory response in MRC1-KO, indicating MRC1 expression on BAMs contributes to beneficial early neuroinflammatory response following TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1ac5ec2bb9a4f897f1ee154ba78ff99b4c7b8daa" target='_blank'>
              The border-associated macrophage marker MRC1 contributes to an early neuroprotective inflammatory response to traumatic brain injury in mice
              </a>
            </td>
          <td>
            Jenny Strehle, Pawit Somnuke, Shuailong Li, Sudena Wang, Tobias Hirnet, Yong Wang, Michael K. E. Schäfer
          </td>
          <td>2025-10-30</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Abstract Background Survivors of COVID-19 frequently report psychiatric and cognitive sequelae. The origin of such sequelae has not been determined, as it has been a challenge to resolve whether these symptoms have a viral origin or are related to the contextual stressors associated with the pandemic. Using a mouse model of post-acute sequelae of SARS-CoV-2 infection (PASC), we examined neurobiological mechanisms underlying these effects without the confounding influence of contextual factors. Results SARS-CoV-2 infection induced cognitive, but not anxiety- or depression-like, behavioral deficits. Cognitive impairments correlated with severity of the acute disease. Infected mice showed significant alterations in brain cytokine levels, as well as in kynurenine pathway (KP) metabolites, both of which were associated with acute disease severity. Microbiome taxonomic profiling revealed group-specific differences, indicating that certain bacterial species may contribute to PASC development. Conclusions Our findings suggest that SARS-CoV-2 infection causes cognitive deficits in PASC, modulated by acute disease severity, while anxiety- and depression-like behaviors appear unrelated to the viral infection itself. This supports the idea that such psychiatric symptoms may stem from pandemic-related stressors rather than infection. Altered cytokine signaling and KP metabolism may play key roles in the pathophysiology of PASC, identifying potential biomarkers and therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0fb3ed4fe779a93447277b5e14c32a1a056c5b57" target='_blank'>
              Neuropsychiatric- and cognitive post-acute sequelae of SARS-CoV-2 infection – evidence from K18-hACE C57BL/6 J mice
              </a>
            </td>
          <td>
            Marco Maria Santi, Eleonora Genovese, T. Schou, Matheus da Silva, Sophie Erhardt, L. Schwieler, Jacob Ahlberg Weidenfors, Giorgia Marino, S. R. Paludan, Sâmia Joca, G. Wegener, L. Reinert, C. Bay-Richter
          </td>
          <td>2025-09-30</td>
          <td>International Journal of Neuropsychopharmacology</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="Myeloid cells play critical roles as Fc effector cells in antibody‐mediated immunity. Granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) is a pleiotropic cytokine that promotes the recruitment and activation of multiple myeloid populations and has been used in combination with vaccines/treatments against infectious diseases, inflammatory conditions and cancers. To evaluate GM‐CSF‐mediated kinetics of immune cell expansion and immune outcomes, we compared subcutaneous (subQ) and topical hypoosmolar (intravaginal/intrarectal) administration in vivo using rhesus macaques (RM), as they provide easy access to longitudinal mucosal tissue sampling and are a critical model species for vaccines/therapeutics development. While topical GM‐CSF did not result in a major change, neutrophils, eosinophils and monocytes were elevated within 1–3 days of subQ GM‐CSF administration, with peak eosinophil and neutrophil enrichment in blood at days 7 and 8, respectively. Corresponding elevations of neutrophils, eosinophils, total CD64+ and total CD32+ were observed at days 7 and 14 in rectal biopsies, indicating general Fc effector cell accumulation in these animals. Histological evaluations of vaginal biopsies showed myeloid cell infiltration at day 14 of subQ GM‐CSF treatment. Further, subQ GM‐CSF administration resulted in myeloid cell activation and trafficking, as evidenced by elevated levels of cytokines (CXCL13, MCP‐1, IL‐1RA). Importantly, neither subQ nor topical GM‐CSF administration induced overt systemic inflammation or adverse clinical impacts. Overall, our findings delineate the kinetics of systemic and mucosal myeloid cell expansion, activation and trafficking achieved by subQ GM‐CSF administration in RM. These findings will inform the use of GM‐CSF as an adjuvant in clinical applications where myeloid cell mobilization is advantageous.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/492d90767cafd39d09bc074bbefa23b57af9983b" target='_blank'>
              Myeloid cell recruitment and activation through systemic and mucosae‐directed cytokine therapy
              </a>
            </td>
          <td>
            C. Manickam, Rhianna Jones, Nihar R. Deb Adhikary, Kyle W. Kroll, Karen Terry, Hari Balachandran, Griffin Woolley, Georgia D Tomaras, François J. Villinger, R. K. Reeves
          </td>
          <td>2025-10-07</td>
          <td>Immunology and Cell Biology</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="Abstract Multiple sclerosis (MS) is a chronic, autoimmune, demyelinating disease of the central nervous system (CNS) in which macrophages play a pivotal and multifaceted role. These highly plastic immune cells are key effectors in the immunopathology of MS, contributing to both inflammatory-driven demyelination and subsequent tissue repair. Historically, macrophage function was viewed through the binary lens of pro-inflammatory M1 and anti-inflammatory M2 polarization. However, recent research reveals a far more complex spectrum of activation states within the dynamic microenvironment of MS lesions. Understanding the intricate signals and molecular pathways that govern macrophage polarization in the CNS represents a critical frontier for therapeutic innovation. Interventions aimed at rebalancing macrophage phenotypes have yielded encouraging results in preclinical models, and some therapeutic agents are now advancing into clinical trials. Future investigations are focused on the diverse functions of macrophages in MS pathogenesis, including their involvement in oxidative stress, antigen presentation, and myelin debris clearance. A particularly innovative approach involves harnessing macrophages as cellular vehicles for targeted drug delivery across the blood-brain barrier, offering a potential solution to one of the most significant challenges in CNS therapeutics. The primary challenge now lies in the safe and effective clinical translation of these macrophage-centered therapies. Successfully navigating this transition from bench to bedside holds the potential to deliver transformative treatments that can halt disease progression and restore neurological function for individuals living with this debilitating disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aad33ff0adee236c1c773c1750932b0d5634824d" target='_blank'>
              Emerging Insights into the Role of Macrophages in Multiple Sclerosis: Pathogenesis and Potential Therapeutic Strategies
              </a>
            </td>
          <td>
            Jundong Yang, Ziyue Fu, Qiyuan Zou, Zhaoyinqian Li, Yuhan Xing
          </td>
          <td>2025-10-01</td>
          <td>Journal of Inflammation Research</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="The Coronavirus Disease 2019 (COVID-19) pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has revealed the virus's ability to induce multi-organ damage, including significant liver injury. The molecular mechanisms of liver dysfunction in COVID-19 patients are explored, focusing on direct viral infection, immune-mediated damage, and the gut-liver axis. SARS-CoV-2 enters liver cells through the Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) receptors, but alternative pathways, such as CD209/Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin (DC-SIGN) and AXL receptors, can also contribute to viral entry. Additionally, immune responses, particularly the cytokine storm, exacerbate liver inflammation, leading to hepatocyte damage. Pre-existing liver conditions, such as metabolic-associated fatty liver disease (MAFLD), alcohol-related liver disease (ALD), and liver fibrosis, heighten the risk of severe outcomes in COVID-19 patients. Post-COVID-19 liver complications, including fibrosis progression and persistent liver damage, have been reported, with emerging evidence suggesting chronic inflammation, viral persistence, and autoimmune reactions as potential contributors. Furthermore, Drug-Induced Liver Injury (DILI) from COVID-19 treatments remains a concern, highlighting the need for careful management. Consequently, understanding the interplay between SARS-CoV-2 and the liver is critical for improving patient outcomes and developing targeted therapies to mitigate liver-related complications in both acute and Long COVID-19 phases. This article is categorized under: Infectious Diseases > Molecular and Cellular Physiology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d8e7ab48363fa154c104250ae482911ee316a6df" target='_blank'>
              SARS-CoV-2: A Liver Brief.
              </a>
            </td>
          <td>
            Youness Limami, Hicham Wahnou, Martin Ndayambaje, Soufyane Hba, Oumaima Chgari, Mounia Ammara, Riad El Kebbaj, Abdallah Naya, M. Oudghiri, Raphael Georges Duval
          </td>
          <td>2025-11-01</td>
          <td>WIREs mechanisms of disease</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a chronic, immune‐mediated autoimmune disease characterized by the infiltration of autoreactive T cells and other inflammatory immune cells from the periphery into the central nervous system. Currently, there is no cure for MS, and treatment consists of disease‐modifying therapies (DMTs), most of which modify or delete specific immune cell populations. These populations express crucial MS treatment‐associated receptors, which may be differentially expressed in each patient, and thus each drug may affect individuals differently. Here, we developed the first comprehensive 24‐parameter flow cytometry immunophenotyping panel to evaluate treatment‐associated receptor expression on the major MS‐associated immune cells in whole blood. Analyzing whole blood samples from treatment‐naïve individuals with MS using this panel, we demonstrated that expression levels of these receptors vary between individuals. Response to the chosen DMT treatment also differed across participants. When monitoring the receptor expression during the course of treatment, we detected an increased response to treatment when receptor expression was elevated at the start of treatment. This panel reliably detects these receptors in MS treatment‐naïve participants and enables monitoring of their expression throughout treatment. This tool will enable deep interrogation of the immune receptors targeted by MS therapies and highlights that treatment‐associated receptor expression levels might be used to predict or correlate with treatment response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/019f2dcb4e902228e625f81330b78afadd2958ea" target='_blank'>
              Monitoring Treatment‐Associated Receptor Expression in Multiple Sclerosis Using a Newly Developed Panel for Spectral Flow Cytometry
              </a>
            </td>
          <td>
            Katharina Robichon, Jennifer Taylor, Imogen Milner, Kathryn E Hally, A. L. La Flamme
          </td>
          <td>2025-09-23</td>
          <td>Cytometry Part A</td>
          <td>1</td>
          <td>27</td>
        </tr>

        <tr id="Leprosy is a chronic infectious disease that targets the peripheral nervous system, leading to peripheral neuropathy. Mycobacterium leprae primarily infects Schwann cells, adipocytes, and macrophages, altering their metabolism and gene expression. This study investigates the metabolic interaction between M. leprae and Schwann cells, with a focus on indoleamine 2,3-dioxygenase (IDO), a key enzyme in tryptophan catabolism via the kynurenine pathway. We found that M. leprae induces IDO expression in Schwann cells, suggesting a role in immune modulation and neuropathy. Inhibition of IDO with 1-methyl-L-tryptophan (1-MT) reduced Schwann cell viability and metabolic activity in response to M. leprae. After 24 h of infection, M. leprae impaired mitochondrial membrane potential, although no significant changes in autophagy or mitochondrial ultrastructure were observed by electron microscopy. Interestingly, IDO1 inhibition upregulated the expression of antioxidant genes, including GPX4, NFE2L2, and HMOX1. In conclusion, these findings highlight a central role for IDO in shaping the metabolic and immunological response of Schwann cells to M. leprae infection. IDO induction contributes to immune regulation and cellular stress, while its inhibition disrupts cell viability and promotes antioxidant gene expression. These results position IDO as a potential therapeutic target for modulating host–pathogen interactions and mitigating nerve damage in leprosy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/abb3610626dbc037a9c11480f7a7205f2b79ea22" target='_blank'>
              IDO-Mediated Immune and Metabolic Dysregulation in Schwann Cells Exposed to Mycobacterium leprae
              </a>
            </td>
          <td>
            Atta Ur Rahman, Raíssa Couto Santana, Mylena Masseno de Pinho Pereira, Claudia Luciana dos Santos Moura, Débora Santos da Silva, Otto Castro Araujo, Thyago Leal-Calvo, Isabela Espasandin, Tatiana Pereira da Silva, E. Sarno, Bruno J. de Andrade Silva, R. Menna-Barreto, M. M. Jardim, C. S. de Macedo, F. A. Lara, Roberta Olmo Pinheiro
          </td>
          <td>2025-10-01</td>
          <td>Cells</td>
          <td>0</td>
          <td>52</td>
        </tr>

        <tr id="We performed a large-scale immunogenomic analysis of ∼13,000 transcriptomic profiles from 10 autoimmune diseases, integrating publicly available datasets from both blood and tissue. Using meta-analysis, we identified core immune mechanisms underlying autoimmunity, including strong interferon responses, inflammation, and adaptive immune suppression, alongside disease-specific signatures. To enhance biological interpretability, we derived higher-order immune features - such as cell type proportions, cytokine levels, pathway activity, transcription factor regulation, and miRNA activity - and organized them into 15 coherent immune modules. These modules enabled systematic cross-disease comparisons, revealing shared and distinct immunopathological patterns. The inflammation module, in particular, was associated with disease severity and predicted treatment response across multiple conditions. This modular framework offers a powerful tool for understanding immune dysregulation and advancing precision medicine in autoimmune diseases. To support reproducibility and enable others to build upon this work, we developed an interactive app to explore and download the complete dataset and associated results.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/33657b128cad4b7bef3c91009696d7561897ed33" target='_blank'>
              The Integrated Cellular and Molecular Landscape of Autoimmunity
              </a>
            </td>
          <td>
            R. Appierdo, G. Pepe, M. Helmer-Citterich, Marina Sirota, Francesco Vallania, P. Gherardini
          </td>
          <td>2025-09-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Extracellular vesicles (EVs) are rapidly gaining recognition as critical mediators of inter-cellular communication during viral infections. To contribute to fill the gap in knowledge regarding the role of EVs in adenovirus infection, we used human adenovirus type 4 of species Mastadenovirus exoticum (HAdV-E4), a prevalent respiratory and ocular pathogen, and characterized the cargo and biological properties of EVs released by HAdV-E4-infected A549 lung epithelial cells at a pre-lytic stage of infection. Using immunocapture-based isolation and multi-omics approaches, we found that infection profoundly alters the EV uploaded proteome and small non-coding RNA repertoire. Mass spectrometry identified 268 proteins unique to EVs purified from infected cells (AdV-EVs), with enrichment in pathways supporting vesicle trafficking and viral protein translation, and importantly also a few virus-encoded proteins. Small RNA transcriptome analysis showed differential uploading in AdV-EVs of various small non-coding RNAs, including snoRNAs, as well as the presence of virus associated RNAs I and II. Notably, AdV-EVs contained viral genomic DNA and were capable of initiating productive infection upon delivery to naïve cells in the absence of detectable viral particles. Our data suggest that EVs released during HAdV-E4 infection may serve as vehicles for non-lytic viral dissemination and highlight their possible role in intra-host dissemination.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2099efee27dc1f09a50509011e989cc86d99ff60" target='_blank'>
              Cargo and Biological Properties of Extracellular Vesicles Released from Human Adenovirus Type 4-Infected Lung Epithelial Cells
              </a>
            </td>
          <td>
            Alessio Noghero, Stephanie Byrum, C. Okeoma, A. Kajon
          </td>
          <td>2025-08-11</td>
          <td>Viruses</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3659e67328ffa6a7afc24383c34110e1246de0a3" target='_blank'>
              Single-Cell Atlas of CD4+ T-Helper 2 Cells Reveals Distinct Cytokine Functions Across Diseases
              </a>
            </td>
          <td>
            Son Vo, Maria Suprun, Han Do, My Ngo, Rajesh Rao, Saurabh Vishnu Laddha, Marta E Polak, Calixte Monast, Son Pham
          </td>
          <td>2025-09-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e5941ecec7872e6e7a4fe85dc2f11895a3625725" target='_blank'>
              PD-1 signaling is essential for the early accumulation of HBV-specific CD8+ T cells during HBV infection
              </a>
            </td>
          <td>
            Xiaoqing Zeng, Wen Pan, Ziwei Li, Zhaoli Liu, Hongming Huang, Xuecheng Yang, K. Sutter, Mengji Lu, Ulf Dittmer, Gennadiy Zelinskyy, Xin Zheng, Dongliang Yang, P. Kennedy, Yanqin Du, Jia Liu
          </td>
          <td>2025-09-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="INTRODUCTION
Cytokine storm can result from uncontrolled proinflammatory cytokines released in SARS-CoV-2 infection that cause damage to several organs. Il-6 is one of the major mediators of cytokine storm. IFN-α2 has been reported to have anti-viral potential and the pre-infection levels of proinflammatory cytokines have been suggested to drive the fate of the disease. There is a paucity of information on how anti-viral cytokines at the onset of infection affect the disease progression. This study aims to profile IL-2, IL-6, IL-10, and IFN-α2 expression levels for 44 days post-diagnosis and their effects on recovery.


METHODS
Peripheral venous blood was collected from 38 SARS-CoV-2 infected participants who came for diagnosis at the Center for Research on Emerging and Reemerging Diseases. IL-2, IL-6, IL-10, and IFN-α2 levels were measured using a Luminex panel.


RESULTS
Males had higher SARS-CoV-2 viral load than females, although the difference was not statistically significant (p=0.08). Age-related variation was also observed, with individuals aged 40-60 showing significantly higher viral load than those over 60 (p=0.045). Cytokines analysis revealed that males had significantly higher levels of IFNα-2, IL-2, and IL-6 (p=0.0031, p=0.009, and p=0.022 respectively) than females upon diagnosis, with cytokines levels decreasing over time in males but increasing in females. Cytokine levels trended higher in symptomatic individuals, although differences were not significant.


CONCLUSION
These findings highlight the influence of sex, clinical status, and viral load on cytokine dynamics in COVID-19, with potential implications for understanding disease severity and immune response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a96153529dbc58b976dae603414f6f5491296d91" target='_blank'>
              Cytokines dynamics and biological sex differences in SARS-CoV-2 infected people in Cameroon.
              </a>
            </td>
          <td>
            Hillary Tene, Romuald Ngamaleu, R. Djounda, Rachel Minomo, Sabine Ngale, Micheal Besong, Honore Awanakam, Krystelle Nganou Makamdop, Rene Essomba, Jude Bigoga, Daniel C. Douek, L. Esemu
          </td>
          <td>2025-09-22</td>
          <td>Clinical and experimental immunology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Inflammasomes and interferons are two critical defense mechanisms of innate immunity, and their imbalance is a key strategy employed by viruses to evade host immune surveillance. During porcine reproductive and respiratory syndrome virus (PRRSV) infection, an arteritis virus, a characteristic “high inflammation, low interferon” immune imbalance is observed. This study identifies PRRSV non-structural protein NSP5 as a central mediator of this immune imbalance. We demonstrate that NSP5 recruits NLRP3 to the endoplasmic reticulum (ER)-mitochondrial interface, triggering ER stress and Ca2+ leakage, which subsequently activates the NLR family pyrin domain containing 3 (NLRP3) inflammasome. Notably, a specific NSP5 mutation (G30A) abolishes its ability to activate NLRP3. PRRSV carrying this mutation exhibits suppressed NLRP3 activation and IL-1β release. Concurrently, NSP5 retains STING in the ER, preventing its trafficking and inhibiting type I interferon induction. This dual mechanism ultimately drives the high inflammation and low interferon phenotype observed during PRRSV infection. Importantly, our findings reveal that a single viral protein can orchestrate immune imbalance, suggesting a potentially widespread strategy for viral evasion of host immune surveillance.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4e730d92266f5f6b0990407c8ac29dced1f7ed68" target='_blank'>
              PRRSV NSP5 orchestrates dual immune disruption by targeting NLRP3 and STING
              </a>
            </td>
          <td>
            Xiangyu Huang, Xuyan Xiang, Xiaohan Jiang, Weiyu Qu, Yufei Zhang, Zhenchao Zhao, Minjie Li, Haiwei Wang, Xin Li
          </td>
          <td>2025-10-16</td>
          <td>Veterinary Research</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Parrots, valued companion animals with a concerning conservation status, can act as reservoirs for zoonotic diseases. During various infections, systemic inflammation significantly impairs host health. However, the regulation of inflammatory responses in birds, particularly in cognitively advanced parrots, remains poorly understood. Here, we examine parrot systemic inflammation in response to virus-mimicking stimulation. In budgerigars (Melopsittacus undulatus), a novel model for neuroinflammation research, we induced sterile inflammation with synthetic poly(I:C) RNA and analysed dose-, time- and tissue-dependent gene expression patterns of key markers, including TLR3, NLRP3, CASP1, IL1B and IL6, during acute immune response. We report a significant relationship between cytokine expression (IL1B, IL6) in the intestine (local response) and brain (systemic response) that has not yet been described after viral stimulation in parrots. Peripheral IL6 expression was upregulated at 3–6 h after stimulation with poly(I:C). In the brain, multiple genes (TLR3, IL1B and IL6) showed activation early during the immune response. These findings highlight the susceptibility of parrots to neuroinflammation following viral infections, having specific relevance for basic research in neurobiology, immunology and behavioural science, and also veterinary research in psittacine birds. Our study provides a foundation for future comparative research on avian neuro-immune crosstalk and neuroinflammation-related behavioural disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b23dca0d96ff356c079d40ec7845a15398f0ccf4" target='_blank'>
              The neuro-immune crosstalk between periphery and central nervous system during acute immune response to virus-mimicking RNA in parrots
              </a>
            </td>
          <td>
            Balraj Melepat, Daniel Divín, Kateřina Marková, Tao Li, Nithya Kuttiyarthu Veetil, Eleni Voukali, Lucie Schmiedová, Martin Těšický, Michal Vinkler
          </td>
          <td>2025-10-01</td>
          <td>Royal Society Open Science</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Zika virus (ZIKV) can infect and replicate in the endoplasmic reticulum (ER) of different human cell types, including neural progenitor cells, radial glial cells, astrocytes, and microglia in the brain. ZIKV infection of microglia is expected to trigger both ER stress and the induction of an antiviral response through production of type-I interferons and pro-inflammatory cytokines, contributing to neuroinflammation during infection. Despite their critical role in ZIKV pathogenesis, the interplay between ER stress and the antiviral response during infection has not been fully characterized in human microglia. In this work, we show that infection of a human microglia cell line with ZIKV triggers the induction of an antiviral response and the activation of the endonuclease activity of the unfolded protein response sensor IRE1. Interestingly, we observed that both IRE1 and XBP1 were sequestered to the viral replication sites during infection. Moreover, pharmacological inhibition or hyperactivation of the endonuclease activity of IRE1 resulted in reduced viral titers. As such, while inhibition of IRE1 resulted in an increased type-I interferon response, hyperactivation led to a decrease in ZIKV RNA levels and the appearance of ER-derived cytoplasmic structures containing NS3, IRE1, and XBP1. Together, our data indicate that regulation of the endonuclease activity of IRE1 is critical for both ZIKV replication and immune activation, highlighting the potential of the ER stress sensor as a target for the development of antivirals to treat ZIKV infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c49266713c41489835395ed05f1e9648bda8bc34" target='_blank'>
              Activation of IRE1 Endonuclease Activity Regulates Zika Virus Replication and Antiviral Response During Infection in Human Microglia
              </a>
            </td>
          <td>
            Tomás Hernández-Díaz, A. Oyarzún-Arrau, Aracelly Gaete-Argel, Delia López-Palma, Javier López-Schettini, Dominique Fernández, F. Valiente-Echeverría, Fabiola Osorio, R. Soto-Rifo
          </td>
          <td>2025-09-24</td>
          <td>Viruses</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="SARS-CoV-2 has been shown to induce autoimmunity. Due to the idiotype-antiidiotypic interactions between lymphocytes to SARS-CoV-2 S protein and lymphocytes to angiotensin converting enzyme 2 (ACE2), the immune response to S protein can cause induction of anti-ACE2 lymphocytes. The ubiquity of ACE2 within the human body endows autoimmune reactions to ACE2 with the role of the main factor causing injuries of various tissues. Immunization of Wistar rats with S protein caused hyperplasia and dedifferentiation of type II pneumocytes, extensive injury of the proximal tubules, infiltration of CD4+ T, CD45RA+ B lymphocytes in the lungs and CD4+ T, CD8+ T lymphocytes in the kidneys. Both type II pneumocytes and proximal tubule epithelium express ACE2. Damage to ACE2 expressing cells in the absence of other lesions in the studied organs suggests that ACE2 might be the target of an autoimmune attack induced by S protein. Our findings clarify the mechanism of multiple tissue damage in COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/38ed0d61a3e406d30838aa29200df0543c5138f3" target='_blank'>
              Autoimmune reactions to ACE2 triggered by SARS-CoV-2 S protein and their histopathological consequences
              </a>
            </td>
          <td>
            L. Beduleva, K. Fomina, T. Khramova, A. Terentiev, Daria Menshikova, Oksana Terentieva, I. Menshikov, A. Sidorov, Polina Makhankova, Nadezhda Abisheva
          </td>
          <td>2025-10-24</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Age is a critical factor in immune responses to infection. In malaria, severe disease risk increases with age in non-immune individuals. Malaria severity is in part driven by inflammation, but mechanisms contributing to age-dependent disease risk are incompletely understood. We assessed inflammatory cytokines during malaria in non-immune children and adults, and innate cell responses in vitro to malaria parasites in naive children and adults. We show during malaria age is associated with increased inflammatory chemokines CCL2, CCL3, CXCL8, CXCL9, along with CRP, and IDO, which associate with symptoms. In naive individuals, classical monocyte and Vδ2+ γδ T cells from adults have higher inflammatory cytokine production, and transcriptional activation following stimulation with parasites. Classical monocyte responses in adults are dominated by CCL2, while in children increased IL10 and enrichment of IL10 signaling pathways is detected. Findings identify age-dependent cellular mechanisms that play crucial roles in driving inflammatory responses in malaria. How age affect the immune response to malaria is not fully understood. Here, the authors characterise the transcriptome and serum inflammatory cytokines in children and adults in response to malaria, showing that there is an increase of inflammatory chemokine and cellular responses in adults compared to children.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/08d5c0c81051d13694cfc33dd1cf3b4215156753" target='_blank'>
              Age is an intrinsic driver of inflammatory responses to malaria
              </a>
            </td>
          <td>
            Jessica R. Loughland, Nicholas L Dooley, Zuleima Pava, Arya SheelaNair, D. Andrew, Peta E. Tipping, Peter Bourke, C. Engwerda, J. A. Lopez, Kim A. Piera, Timothy William, Bridget E. Barber, M. Grigg, N. Anstey, Gabriela Minigo, Michelle J. Boyle
          </td>
          <td>2025-09-30</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="Pneumococcal infection of the leptomeninges triggers a strong inflammatory response, contributing to tissue damage and adverse outcome in meningitis. While border-associated macrophages (BAM) are thought to initiate immune responses against pathogens, their exact role in pneumococcal meningitis (PM) - especially at later stages - remains unclear. This study examined the impact of BAM depletion on disease progression. Mice received intracisternal injections of clodronate liposomes (CL) to deplete BAM, followed three days later by intracisternal infection with Streptococcus pneumoniae. At 18 h post-infection, CL-treated mice exhibited clinical signs similar to controls treated with phosphate-buffered saline liposomes (PBSL). However, CL-treated mice had lower cerebrospinal fluid leukocyte counts, increased expression of brain immune mediators, and elevated plasma levels of neuronal damage (NEFL) and astrocyte activation (S100B) markers. Over a 42-h observation period - during which ceftriaxone therapy was started 18 h post-infection - CL-treated mice showed significantly worse outcomes: 9 of 12 reached termination criteria versus 1 of 9 PBSL-treated mice. This correlated with more severe neuropathology, higher bacterial loads, and persistent inflammation. Notably, infection with a pneumolysin-deficient mutant conferred strong protection against disease aggravation caused by macrophage depletion, whereas caspase-1 inhibition - despite its known immunosuppressive effects in experimental PM - did not. These findings underscore a critical immunoregulatory role for BAM in PM, particularly in resolving rather than initiating inflammation. Their absence exacerbates disease severity, mainly due to increased bacterial proliferation and elevated levels of bacterial toxins.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6563837df86067b2d0826abdc0bf8ed3eb50df5b" target='_blank'>
              Pharmacologic depletion of border-associated macrophages worsens disease in a mouse model of meningitis
              </a>
            </td>
          <td>
            Susanne Dyckhoff-Shen, I. Masouris, H. Pfister, Stefanie Völk, Sven Hammerschmidt, Matthias Klein, U. Koedel
          </td>
          <td>2025-09-23</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>55</td>
        </tr>

        <tr id="Virus-specific CD4+ T cells typically undergo T helper (Th) 1 differentiation and contribute to a type 1 immune response in infection with lymphocytic choriomeningitis virus (LCMV). Using this model pathogen, we performed an in-depth analysis of the quantitative expression stability of the Th1 key transcription factor T-bet. Previously, it was shown that virus-specific Th1 cells arising in acute infections expressed T-bet at distinct intensities and maintained their T-bet expression differences after viral clearance as memory cells for weeks in the steady state. However, it was unclear whether differential T-bet expression was associated with heterogeneity inside the Th1 population and if the quantitative T-bet memory, particularly of those cells expressing T-bet at low levels, could withhold the strong and continuous stimulation present during chronic infection. Using T-bet-ZsGreen reporter mice, virus-specific Th1 cells were characterized phenotypically at protein, RNA, and DNA/chromatin accessibility levels. The Th1 cells arising during acute LCMV Armstrong infection showed a continuous spectrum of T-bet expression, ranging from cells with very high T-bet to cells with low T-bet. Even though the cells with low T-bet expression clearly possessed Th1 characteristics, they additionally showed certain Tfh-like features at protein and RNA level. When virus-specific Th1 cells were sorted according to T-bet-ZsGreen reporter expression intensity, adoptively transferred, and rechallenged by infecting the host animals with the chronic Clone 13 strain of LCMV, they maintained quantitative differences in T-bet reporter and IFN-γ expression levels. A subpopulation of the progeny of the former T-betlow cells still showed a mild Tfh-associated phenotype. Independent of their past and present T-bet expression level, all virus-reactive CD4+ T cells acquired phenotypic signs of exhaustion as characterized by upregulation of PD-1, LAG3, and TOX and vast absence of effector cytokine co-expression in the chronic infection environment. Collectively, our findings highlight the heterogeneity of T-bet+ antiviral CD4+ T cells and the stability of quantitative differences in individual virus-specific CD4+ T cells during chronic viral challenge infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bc9e88d2fafc16f74c1bf59bb61267ab8fcd6cb4" target='_blank'>
              Stable characteristics of intrapopulation heterogeneity in virus-specific Th1 cells during chronic viral challenge infection
              </a>
            </td>
          <td>
            V. Plajer, A. Madrigal-Avilés, Maria Dzamukova, Nayar Durán-Hernández, Philippe Saikali, Vivien Holecska, Isabel Panse, Katrin Lehmann, Jinfang Zhu, Mir-Farzin Mashreghi, Ahmed N. Hegazy, Caroline Peine, M. Löhning
          </td>
          <td>2025-09-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Intervertebral disc (IVD) homeostasis and function depend on the immunological privilege status, while immune cell infiltration constitutes a pivotal pathological driver of intervertebral disc degeneration (IDD). Nevertheless, the immune infiltration landscape and associated molecular targets in IDD remain elusive. We therefore integrated bioinformatic analysis of public datasets and single-cell RNA-sequencing analysis (scRNA-seq) data, flow cytometric (FACS) and experimental validation to delineate immune infiltration dynamics and identify therapeutic targets. CIBERSORT deconvolution analysis revealed significant increases in follicular helper T cells (p < 0.05) and M2 macrophages (p < 0.05) in IDD, with M1 macrophages demonstrating an upward trend. WGCNA showed that the blue module was associated with M1 macrophages infiltration (positive correlation 0.87, P < 0.001), among which VAMP8, JUN and others were mainly enriched in macrophage activation and myeloid leukocyte activation. FACS quantification established postoperative day 14 as the peak of leukocyte infiltration in rat IVDs following puncture. scRNA-seq resolved seven cellular subsets within degenerated rat IVDs: annulus fibrosus cells, smooth muscle cells, fibroblasts, macrophages, monocytes, vascular endothelial cells, and nucleus pulposus (NP) cells, with pronounced expression of Jun and Vamp8. Western blotting confirmed upregulated VAMP8 and JUN expression in TNF-α-stimulated (50 ng/ml, 24 h) NP cells. Immunohistochemistry further demonstrated elevated VAMP8 and JUN levels during rat IDD progression. This work identifies post-puncture day 14 as the critical window for peak immune infiltration in rat IVDs, and reveals VAMP8 and JUN are macrophage-associated regulators of IDD pathogenesis, thereby revealing promising targets for immunomodulatory interventions against disc degeneration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ce2d542441a087ecf2f2a4662507d8231cb1eca0" target='_blank'>
              Comprehensive profiling of immune cell infiltration and biomarker identification in intervertebral disc degeneration
              </a>
            </td>
          <td>
            Yuanhao Wang, Bingtao Hu, Lijun Tian, Guowang Li, Baoshan Xu
          </td>
          <td>2025-09-24</td>
          <td>Journal of Orthopaedic Surgery and Research</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="The COVID-19 pandemic caused by SARS-CoV-2 has had a significant global impact on the respiratory system and multiple organ systems, including the nervous system. Neurological manifestations associated with COVID-19 infection and its vaccines have been increasingly recognized, ranging from problems with smell and taste to more severe conditions such as encephalitis, stroke, and Guillain–Barré syndrome. This narrative review critically evaluates the neurological manifestations of COVID-19 infection and its vaccines, providing insights into potential pathophysiological mechanisms. A comprehensive literature search was conducted, and data were retrieved from various databases. The prevalence, types, and severity of neurological symptoms in COVID-19 patients were discussed. The possible mechanisms of neurological injury in COVID-19 were explored, including direct viral invasion, hypoxic brain injury, immune-mediated damage, and cerebrovascular injury. Furthermore, the review addressed the neurological complications associated with COVID-19 vaccination. While severe vaccine-related adverse effects remain rare, understanding their occurrence is essential for risk assessment and public health interventions. In conclusion, COVID-19 can affect the nervous system in various ways, leading to various neurological symptoms. Further research is necessary to enhance our understanding of these manifestations and develop effective preventive and treatment strategies to manage this global health crisis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0797cde6f5eba2cc67ca74a43dd2acf09ade5658" target='_blank'>
              Neurological manifestations of COVID-19 and its vaccines: an updated comprehensive review with an insight into pathophysiology
              </a>
            </td>
          <td>
            Khabab Abbasher Hussien Mohamed Ahmed, Tagwa Kalool Fadlalla Ahmad, Mohamed Ismail Abdu Ismail, A. Elgadi, Esraa Hassan Salih Elhaj, Ghassan E. Mustafa Ahmed, Faheemullah Khan, Mohammed Babiker Habbiballah Mohammed, G. Manhal, Ahmed Daffalla Mussaad Mohammed, Mustafa Mohamed Ibrahim Ali, Mohammed Elmustafa Adil Abdullah Mohammed, Mostafa Meshref, Abbasher Hussien
          </td>
          <td>2025-09-18</td>
          <td>Annals of Medicine and Surgery</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Chronic active lesions are a manifestation of multiple sclerosis (MS) and have been associated with disease progression. While astrocytes are heavily implicated in MS, little is known about their role in lesions, particularly in the lesion core. Here, we sought to gain insight into the spatial relationship between astrocytes and defined regions of chronic active lesions, and to better understand the environment within the relatively understudied lesion core, an area primarily composed of astrocytes. We analyzed four defined protein panels, focusing on astrocytes, in postmortem fresh-frozen cortical white matter tissue using NanoString GeoMx spatial protein profiling to compare normal appearing white matter (NAWM), the chronic active perilesion, rim, and core. We then performed immunofluorescent microscopy to determine the localization patterns of identified proteins within astrocytes. The most significant differences were observed between the chronic active lesion core and both NAWM and the perilesion. Proteins upregulated in the core relative to NAWM or the perilesion included the MAPK signaling pathway, immune checkpoint proteins, and indicators of phagocytosis. Our data indicate that astrocytes in the lesion core are distinct and actively influence the microenvironment. We posit that the differentially upregulated astrocytic signaling pathways, namely MAPK, immune checkpoints, and debris engulfment, are indicative of reactive astrocytes providing support to demyelinated axons by tempering the inflammatory milieu and clearing debris within the lesion core.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c0a97d1382855a706882af091c7b1299092d9d4a" target='_blank'>
              Spatial protein profiling reveals active roles for astrocytes in the chronic active lesion core during multiple sclerosis
              </a>
            </td>
          <td>
            Brandon C. Smith, Anthony Chomyk, Maria L. Habean, Benjamin C. Shaw, Rachel A. Tinkey, Bruce D. Trapp, Jessica L. Williams
          </td>
          <td>2025-11-01</td>
          <td>Acta Neuropathologica</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Introduction American cutaneous leishmaniasis (ACL) constitutes a neglected skin disease that causes severe disability and significant social stigma for millions of people each year. This parasitic infection is caused by several species of the protozoan Leishmania, including Leishmania amazonensis. There is therefore an urgent need to develop effective new tools to control ACL, primarily due to the limitations of current prophylactic and therapeutic strategies, which are exacerbated by the growing burden of the disease and its social impact. In recent years, scientific research has focused on extracellular vesicles (EVs), which are lipid-enclosed rounded nanostructures that carry macromolecules to recipient cells and are part of eukaryotic biology. The role of Leishmania-derived EVs in host pathogenesis has attracted considerable attention among researchers, with studies suggesting that EVs may play a key role in modulating the host immune response. Therefore, this study examined the immunogenicity and protein cargo of EVs shed by L. amazonensis, exploring their effect on immune activation in the murine macrophages (MΦs) lineage. Methods Nanoparticle tracking analysis, microscopy, proteomic methodologies, colorimetric assays, serological immune methods, PCR, and multiparametric flow cytometry were employed. Results EVs derived from L. amazonensis cultured promastigotes contain key components, such as the 63 kDa surface glycoprotein, intracellular heat shock protein 70, and α-type proteasome subunit, which may be involved in parasite survival. Moreover, EVs are recognized by mouse- and human-specific antibodies, indicating that they have the potential to elicit humoral immune responses and can be inactivated by host-specific antibodies. Depending on the concentration, EVs can drive MΦs to express MHC molecules that are essential for antigen presentation to T lymphocytes, thereby being able to promote a cellular immune response. EVs favor IL-1β+MΦs contraction, and low nitric oxide production, and activate the arginase pathway to produce urea along with the generation of proinflammatory cytokines. This MΦs modulation may support parasite control through the specific activation of T cells while preserving skin homeostasis, thereby reducing the pathology associated with L. amazonensis infection, which causes ACL and leads to the development of chronic disease. Discussion Thus, this study’s findings suggest that although L. amazonensis-derived EVs can trigger MΦs activation, favoring a pro-inflammatory immune response, they also have the potential to ensure parasite survival while limiting host pathogenesis. This can be advantageous for parasite transmission and essential for completing the parasite life cycle.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79f613bb205b5bc2151b97424d0dce4df5f3b5dd" target='_blank'>
              Unleashing the immune modulatory potential of Leishmania amazonensis-derived extracellular vesicles in American cutaneous leishmaniasis
              </a>
            </td>
          <td>
            Bruna Eugênia de Freitas, A. Rodrigues, Joana Palma-Marques, Juliana Inês Weber, A. Valério-Bolas, Rodrigo Pedro Soares, A. Torrecilhas, Micheli Ferla, Munira Muhammad Abdel Baqui, Raul Alexander Gonzales Cordova, G. Alexandre-Pires, I. Pereira da Fonseca, H. M. de Andrade, G. Santos-Gomes
          </td>
          <td>2025-09-22</td>
          <td>Frontiers in Molecular Biosciences</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="

 Despite extensive research, the pathogenesis and predispositions underlying long COVID (long-term coronavirus disease 2019) remain poorly understood.



 To address this, we analyzed the immunological landscapes of 44 patients with long COVID and 44 matched convalescents using single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) and validated the findings with plasma cytokine measurements via Luminex technology.




 While the immune cell compositions showed minimal quantitative differences only among natural killer (NK) cells, the transcriptome analyses identified distinct gene expression patterns, particularly in classical monocytes: patients with long COVID exhibited downregulation of the inflammation-associated genes, including
 IL1B
 and
 CXCL2
 . Imputation of the transcription factor activity hinted at a reduced inflammasome activity (via
 SNAI1
 ) and an impaired monocyte differentiation (via
 ATF2
 ) in long COVID. The RNA velocity data supported the presence of immature classical monocytes in these patients.




 These findings show that monocytes might be dysregulated and/or exhausted in patients with long COVID.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3892a0439deb222191d646b042b2e39ae2bf0fef" target='_blank'>
              Transcriptome analysis of classical blood cells reveals downregulation of pro-inflammatory genes in the classical monocytes of long COVID patients
              </a>
            </td>
          <td>
            Florian Fricke, Franz Mai, Christine Wossidlo, Felix Steinbeck, Wendy Bergmann-Ewert, Marcel Kordt, Karin Kraft, Britta Müller, Emil C. Reisinger, Brigitte Müller-Hilke
          </td>
          <td>2025-11-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="The rapid evolution of SARS-CoV-2 variants, have posed significant public health challenges due to their heightened transmissibility and varying clinical outcomes. While the impact of these variants in humans has been extensively studied, their effect on domestic animals has not been explored thoroughly. Given the close contact between humans and pets, combined with documented cases of virus transmission from humans to domestic animals and the potential for these animals to act as viral reservoirs, highlights the importance of understanding the molecular dynamics of SARS-CoV-2 infection in them. Consequently, there is an increasing demand for infection models that closely mimic viral behavior in animal tissues. In vivo infection of cats or any other non-laboratory animal species is extremely resource intensive, time consuming, require ABSL3 facilities, and animal ethical clearances which are not practically possible for the majority of researchers. In this scenario the ex vivo cultures model can be an excellent alternative. Therefore, in this study, we have utilized an ex vivo lung explant culture model derived from domestic cats to examine the host’s response to Delta and Omicron variants of SARS-CoV-2 in cat lung explant culture. Comprehensive transcriptomic profiling at multiple time points post-infection revealed significant disruptions in genes associated with cell adhesion, structural components, extracellular matrix (ECM) organization and regulation, secreted and growth factors, and immune responses. Our study revealed that the Delta variant triggered early activation of genes associated with tissue damage as early as 12 hours post-infection (hpi). By 24 hpi, both the Delta and Omicron variants showed significant activation of these genes, with the Delta variant linked to the activation of a larger number of tissue damage-related genes. Notably, we identified several hub genes, including MMP9, CCL5, MCP-1/CCL2, VWF, HGF, ANGPT1, CD34, CD68, SPP1, IGF1, CSF1, and VCL, involved in critical signaling pathways such as focal adhesion, PI3K-Akt signaling, and TNF signaling. These hub genes hold potential as valuable biomarkers. This study provides key insights into the pathogenesis of SARS-CoV-2 in cats and highlights the utility of ex vivo lung explant cultures as a platform for studying viral infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/16a62fa43a3e05e7fdf94655592782dee97b8e0c" target='_blank'>
              Comparative temporal transcriptome analyses of SARS-CoV-2 delta and omicron variants ex-vivo infection in cat lung explant culture
              </a>
            </td>
          <td>
            Anuradha Panwar, A. Raut, Sandeep Bhatia, A. Pateriya, Amod Kumar, Richa Sood, Suneela Saran, Prakriti Sehgal, Arya J. Mohan, Akash Zararia, A. Mishra
          </td>
          <td>2025-10-22</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Introduction The transition from inflammation to proliferation is a critical but poorly understood phase in wound healing. To elucidate the cellular and molecular dynamics of this pivotal stage, we performed single-cell RNA sequencing (scRNA-seq) on mouse skin biopsies 4 days after injury. Methods By employing our newly developed R packages, OptiRes for optimized clustering and TidyGenePlot for annotation, we identified 21 distinct cell types. CellChat analysis was used to identify intercellular communication clusters. Findings on chemotactic signaling through CCR5, CCR1, and ACKR1 were validated in vivo, and the functional significance was confirmed by demonstrating that inhibition of CCR pathways reduced phagocyte infiltration. Results Our analysis revealed a dynamic shift in cellular composition, characterized by an influx of neutrophils, classical monocytes, and M1 macrophages. This recruitment of phagocytes was driven by enhanced chemotactic signaling through CCR5, CCR1, and ACKR1. Furthermore, CellChat analysis identified four distinct intercellular communication clusters, highlighting the early activation of VEGF and EGF signaling pathways, which are essential for angiogenesis and re-epithelialization. Discussion Together, these findings provide a high-resolution map of the cellular and molecular landscape during the transition from inflammation to proliferation, offering novel insights into the mechanisms that orchestrate tissue repair and identifying potential intervention manner to enhance wound healing.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dea50aded0034e870eae144612b4869eb621ef6d" target='_blank'>
              Bridging inflammation and proliferation: scRNA-seq analysis of chemotactic and growth factor signaling in mouse skin wound repair
              </a>
            </td>
          <td>
            Lingzhang Meng, Hongmian Li, Jian Song, Wenxian Lin, Xiuli Mao, Xiamin Zhang, Mingyu Yang, Kezhao Wu, Liu Lu, Feiteng Liang, Feng Long, Yueyong Li, Qiang Tang
          </td>
          <td>2025-09-25</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Malaria, an infectious disease caused by Plasmodium, is primarily characterized by anemia and splenomegaly. CD8 ⁺ T cells are known to play a key role in anti-malaria immunity. Lymphocyte Activation Gene 3 (LAG3), a critical immune checkpoint molecule, is pivotal in CD8 ⁺ T cell-mediated anti-tumor responses. However, the role of LAG3 ⁺ CD8 ⁺ T cells in anti-malarial immunity and the regulatory factors governing LAG3 expression in CD8 ⁺ T cells remain unclear. In this study, C57BL/6 mice were subcutaneously infected with Plasmodium yoelii NSM. Splenic lymphocytes were isolated and analyzed using flow cytometry (FACs) and single-cell RNA sequencing (scRNA-seq). Results showed a significant upregulation of LAG3 expression in splenic CD8 ⁺ T cells post-infection. These LAG3 ⁺ CD8 ⁺ T cells displayed enhanced activation, responsiveness, proliferative capacity, and cytokine production. Additionally, activated nuclear factor of activated T cells 1 (NFATc1) was found to co-express with LAG3 in splenic CD8 ⁺ T cells from infected mice. Dual-fluorescence reporter gene assays in 293T cells identified NFATc1 as a key transcription factor that binds to the LAG3 promoter sequence. Knockdown of NFATc1 via small interfering RNA (siRNA) reduced LAG3 expression. In conclusion, our findings suggest that splenic LAG3 ⁺ CD8 ⁺ T cells in Plasmodium yoelii NSM-infected C57BL/6 mice display enhanced functionality and imply that NFATc1 could positively regulate LAG3 expression.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/701cb5eebc64fee04dae0516c62ef93e3f03170b" target='_blank'>
              NFATc1 regulates LAG3+CD8+ T cells in the spleen of mice infected with Plasmodium yoelii NSM
              </a>
            </td>
          <td>
            Xingfei Pan, Feng Mo, Li Pan, Wei Xiao, G. Liang, Xiongyu Xie, Haiwen Yuan, Haixia Wei, Shan Zhao, Lu Li, Lei Jia, Hongyan Xie, Jun Huang
          </td>
          <td>2025-10-01</td>
          <td>PLOS Neglected Tropical Diseases</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a25d1a5423c9c1eef83bca0be3e66901f651d912" target='_blank'>
              Pre-treatment naïve T cells are associated with severe irAE following PD-1/CTLA4 checkpoint blockade for melanoma
              </a>
            </td>
          <td>
            K. Marks, Alice Horisberger, M. Elahee, I. Adejoorin, Nilasha Ghosh, M. Postow, L. Donlin, Anne R. Bass, Deepak A. Rao
          </td>
          <td>2025-10-31</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>93</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/142b5f26c2f76fb27e002bd4d17b50dbd3ea1a15" target='_blank'>
              Structural insights into TLR4 activation by SARS-CoV-2 spike protein: implications for inflammatory response modulation.
              </a>
            </td>
          <td>
            Priya Prakasam, Thripthi Nagesh Shenoy, Abdul Ajees Abdul Salam, Syed Ibrahim Basheer Ahamed
          </td>
          <td>2025-09-13</td>
          <td>Molecular diversity</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1d8a754f463ab7baffd2a9daeb1d70ff841b56ea" target='_blank'>
              Fibroblast orchestration of inflammaging via NF-kB activation
              </a>
            </td>
          <td>
            Nancy C. Allen, Christian Ringler, Jin Young Lee, Nabora S. Reyes, Ritusree Biswas, Sofia E Caryotakis, M. Magnen, Pedro Ruivo, V. Auyeung, M. Looney, Averil Ma, Ari B. Molofsky, Tien Peng
          </td>
          <td>2025-10-01</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9880e0d28a227f3fc76f6d681761463265aed5cb" target='_blank'>
              Effects of different environments and microbial exposures on the adult immune system of the C57BL/6 laboratory mouse strain
              </a>
            </td>
          <td>
            Kabeer Haneef, Meng Xie, Carlos F. Ibáñez
          </td>
          <td>2025-10-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disorder of the central nervous system (CNS). Age is the strongest predictor of disease phenotype, with the majority of older adults transitioning to a progressive form marked by irreversible neurological decline. This clinical progression is associated with smoldering, CNS-compartmentalized inflammation and neurodegeneration, for which there are currently no effective disease-modifying therapies. Cellular senescence, characterized by the secretion of pro-inflammatory mediators collectively known as the senescence-associated secretory phenotype (SASP), increases with age and contributes to tissue injury. In MS, neuroinflammation can further promote cellular senescence, creating a self-reinforcing cycle of damage. Senescent microglia have been identified within MS lesions, where their SASP may impair remyelination and exacerbate neurodegeneration. Senolytic agents selectively target and eliminate senescent cells by disrupting anti-apoptotic pathways. In experimental autoimmune encephalomyelitis (EAE), a widely used model of MS, senolytic treatment reduces senescent microglia burden and attenuates disease severity in an age- and drug-dependent manner. Specifically, here we show that middle-aged mice (40–44 weeks) with EAE exhibit improved clinical outcomes and survival following treatment with either dasatinib plus quercetin (D+Q) or navitoclax. Early-phase clinical trials of senolytics in age-related diseases have demonstrated functional benefits, including improved gait speed in idiopathic pulmonary fibrosis and CNS penetrance in Alzheimer’s disease. Translating senolytic therapy to MS will require careful selection of CNS-penetrant and well-tolerated agents, identification of appropriate patient populations, and deployment of responsive biomarkers. Senolytic therapy represents a promising geroscience-based strategy to meet the urgent therapeutic need in progressive MS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/833c0a2c74e7a7ab280e18c8d71dabfd9c454a2a" target='_blank'>
              Targeting senescent microglia in progressive multiple sclerosis: a geroscience-informed approach
              </a>
            </td>
          <td>
            Jeffrey Atkinson, Amy Dokiburra, Hayley Groover, Jonathan P. Godbout, B. Segal, Yinan Zhang
          </td>
          <td>2025-10-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e074c56d374fdaac1cf557896d7c71f80862340a" target='_blank'>
              Viral infections shape inter-individual immune variability
              </a>
            </td>
          <td>
            Chad Hogan, Zafiirah Baurhoo, Nathália Beller, Ernest Turro, S. Asgari
          </td>
          <td>2025-09-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="COVID-19 research now provides a coherent picture of the virus's immunological impacts, highlighting immune-evasion mechanisms, the particular vulnerabilities of patients with inborn errors of immunity (IEI), and evolving therapeutics for severe disease. SARS-CoV-2 exploits ACE2 for cell entry and can utilise CD147 to infect immune cells, undermining antiviral defences; recent work details cytokine storm biology, NLRP3 inflammasome activation, and suppression of type I interferon responses. IEI patients are disproportionately affected, often with severe, prolonged courses and persistent PCR positivity. Therapeutic approaches such as convalescent plasma, anti-cytokine agents interferon alpha-2b, and plasma exchange show variable effectiveness, while vaccine performance is challenged by ongoing viral evolution. Together, these insights underscore the need for tailored treatment strategies for IEI populations, vigilant monitoring for immune-escape variants, and continuous adaptation of therapeutic and preventive measures. The aim of this review is to synthesise these findings, evaluate their implications for clinical management, and highlight future directions for research and patient care.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1f582b3a29cce6c91c09a0b1c7c85ccffbfc52a0" target='_blank'>
              Lessons From COVID-19 on Inborn Errors of Immunity: A Five-Year Narrative Review.
              </a>
            </td>
          <td>
            Gamze Sonmez, Gizem Gunduz, S. Esenboğa, D. Çağdaş
          </td>
          <td>2025-10-28</td>
          <td>Scandinavian journal of immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Neutrophils are critical first responders of the innate immune system, rapidly recruited to sites of infection or sterile injury. Upon activation by pathogen- or damage-associated molecular patterns, neutrophils initiate antimicrobial responses, including cytokine release, phagocytosis, and the formation of neutrophil extracellular traps (NETs). While NETosis plays a protective role, excessive NET formation can exacerbate inflammation and tissue damage. Pulmonary exposure to ricin, a potent toxin derived from Ricinus communis, results in acute lung injury characterized by neutrophil infiltration, cytokine production, vascular leakage, and pulmonary edema. This study investigated the contribution of NETosis to ricin-induced lung pathology and explored the therapeutic potential of targeting NETosis with a long acting recombinant DNase I (PRX-119) to attenuate lung injury. CD1 outbreed mice were pulmonary exposed to ricin, and bronchoalveolar lavage fluid (BALF) and lung tissues were collected at various time points post-exposure. NETosis was assessed by immunofluorescence and Western blot analysis of markers, including peptidyl arginine deiminase 4 (PAD4), citrullinated histone H3 (citH3) and myeloperoxidase (MPO). Therapeutic intervention included administration of a NET-degrading DNase agent in combination with an anti-ricin antibody. Cell-free DNA levels, NETosis markers, neutrophil infiltration, lung histopathology, vascular permeability and the expression of pro- and anti-inflammatory mediators were evaluated. Weight loss and survival were also monitored and compared between anti-ricin monotherapy and combined anti-ricin and plant-produced human recombinant long acting (LA) DNase I (PRX-119), a novel NET degradation therapy. Ricin exposure led to elevated pulmonary levels of PAD4, citH3 and MPO, accompanied by extensive NET formation in both BALF and lung tissue. Mice receiving combined therapy with a newly developed DNase I - based agent (PRX-119) and an anti-ricin antibody treatment exhibited significantly improved survival and reduced weight loss compared to antibody monotherapy. The combined treatment not only significantly reduced NETosis markers, but also improved lung histopathology, reduced vascular leakage and pulmonary edema and altered the levels of proteins involved with pro- or anti-inflammatory effects, Dkk-1, CD93 and Periostin. These findings demonstrate for the first time that NETosis plays a significant pathological role in ricin-induced lung injury. Moreover, they underscore the therapeutic potential of combining advanced NET-degrading agents, specifically PRX-119, an advanced DNAse I under development, with toxin-neutralizing antibodies as a promising strategy to reduce acute lung damage and enhance clinical outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0a613f3370ffaa897cf377a8fe17b4cbf15502b3" target='_blank'>
              NET degradation attenuates ricin-induced acute lung injury and protects mice from ARDS
              </a>
            </td>
          <td>
            A. Sapoznikov, Y. Evgy, Liat Fux, Ilya Ruderfer, Yakir Nataf, Yael Hayon, Shay Zamin, Roey Mizrachi, Rachel Pessah, Y. Gal, Alon Ben-David, N. Erez, Reut Falach
          </td>
          <td>2025-09-29</td>
          <td>Molecular Medicine</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/662c0a4546b496eb7b71aadd2e98cd82d2407b6f" target='_blank'>
              Endothelial activation and oxidative stress in pulmonary endothelial cells following sever COVID-19.
              </a>
            </td>
          <td>
            Zohreh Arab, S. Rezaee, Fatemeh Sadat Mohammadi, Amir-Hashem Asna-Ashari, Alireza Shariati, M. Mahmoudabady, S. Niazmand
          </td>
          <td>2025-10-05</td>
          <td>Journal of thrombosis and thrombolysis</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has led to a global health crisis by triggering extensive systemic and immune dysregulation. Granulocytes, including neutrophils, eosinophils, and basophils, are critical components of the innate immune system that play dual roles in protection and pathogenesis during infection. In this review, we examine the multifaceted roles of granulocytes in COVID-19 and their impact on disease severity through excessive inflammation, cytokine storm, and tissue damage. Neutrophil extracellular traps (NETs) and the overactivation of neutrophil subtypes contribute to the development of thrombosis and acute respiratory distress syndrome. In contrast, eosinophils and basophils modulate T helper 2-type and allergic responses that may influence recovery or disease progression. We further summarize the therapeutic strategies targeting granulocyte activation and signaling pathways, including IL-1, IL-6, IL-17, IL-5 receptor, granulocyte-macrophage colony-stimulating factor inhibitors, and antihistamines, emphasizing their clinical outcomes, approval status, and the global regions in which they are studied. Understanding the regulatory mechanisms of granulocyte activation and inhibition provides new insights into COVID-19 immunopathology and opens pathways for targeted immunomodulatory therapy. These findings underscore the importance of balancing protective immune functions with controlled anti-inflammatory interventions to mitigate the severe complications of SARS-CoV-2 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c1949f61557e86e96575d6b1c878127a5eaa2ccc" target='_blank'>
              COVID-19: Understanding the Granulocyte Response and Exploring Their Therapeutic Interventions.
              </a>
            </td>
          <td>
            Zahra Farjami, Mina Moradi, Neshat Ebrahimi, Mohammad Mehdi Akbarin
          </td>
          <td>2025-10-31</td>
          <td>Viral immunology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="SARS-CoV-2 infection remains a global health concern, with its impact on host immune responses not fully understood. In a case–control study, we examined how COVID-19 affects DNA methylation patterns in the upper respiratory airway of hospitalized individuals. DNA methylation arrays were performed on nasopharyngeal samples at inclusion/hospitalization and 6 weeks post-inclusion. We found a distinct DNA methylation pattern in COVID-19 patients compared to healthy controls, identifying 510,099 differentially methylated CpGs. Within the transcription start sites (TSSs) and gene body, COVID-19 patients displayed a higher number of genes/CpGs with elevated methylation levels. Enrichment analysis of TSS-methylated genes revealed effects of SARS-CoV-2 on genes associated with type I interferons, anti-viral and inflammatory responses, and immune functions. Some CpG methylations were transient, and normalized at group level by 6 weeks post-inclusion. Several IFN-regulated genes, including OAS1, OAS3, IFIT3, and MX1, were identified. Among the top regulators were IL17A and ERK1/2, both involved in inflammatory processes. Networks nodes included IGF1 and EGF, associated with processes including tissue repair and activation of immune responses. Overall, our data suggests that COVID-19 can impact the upper airway by modifying gene methylation patterns. This could have implications for conditioning of the airways, how individuals respond to future airway infections, and therapeutic interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c17feb2000b785e79540fe240ded0e083db9f8dc" target='_blank'>
              Altered DNA Methylation Pattern Contributes to Differential Epigenetic Immune Signaling in the Upper Respiratory Airway of Unvaccinated COVID-19 Patients
              </a>
            </td>
          <td>
            Melissa Govender, Jyotirmoy Das, Francis R. Hopkins, Cecilia Svanberg, Johan Nordgren, M. Hagbom, Jonas Klingström, Åsa Nilsdotter-Augustinsson, Y. Yong, V. Velu, S. Raju, Johanna Sjöwall, Esaki M. Shankar, Sofi A Nyström, Marie Larsson
          </td>
          <td>2025-10-27</td>
          <td>Cells</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="Parkinson’s disease (PD) is a complex neurodegenerative disorder with growing evidence suggests peripheral immunity plays a role in its pathogenesis. However, the specific peripheral immune cell types and gene expression profiles associated with PD remain unclear. In this study, we integrated single-cell expression quantitative trait loci (sc-eQTL) data from 14 immune cell types in the OneK1K cohort with large-scale genome-wide association study (GWAS) data for PD. Using Mendelian randomization (MR) and Bayesian colocalization analyses, we identified 28 immune-cell-specific eGenes with significant associations to PD risk, among which 24 showed strong or moderate evidence of shared genetic signals. Notable candidates included FDFT1, ARSA, CTSB, and HLA-DQA1, each displaying cell-type-specific associations in CD4+ T cells, CD8+ T cells, B cells, and monocytes. Replication using an independent sc-eQTL dataset from the DICE project confirmed consistent findings for several eGenes. Additional validation through peripheral blood single-cell RNA sequencing (scRNA-seq) revealed distinct expression patterns and significant changes in PD patients. Phenome-wide association studies (PheWAS) showed multiple associations with immune-related traits and minimal associations with unrelated traits, indicating a favorable safety profile for therapeutic targeting. Drug repurposing analysis identified several candidate compounds, including felodipine, amodiaquine, alprazolam, and tetrandrine, some of which are predicted to cross the blood-brain barrier. Molecular docking simulations further supported strong binding interactions between these compounds and PD-associated targets such as CTSB and ARSA. This integrative approach highlights key immune-cell-specific genes involved in PD and proposes several repurposable drugs with central nervous system potential, paving the way for more targeted therapeutic strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ffb980d40fb7d6bac55ca9430e70ad133c3ef67a" target='_blank'>
              Peripheral immune cell-specific genes in Parkinson’s disease uncovered by multi-omics with therapeutic implications
              </a>
            </td>
          <td>
            Yanggang Hong, Jingxuan Zhou, Yirong Wang, Sihan Song, Han Chen, Yuze Mi, Xiucui Li
          </td>
          <td>2025-10-21</td>
          <td>NPJ Parkinson's Disease</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Sepsis is a life-threatening disease characterized by a dysregulated immune response, and neutrophils serve an important role in pathogen clearance, multiple organ failure and immune regulation. With the discovery of multiple phenotypical and functional variants of neutrophils in sepsis, the heterogeneity of neutrophils is crucial, as it impacts the effectiveness of the immune response and the overall outcome of sepsis. Various genome, transcriptome, proteome and metabolome properties may contribute to this heterogeneity. Multi-omics approaches unveil complex details of neutrophil behavior in the context of sepsis, highlighting how neutrophil phenotypes are differentially recruited and activated in response to various stimuli. The present review aimed to provide an overview of the differences in neutrophil phenotypes and functions during sepsis, focusing on neutrophil heterogeneity identified via multi-omics methods. Comprehensive understanding of multi-omics data regarding neutrophil heterogeneity enhances the diagnostic accuracy of sepsis and provides a scientific basis for individualized treatment strategies, potentially improving patient outcomes by targeting specific neutrophil functions and states.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6398a46a0b1e9cb56ac0fcca17bb6c1b512a1b39" target='_blank'>
              Multi-omics reveal neutrophil heterogeneity in sepsis (Review)
              </a>
            </td>
          <td>
            Zhiqiang Lin, Deng Chen, Peidong Zhang, Jialiu Luo, Shunyao Chen, Shuaipeng Gu, Yu-Jie Chen, You-Xie Shen, Tingxuan Tang, Teding Chang, , Cong Zhang, Zhao-Hui Tang
          </td>
          <td>2025-10-14</td>
          <td>International Journal of Molecular Medicine</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Significance We identify goblet cells as regulators of viral infections at mucosal surfaces. Goblet cell-derived mucus effectively shields nasal and intestinal epithelia from swine influenza virus (SIV) and porcine epidemic diarrhea virus (PEDV), with virus-driven modulation of mucus secretion determining infection containment or dissemination. Remarkably, PEDV not only suppresses mucus secretion but also rapidly induces goblet cell-associated antigen passages (GAPs) through an acetylcholine–cholinergic receptor muscarinic 3 neuro-epithelial axis. GAPs enable luminal bacteria to cross the intact epithelial barrier during the initial infection phase, triggering an acute inflammatory cascade that significantly exacerbates mucosal damage. Our findings reveal goblet cells and their neuronal signaling circuits as key determinants of viral mucosal pathogenesis and promising targets for developing broad-spectrum antiviral interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/890992aa0c43464d9330c6c8d499c8354fe42288" target='_blank'>
              Goblet cells dictate viral tropism and pathogenesis in nasal and intestinal mucosae
              </a>
            </td>
          <td>
            Wenqian Wang, Wenwen Chao, Hui Zeng, Rongfeng Tang, Ruiling Liu, Chengcheng Wang, Xuan Wu, Jiaxin Qi, Yunlei Cao, Yuchen Li, Qian Yang
          </td>
          <td>2025-10-08</td>
          <td>Proceedings of the National Academy of Sciences of the United States of America</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="In response to an infection, the host T cell compartment develops immunological memory to ensure rapid responses upon re-infection with the same pathogen. However, these memory responses can also modulate immune reactions to unrelated pathogens through bystander activation. Herein, T cells are activated in an antigen-independent manner, often triggered by innate cytokines or Toll-like receptor ligands. To uncover new strategies for modulating immune responses, it is essential to deepen our understanding of this alternative mechanism of T cell activation, particularly in humans. Therefore, we studied the response of human CD8+ T cells to innate bystander stimuli in vitro. Thereby, we measured the induction of activation markers and proliferation using flow cytometry, and depleted or blocked several potential modulatory components to identify mediators of bystander CD8+ T-cell responses. Our study demonstrates that CD8+ T cells can be activated as bystander cells in response to innate stimuli present during a viral infection, including IL-15, IFN-α, and TLR7/8 and 9 agonists (R848 and CpG). Depletion experiments demonstrated that these bystander responses are dependent on monocytes and CD4+ T cells. In addition, we revealed that the bystander responses to the innate stimuli are highly reliant on IL-2 signaling. Altogether, our study underscores the pivotal role of IL-2 in mediating bystander responses of CD8+ T cells to innate stimuli, revealing a novel mechanism of immune response modulation during viral infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fc56083194a00b756c976473122860d219d86c29" target='_blank'>
              IL-2 mediates human bystander CD8+ T-cell responses to innate immune signals.
              </a>
            </td>
          <td>
            Tamara Johanna Cornelia Schenk, Martijn Vos, Yannick van Sleen, Jeroen Hoeboer, Debbie van Baarle, T. Guichelaar
          </td>
          <td>2025-09-22</td>
          <td>Journal of immunology</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b5151f90f811e456ad4218b04e57c27b24b53bb8" target='_blank'>
              Glucose-Fueled Histone Modifications Drive HIV-1 Latency Reversal at Hypoxia
              </a>
            </td>
          <td>
            Yetunde I Kayode, Deanna C. Clemmer, A. A. Owolabi, Abdulkareem A Alshaheeb, E. K. McMahon, Anna Tangiyan, Lauren Clark, Glenn E Simmons, Alberto Bosque, Melanie R. McReynolds, Harry E. Taylor
          </td>
          <td>2025-09-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="
 A
 BSTRACT



 The mortality of COVID-19 is largely the result of cellular injury and inflammation of pulmonary and nonpulmonary vital tissue after severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infection. Evidence has accumulated that this inflammation is associated with multiple cytokine overexpression, named Cytokine Storm Syndrome (CSS) or Cytokine Release Syndrome (CRS). The commonly used techniques to predict CSS/CRS and thereby severe COVID-19 are dependent on costly instrumentation and consumables, and frequent calibration and costly controls on a regular basis.



 We determined the specific cytokine gene (IL-1β, IL-6, IL-2, TGFβ, and IFN-γ) expression levels as a biomarker early in the disease process (Day-5) for severe disease using multiplex qRTPCR technique using real-time thermo-cyclers which are now available in all peripheral centers. Day-5 quantitative biomarker (C-Reactive Protein, IL-6, Ferritin, and D-Dimer) and day-7 IgG anti-SARS-CoV-2 levels were determined through the routine autoanalyzers and immune assays. We evaluated whether each of these specific biomarkers with age, gender, comorbidities, and severity can aid early detection of severity.




 The present research identifies age > 65 years, presence of diabetes mellitus, hypertension or multimorbidity and lack of COVID-19 vaccination, and D-Dimer levels at Day-5 to be associated significantly (
 P
 value < 0.05) with severe COVID-19 infection. Crucially, Day-5 gene expression levels of IL-2, IL-6, and IFN-γ were inversely associated with COVID-19 severity and significantly lower (
 P
 < 0.05) in those with severe COVID-19 vis. healthy controls.




 We propose IL-2, IL-6, and IFN-γ gene expression study through a multiplex qRTPCR assay and the D-dimer test as rapid tools to triage COVID-19 patients during management and identify need for escalating therapy.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7f5886606e5602e6e19694b99d3ff1ed2cbe4e18" target='_blank'>
              Early detection of cytokine storm and IgG levels to predict and prevent severe COVID-19 infection
              </a>
            </td>
          <td>
            Pramathadhip Paul, T. K. Mandal, Purba Mukherjee, Indranil Thakur, Rajsekhar Maiti, Sujit Kumar Bhattacharyya, Piyali Haldar, Subhenjit Ray, R. R. Ghosh, Ramaprasad Roy, Utpal Dan, S. Chatterjee
          </td>
          <td>2025-10-01</td>
          <td>Journal of Family Medicine and Primary Care</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c18b6c3d94e0b245a2073ceeb35d02bd592fc6fc" target='_blank'>
              The compounding roles of gut-immune-brain axis and COVID19 in manifestation of idiopathic Parkinson’s disease
              </a>
            </td>
          <td>
            Ankita Das, Vani Vivek, P. Aich
          </td>
          <td>2025-11-08</td>
          <td>Discover Immunity</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Traumatic brain injury (TBI) initiates a prolonged and complex immune response that critically shapes both secondary injury and long-term recovery. Among adaptive immune cells, CD4⁺ T cells have emerged as central regulators of neuroinflammatory processes, acting as a double-edged sword that can be either neuroprotective or neurotoxic. This review focuses on the roles of major CD4⁺ T cell subsets-Th1, Th2, Th17, and Tregs-in modulating the immune landscape following TBI, with an emphasis on their temporal dynamics, phenotypic plasticity, and therapeutic potential. We examine how blood-brain barrier disruption and innate immune activation facilitate T cell infiltration into the central nervous system, and outline the cytokine networks and signaling pathways that orchestrate CD4⁺ T cell differentiation and functional polarization. Advances in single-cell RNA sequencing (scRNA-seq) have provided new insights into the transcriptional heterogeneity of CD4⁺ T cells post-TBI, offering novel angles for therapeutic targeting. In addition, we assess current strategies for targeting CD4⁺ T cells therapeutically and examine translational challenges, particularly the translational gap between animal models and human disease. To provide a focused synthesis, this review does not delve into all immune cell types or other aspects of neuroinflammation that may also play significant roles in TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5bb08683dbcd2c252e04f0b54a89e13ce83a8999" target='_blank'>
              The immunological paradox of CD4⁺ T cells in traumatic brain injury (Review Article).
              </a>
            </td>
          <td>
            Qian Zhao, Bo-Ao Chen, Wen-Qing Ai, Nadezhda Brazhe, Dan Liu, Ling-Qiang Zhu, Ming Wen
          </td>
          <td>2025-10-15</td>
          <td>International journal of surgery</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Dengue virus (DENV) is a major arthropod‐borne pathogen, endemic in over 100 countries and posing global health challenges. While innate immune responses and viral evasion mechanisms have been extensively studied in animal models and mononuclear cells, severe dengue can affect multiple tissues, including the central nervous system (CNS), leading to neurological manifestations. However, the CNS immune response remains poorly understood. This study analyzed molecules linked to innate immunity in CNS lesions from fatal dengue cases. Histopathological examination of the cerebral cortex revealed marked neuronal damage—chromatolysis, pyknotic nuclei—accompanied by microglial hyperplasia, white matter demyelination, perivascular inflammation, vascular congestion, vasogenic edema, and occasional hemorrhage or meningitis. DENV antigen was detected in endothelial cells of cortical and leptomeningeal vessels and in glial cells or macrophages. Immunohistochemistry revealed altered expression of innate immune markers: RIG‐I was sparsely expressed, STING was absent, and IFN‐α/β levels were reduced compared to controls. Notably, IRF2 expression was markedly elevated, with strong labeling in neurons, glial, and endothelial cells. These findings suggest an atypical pattern of immune activation in the CNS during severe dengue and highlight a potential role for IRF2 in modulating cerebral immune responses, offering new insights into the neuropathogenesis of dengue.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b8f7f91bd3195b66fc9031dd8d09c37a3bc65daf" target='_blank'>
              Histopathological Alterations and Dysregulation of Type I Interferon Signaling in the Human Cerebral Cortex During Severe Dengue
              </a>
            </td>
          <td>
            Leandro Mantovani de Castro, E. R. Fernandes, J. Quaresma, Carmen Lucia Penteado Lancelotti, Maria Irma Seixas Duarte, L.V. Carvalho, R. Penny, P.F.C. Vasconcelos, Evandro Sobroza de Mello, M. Sotto, C. Pagliari
          </td>
          <td>2025-10-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/618bcfb789463c1d6cd34f9be203229ced80b89b" target='_blank'>
              Multi-omic profiling reveals age-related immune dynamics in healthy adults.
              </a>
            </td>
          <td>
            Qiuyu Gong, Mehul Sharma, Marla C. Glass, Emma L. Kuan, Aishwarya Chander, Mansi Singh, Lucas T. Graybuck, Z. Thomson, Christian M. LaFrance, S. Rachid Zaim, Tao Peng, L. Okada, P. Genge, Kathy Henderson, Elisabeth M. Dornisch, Erik D Layton, Peter J. Wittig, A. Heubeck, Nelson M. Mukuka, Julian Reading, Garrett Strawn, Teminijesu Titus-Adewunmi, Kathleen Abadie, Charles R. Roll, Veronica Hernandez, Vaishnavi Parthasarathy, Tyanna J. Stuckey, B. Musgrove, Elliott G. Swanson, Cara Lord, M. Weiss, C. Phalen, Regina R Mettey, Kevin J. Lee, John B. Johanneson, Erin K. Kawelo, Jessica Garber, Upaasana Krishnan, Megan E. Smithmyer, E. Wherry, L. Vella, S. E. Henrickson, Mackenzie S. Kopp, Adam K. Savage, Lynne A. Becker, Paul Meijer, E. Coffey, Jörg J. Goronzy, Mikael Sigvardsson, Cate Speake, Thomas F. Bumol, Ananda W. Goldrath, Troy R. Torgerson, Xiao-jun Li, Peter J. Skene, J. Buckner, Claire E. Gustafson
          </td>
          <td>2025-10-29</td>
          <td>Nature</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="ABSTRACT Aspergillus fumigatus is a ubiquitous mold that is the primary etiological agent of invasive pulmonary aspergillosis (IPA), a severe lung infection in immunocompromised patients with extreme mortality. Innate immunity is critical for controlling the severity of IPA. Regarding dendritic cells (DCs), studies have shown protective roles for monocyte-derived DCs and plasmacytoid DCs during IPA. Here, we examined the role of type 1 conventional dendritic cells (cDC1s) during A. fumigatus lung infection. We first show that global depletion of DCs resulted in impaired lung clearance of A. fumigatus, indicating a protective role for DCs, as expected. Unexpectedly, however, mice lacking cDC1s (Batf3−/−) cleared A. fumigatus more efficiently than wild-type C57BL/6 control mice. Enhanced fungal clearance was also observed in two additional cDC1-deficient strains, Cd11cCre/Irf8flox/flox mice and interferon regulatory factor 8 +32−/− mice. Batf3−/− mice displayed an enhanced type 17 immune response, which we have shown to be required for optimal immunity during IPA. Moreover, elevated type 17 responses correlated with differential production of IL-33 (decreased in Batf3−/−) and PGE2 (increased in Batf3−/−), an axis we have reported to promote type 17 responses during IPA. We further show that alveolar macrophages from Batf3−/− mice had increased fungicidal activity against A. fumigatus. In contrast, alveolar macrophages cultured in the presence of bone marrow-derived cDC1s had lower fungicidal activity compared to alveolar macrophages cultured alone, suggesting that cDC1s restrict alveolar macrophage function. Taken together, our data identify cDC1s as a regulator of innate immune responsiveness during IPA. IMPORTANCE Fungal infections have increased at an alarming rate as a result of increased usage of immunosuppressive therapies, growing resistance to antifungal drugs, and global warming. This recently prompted the World Health Organization to publish the first-ever fungal priority pathogens list, which focused on 19 organisms, ultimately deeming 4 pathogens of critical importance based on perceived public health importance. Among these four was the opportunistic mold Aspergillus fumigatus, the etiological agent of the most lethal fungal infection known to humans, IPA. Innate immunity is paramount for controlling IPA with protective roles identified for multiple myeloid cell types. In the current report, employing three complementary animal models, we show that cDC1s hinder the clearance of A. fumigatus from the lung. We further identified specific responses that are regulated by cDC1s. Overall, our study uncovers a new mechanism of immune regulation during IPA. Fungal infections have increased at an alarming rate as a result of increased usage of immunosuppressive therapies, growing resistance to antifungal drugs, and global warming. This recently prompted the World Health Organization to publish the first-ever fungal priority pathogens list, which focused on 19 organisms, ultimately deeming 4 pathogens of critical importance based on perceived public health importance. Among these four was the opportunistic mold Aspergillus fumigatus, the etiological agent of the most lethal fungal infection known to humans, IPA. Innate immunity is paramount for controlling IPA with protective roles identified for multiple myeloid cell types. In the current report, employing three complementary animal models, we show that cDC1s hinder the clearance of A. fumigatus from the lung. We further identified specific responses that are regulated by cDC1s. Overall, our study uncovers a new mechanism of immune regulation during IPA.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7c0baae0af80578fd5fc6eaefbb302ebe396da22" target='_blank'>
              Type 1 conventional dendritic cells regulate innate immunity during fungal pneumonia
              </a>
            </td>
          <td>
            Pari M Dhruva, Thomas E Draper, Camille A Chiller, MaryJane Jones, Chad Steele
          </td>
          <td>2025-09-22</td>
          <td>mBio</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Chlamydia invades multiple mucosal tissues in humans and animals. The body’s first line of defense against chlamydial infection is provided by innate immunity, whereas adaptive immunity plays a crucial role in managing the infection’s progression and preparing the immune system to combat reinfection. Host resistance to chlamydial infection necessitates a coordinated effort between innate and adaptive immune cells. Numerous cell types are capable of producing interferon gamma (IFN-γ) as a defense mechanism against chlamydial infection, thereby effectively mediating the clearance of infection. However, the distinct roles of various immune cell populations in responding to chlamydial infection, as well as their functions during infection progression, remain poorly understood. Therefore, we will discuss the various roles of IFN-γ released by different immune cells in chlamydial infection, focusing primarily on experimental animal models and a review of available data from in vivo cellular immunological studies in humans.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7c375743e3715f5e17dc641ecdc55eebdf06385f" target='_blank'>
              Role of IFN-γ from Different Immune Cells in Chlamydia Infection
              </a>
            </td>
          <td>
            Xuan Chen, Wenjing Yang, Yuchen Hu, Yang Zhou, Zhou Zhou
          </td>
          <td>2025-10-01</td>
          <td>Microorganisms</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Background Chronic obstructive pulmonary disease (COPD) is a significant global health concern, marked by persistent inflammation and immune dysregulation. Although it is widespread and has substantial clinical implications, the systemic immune mechanisms driving disease progression are not fully understood. Since blood contains a diverse array of immune cells and offers a non-invasive means of assessing immune homeostasis and overall physiological status, investigating immune dysregulation through blood sampling offers considerable value for both basic research and clinical application. This approach can provide novel insights into the pathogenesis of COPD. Methods This study employed high-dimensional flow cytometry and RNA sequencing to comprehensively characterize peripheral immune cells from a cohort of 69 COPD patients spanning clinical stages 1 to 4, alongside 41 healthy donors as controls. To capture granulocyte populations typically excluded from peripheral blood mononuclear cell analyses, fresh whole blood samples were analyzed directly. Results Our study revealed a marked shift in the myeloid-lymphoid balance, characterized by elevated neutrophils, eosinophils, and classical monocytes that correlated with disease severity, alongside reduced CD8+ T cells and circulating T follicular helper cells. Transcriptional profiling identified oxidative stress pathways, T cell suppression, and aberrant natural killer (NK) cell activation as hallmarks of advanced COPD. Notably, activated Nkp44+ NK cells were significantly enriched in severe stages, implicating their role in perpetuating inflammation. Smoking exacerbated immune perturbations, including upregulated complement activation and B cell pathways, though cessation partially restored transcriptional homeostasis. Conclusions This study underscores the value of peripheral immune profiling in capturing the heterogeneity of COPD. The results reveal systemic immune dysregulation-especially NK cell hyperactivity and point to potential therapeutic avenues aimed at modulating immune responses to slow disease progression.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aae7cb72f1629c9d76e999fa034c112ee9f0561d" target='_blank'>
              Dysregulated NK cell activation and myeloid-lymphoid imbalance underpin COPD progression: insights from high-dimensional immune profiling and smoking-induced immune remodeling
              </a>
            </td>
          <td>
            Qin Qiao, Yazheng Yang, Ke Huang, H. Niu, X. Ren, Shiwei Qumu, Wei Li, Chen Dong, Ting Yang, Ling Ni
          </td>
          <td>2025-09-19</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Human spaceflight imposes unique physiological stressors that disrupt immune homeostasis, yet the molecular mechanisms underlying postflight immune dysfunction remain poorly understood. Here, we present an integrative, multi-omic secondary analysis of peripheral blood mononuclear cells (PBMCs) from the Inspiration4 mission [28] using publicly available data from NASA’s Open Scenc Data Repository (OSDR), integrating single-nucleus RNA sequencing (snRNA-seq), single-nucleus ATAC sequencing (snATAC-seq), and plasma proteomics. We identify broad transcriptional suppression of key antigen presentation genes—including HLA-A, HLA-B, HLA-C, and CD74—across multiple immune cell types postflight, with HLA-C showing the strongest reduction (log₂FC = –1.7, p < 0.01) in CD16⁺ monocytes. Concordant chromatin accessibility changes were observed in genes such as PDK4, CD86, and NR3C1, indicating epigenetic regulation of metabolic and immunomodulatory programs. Integration of matched snRNA-seq and snATAC-seq data revealed gene-specific coherence in transcriptional and epigenetic responses, particularly in monocytes. Proteomic validation using serum cytokine measurements from the NASA LSDS-8 Alamar panel confirmed statistically significant declines in circulating TGFB1 and CXCL2 (2.8% and 2.3% respectively, p < 0.05), aligning with transcriptional trends. Functional enrichment analysis highlighted postflight repression of interferon signaling, antigen processing, and glucocorticoid-responsive pathways. Given the small sample size (n=4), these findings should be considered preliminary but provide important proof-of-concept evidence for multi-layered immune suppression following spaceflight. Together, these findings delineate a multi-layered signature of immune suppression following spaceflight and establish a framework for cell-type–resolved, cross-platform immunomonitoring in future human missions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1ea0b8f403829875257bb6e7a8243dfba40fa578" target='_blank'>
              Multi-omics profiling reveals immune suppression and antigen presentation deficits following human spaceflight
              </a>
            </td>
          <td>
            Linda Dianling Zhao
          </td>
          <td>2025-10-31</td>
          <td>World Journal of Biology Pharmacy and Health Sciences</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="COVID-19 has caused more than 7 million deaths worldwide, and according to the World Health Organization, it continues to result in more than 1000 reported deaths per month at the time of this writing. It is crucial to understand the immune response to COVID-19 since the virus continues to persist. Natural killer (NK) cells play a critical role in the immune defense against viral infections, including COVID-19. While it is well documented that infected patients have a reduction in lymphocytes and NK cells, gaps in knowledge exist regarding the function of NK cells. To study the function of NK cells in patients hospitalized with COVID-19, peripheral blood was obtained from patients admitted to the medical (non-ICU) wards at a large tertiary hospital. We demonstrated a decrease in the mature cytotoxic subset of NK cells within the peripheral blood of patients hospitalized with COVID-19. We also observed a notable reduction in the cytotoxic function of NK cells against tumor targets. We examined the mechanisms leading to NK cell killing. We found reductions in the intracellular levels of effector molecules, the degranulation of cytotoxic granules, and the extracellular concentrations of released effector molecules. We identified dysfunctional intracellular granule trafficking required to position the granules for degranulation, which would be consistent with the reduced release of effector molecules. We found clusters of inhibitory receptors were upregulated in subsets of NK cells, in keeping with inhibition of cytotoxicity. Additionally, males with COVID-19 showed NK cell defects compared to healthy males, while no significant differences were observed in females. Our findings highlight defects in cytolytic effector molecules, granule trafficking and release, and increased expression of inhibitory receptors on NK cells in patients hospitalized with COVID-19, in addition to a sex difference in cytolytic function, which contributes to defective NK cell function in COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/01cdfabb81491ce2cba0ee7f56a0d8dd7e9e7d8a" target='_blank'>
              The effect of COVID-19 and sex differences on natural killer cell cytotoxicity
              </a>
            </td>
          <td>
            Arushi Dagar, Maria J Polyak, Adley C. H. Mok, David D Feehan, Michael Potemkin, Alain Tremblay, Christopher H. Mody
          </td>
          <td>2025-09-22</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Background People living with HIV are called immunological non-responders (INR) when their CD4+ T cell count is not restored to immunocompetent levels, despite successful viral suppression. INR have increased risk of progression to AIDS, non-AIDS related morbidity, and death. Impaired mucosal barrier function is a prevailing hypothesis for why INR among people with HIV (PWH) have persistently low CD4+ T cell counts. Objective To understand the molecular mechanisms behind incomplete immune recovery in INR, we analyzed gene regulation and protein expression in gut tissues from INR, immunological responders (IR) and healthy controls (HC). Methods The transcriptome was assessed by RNA-sequencing (RNA-seq) and the proteome was examined using shotgun proteomic mass spectrometry in mucosal biopsies from the sigmoid colon and terminal ileum. Results In INR compared to IR, we identified 3326 differentially expressed genes (DEGs) in the colon while no DEGs were observed in the ileum. Gene ontology (GO) analyses revealed that the DEGs in colon of INR, compared to IR, predominantly involved pathways related to immune response, metabolism, and cellular processes. Notably, GO analysis highlighted downregulation of genes associated with B cell-mediated immunity and adaptive responses in INR. Deconvolution analysis indicated that these transcriptomic changes were not solely due to shifts in immune cell composition. Proteomic analysis supported these findings, showing more differential protein composition between INR and IR in colon than ileum. These proteins are associated with the regulation of adaptive immune signaling and essential cellular processes, including cell signaling, tissue repair, and growth, all of which are characteristic features of inflammatory bowel disease (IBD). Conclusion Our findings suggest that incomplete immune recovery during anti-retroviral therapy in PWH is associated with specific dysregulations in the molecular environment of the sigmoid colon, which may share mechanisms with IBD. The identified macromolecules may serve as potential targets for adjuvant treatment to improve the prognosis for INR.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2c7973b900544867274ca44e59969cd94c404f9e" target='_blank'>
              Transcriptomic and proteomic profiling reveal immune and metabolic dysregulation in the colonic mucosa of people living with HIV with incomplete immune recovery
              </a>
            </td>
          <td>
            Mari Kaarbø, Mingyi Yang, Malin Holm Meyer‐Myklestad, Arvind Y M Sundaram, Mirta Mittelstedt Leal de Sousa, Animesh Sharma, A. Medhus, A. M. Dyrhol-Riise, Dag Kvale, J. R. Hov, Pål Aukrust, Magnar Bjørås, D. Reikvam
          </td>
          <td>2025-09-17</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/70fa034fca62c62c38080521a78183435f3c45dc" target='_blank'>
              IFNAR1⁺ Neutrophils Orchestrate Chronic Inflammatory Damage Through Mitochondrial Remodeling
              </a>
            </td>
          <td>
            Cecilia Pessoa Rodrigues, Raquel R. Calçada, Mafalda Arnaud, Lukas Kaltenbach, Mika Manser, Anja Scheidegger, Leon Sidney Strauss, Alina Gavrilov, Sharang Kulkarni, Ece Yildiz, Daniela Liberati, Mairene Coto-Llerena, Tamara Hoening, Markus Martin Kramberg, Julian Behr, Anna Mechling, Marvin Hering, Kara G. Lassen, Oliver Soehnlein, Emma Doran, Daniel Regan-Komito
          </td>
          <td>2025-09-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/695c274c959b0fd1b92ee86ff6aa4f6baf9e49bd" target='_blank'>
              A multicenter spatial transcriptomics atlas of human tuberculosis and non-tuberculous mycobacterial disease
              </a>
            </td>
          <td>
            Xun Jiang, Leonard Christian, Yuesi Xi, Liang Zhou, Ahmed Alaswad, Xiaoyi Zheng, N. V. Unen, L. Neubert, Jana Dietrich, Jan C. Kamp, Moritz Kayser, Mark Kühnel, J. Hohlfeld, Hortense Slevogt, Marius M. Hoeper, N. Kaminski, Tobias Welte, Jan Fuge, Felix C. Ringshausen, R. Homer, D.D. Jonigk, Chengbin Xu, Jonas C. Schupp, Yang Li
          </td>
          <td>2025-10-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="ABSTRACT Studies have shown that 129 mice generate more severe inflammatory responses than C57BL/6 (B6) mice shortly after influenza virus infection. However, the mechanisms for regulation of the magnitudes and kinetics of innate immune responses in different hosts remain to be fully understood. In this study, we found that cysteine sulfinic acid decarboxylase (CSAD), an essential enzyme in the taurine synthesis pathway, inhibits excessive inflammation after viral infection. CSAD KO mice in B6 background initiate stronger inflammatory responses and are more vulnerable to viral infections, exhibiting a phenotype resembling 129 mice. Interestingly, CSAD is differentially expressed in 129 and B6 mice; CSAD is highly expressed in B6 mice than in 129 mice. CSAD inhibits the NF-κB signaling pathway during various virus infections and stimulations. CSAD directly interacts with IKKα at the kinase domain, thus limiting the fast and strong phosphorylation of IKKα and then the downstream signaling pathway. Therefore, CSAD is a novel regulator to fine-tune the intensity of the NF-κB signaling pathway. IMPORTANCE The mechanisms by which host factors regulate the intensity of innate immune responses are important because excessive inflammatory response can be harmful to the host. CSAD, an enzyme in the taurine synthesis pathway, inhibits excessive inflammatory responses after viral infection or stimulation by interacting with IKKα of the NF-κB signaling pathway, thus limiting the downstream activation of signaling and reducing the cytokine and chemokine gene expression. Our studies reveal for the first time that CSAD plays an important role in regulating innate immune responses, adding novel regulators to the complex networks of the NF-κB signaling pathway. Furthermore, our results also help us further understand the variations in the innate immune responses among individuals and provide a novel perspective for the development of new drugs or therapies for infectious diseases. The mechanisms by which host factors regulate the intensity of innate immune responses are important because excessive inflammatory response can be harmful to the host. CSAD, an enzyme in the taurine synthesis pathway, inhibits excessive inflammatory responses after viral infection or stimulation by interacting with IKKα of the NF-κB signaling pathway, thus limiting the downstream activation of signaling and reducing the cytokine and chemokine gene expression. Our studies reveal for the first time that CSAD plays an important role in regulating innate immune responses, adding novel regulators to the complex networks of the NF-κB signaling pathway. Furthermore, our results also help us further understand the variations in the innate immune responses among individuals and provide a novel perspective for the development of new drugs or therapies for infectious diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f1feec513b6404942fec04ebf8bb949f8b0d7fde" target='_blank'>
              CSAD inhibits excessive inflammation during viral infections through the NF-κB signaling pathway
              </a>
            </td>
          <td>
            Yufan Zhang, Xiaotian Yang, Yun Chen, Junnan Shi, Kai Zhou, Li Zhu, Jing Wang, Wei Jiang, Dahui Zhao, Lipeng Gan, Sanguo Ren, Min Fang
          </td>
          <td>2025-09-15</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Toll-like receptor 7 (TLR7) is crucial for recognizing single-stranded viral RNA and initiating type I interferon signalling, which initiates antiviral immune responses. DNA methylation and other epigenetic controls may affect TLR7 expression and play a role in immune dysregulation in post-COVID syndrome. Objectives: To assess the association between immune dysregulation in people with post-COVID syndrome and epigenetic regulation of the TLR7 gene, specifically DNA methylation patterns. Methods: Patients with post-COVID-19 symptoms (≥12 weeks’ post-infection) and age- and sex-matched recovered controls participated in a case-control study. The purpose of peripheral blood mononuclear cells (PBMCs) was to use bisulfite pyrosequencing to analyze the DNA methylation of TLR7 promoter CpG sites, to use qRT-PCR to quantify TLR7 mRNA, and to use flow cytometry to immunophenotype immune cell subsets and type I interferon (IFN-α) production. Analysis was done on statistical relationships among immune parameters, gene expression, and methylation status. Results: In comparison to controls, post-COVID patients showed notable changes in TLR7 promoter methylation patterns, with site-specific hypo- and hyper-methylation associated with corresponding changes in TLR7 expression. Anomalies in B-cell and plasmacytoid dendritic cell (pDC) profiles and dysregulated IFN-α levels were linked to aberrant expression, suggesting persistent innate immune activation. Conclusions: TLR7 epigenetic changes could be a factor in post-COVID-19 persistent immunological dysregulation. These results emphasize TLR7 methylation as a possible therapeutic target and biomarker. To confirm these correlations, more long-term research is needed.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9614460bd9b458a97ea3bceb49565b7aab8a8dcb" target='_blank'>
              Epigenetic Regulation of the TLR7 Gene and Its Correlation with Immune Dysregulation in Post-COVID Syndrome
              </a>
            </td>
          <td>
            Beenish Khalid, Saeeda Baig, Aliya Jafri, G. Farrukh, Sobia Khan Nabeel, Hina Faisal
          </td>
          <td>2025-09-30</td>
          <td>Pakistan Journal of Health Sciences</td>
          <td>0</td>
          <td>1</td>
        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

</body>

<script>

  function create_author_list(author_list) {
    let td_author_element = document.getElementById();
    for (let i = 0; i < author_list.length; i++) {
          // tdElements[i].innerHTML = greet(tdElements[i].innerHTML);
          alert (author_list[i]);
      }
  }

  var trace1 = {
    x: ['2024', '2025'],
    y: [2, 7],
    name: 'Num of citations',
    yaxis: 'y1',
    type: 'scatter'
  };

  var data = [trace1];

  var layout = {
    yaxis: {
      title: 'Num of citations',
      }
  };
  Plotly.newPlot('myDiv1', data, layout);
</script>
<script>
var dataTableOptions = {
        initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;

                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);

                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';

                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    scrollX: true,
    scrollCollapse: true,
    paging: true,
    fixedColumns: true,
    columnDefs: [
        {"className": "dt-center", "targets": "_all"},
        // set width for both columns 0 and 1 as 25%
        { width: '7%', targets: 0 },
        { width: '30%', targets: 1 },
        { width: '25%', targets: 2 },
        { width: '15%', targets: 4 }

      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  }
  new DataTable('#table1', dataTableOptions);
  new DataTable('#table2', dataTableOptions);

  var table1 = $('#table1').DataTable();
  $('#table1 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table1.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
    }
  });
  var table2 = $('#table2').DataTable();
  $('#table2 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table2.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
    }
  });
</script>
<style>
  .child-row-content {
    text-align: justify;
    text-justify: inter-word;
    word-wrap: break-word; /* Ensure long words are broken */
    white-space: normal; /* Ensure text wraps to the next line */
    max-width: 100%; /* Ensure content does not exceed the table width */
    padding: 10px; /* Optional: add some padding for better readability */
    /* font size */
    font-size: small;
  }
</style>
</html>







  
  




  



                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12Z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "..", "features": ["navigation.top", "navigation.tabs"], "search": "../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    

      <script src="../assets/javascripts/bundle.c8d2eff1.min.js"></script>
      
    
<script>
  // Execute intro.js when a button with id 'intro' is clicked
  function startIntro(){
      introJs().setOptions({
          tooltipClass: 'customTooltip'
      }).start();
  }
</script>
<script>
  

  // new DataTable('#table1', {
  //   order: [[5, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });

  // new DataTable('#table2', {
  //   order: [[3, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });
  new DataTable('#table3', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
  new DataTable('#table4', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
</script>


  </body>
</html>